Abbo L, Quartin A, Morris MI, et al. Pulmonary imaging of pandemic influenza H1N1 infection: relationship between clinical presentation and disease burden on chest radiography and CT. Br J Radiol 2010 Aug;83(992):645-51 [Abstract]
Abed Y, Pizzorno A, Hamelin ME, et al. The 2009 pandemic H1N1 D222G hemagglutinin mutation alters receptor specificity and increases virulence in mice but not in ferrets. J Infect Dis 2011 Oct 1;204(7):1008-16 [Abstract]
Abelin A, Colegate T, Gardner S, et al. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective. Vaccine 2011 Feb 1;29(6):1135-8 [Abstract]
ACEP (American College of Emergency Physicians). Public guidance regarding emergency department use for H1N1 flu symptoms. Released Nov 4, 2009 [Full text]
Achonu C, Rosella L, Gubbay JB, et al. Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010. PLoS ONE 2011 Nov 14;6(11):e26427 [Full text]
Acosta B, Pinon A, Valdes O, et al. Rapid diagnosis of pandemic (H1N1) 2009 in Cuba. (Letter) Emerg Infect Dis 2012 Feb;18(2):336-7 [Full text]
Acosta EP, Jester P, Gal P, et al. Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis 2010 Aug 15;202(4):563-6 [Abstract]
Adalja AA, Henderson DA. Original antigenic sin and pandemic (H1N1) 2009. (Letter) Emerg Infect Dis 2010 Jun;16(6):1028-9 [Full text]
Adamson WE, Maddi S, Robertson C, et al. 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in spring 2010, following the winter outbreak. Euro Surveill 2010 Jun 17;15(24):pii=19590 [Full text]
Adamson WE, McGregor EC, Kavanagh K, et al. Influenza A(H1N1) 2009 antibody seroprevalence in Scotland following the 2010/11 influenza season. Euro Surveill 2011 May 19;16(20):pii=19871 [Full text]
Adhikari BR, Shakya G, Upadhyay BP, et al. Outbreak of pandemic influenza A/H1N1 2009 in Nepal. Virol J 2011 Mar 23;8:133 [Abstract]
Adiego Sancho B, Omenaca Teres M, Martinez Cuenca S, et al. Human case of swine influenza A (H1N1), Aragon, Spain, November 2008. (Rapid communications) Eurosurveill 2009 Feb 19;14(7):pi=19120 [Full text]
Agarwal PP, Cinti S, Kazerooni EA. Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. AJR Am J Roentgenol 2009 Dec;193(6):1488-93 [Abstract]
Agrati C, Gioia C, Lalle E, et al. Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course. J Infect Dis 2010 Sep 1;202(5):681-9 [Abstract]
Aguilar-Yanez JM, Portillo-Lara R, Mendoza GI, et al. An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS ONE 2010 Jul 22;5(7):e11694 [Full text]
Aguirre E, Papenburg J, Ouakki M, et al. Comparison of pandemic and seasonal influenza in the pediatric emergency department. Pediatr Infect Dis J 2011 Aug;30(8):633-9 [Abstract]
Aho M, Lyytikainen O, Nyholm JE, et al. Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison -- a serological survey. Euro Surveill 2010 Nov 11;15(45):pii=19709 [Full text]
Ajelli M, Merler S, Pugliese A, et al. Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy. Epidemiol Infect 2011 Jan;139(1):68-79 [Abstract]
Akan H, Gurol Y, Izbirak G, et al. Knowledge and attitudes of university students toward pandemic influenza: a cross sectional study from Turkey. BMC Public Health 2010 Jul 13;10:413 [Abstract]
Akritidis N, Mastora M, Baxevanos G, et al. Electrocardiographic abnormalities in patients with novel H1N1 influenza virus infection. Am J Cardiol 2010 Nov 15;106(10):1517-9 [Abstract]
Al-Mahrezi A, Samir N, Al-Zakwani I, et al. Clinical characteristics of influenza A H1N1 versus other influenza-like illnesses amongst outpatients attending a university health center in Oman. Int J Infect Dis 2012 (published online Apr 23) [Abstract]
Alkuwari MG, Selim NA, Nazzal ZAS, et al. Pandemic influenza A/H1N1 vaccination uptake among health care workers in Qatar: motivators and barriers. Vaccine 2011 Mar 3;29(11):2206-11 [Full text]
Allard R, Leclerc P, Tremblay C, et al. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 2010 Jul;33(7):1491-3 [Abstract]
Allen U, Licht C. Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger? (Commentary) Pediatr Nephrol 2011 Jan;26(1):3-5 [Abstract]
Almansa R, Anton A, Ramirez, et al. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza. BMC Infect Dis 2011 Aug 31;11:232 [Abstract]
Altmann M, Fiebig L, Soyka J, et al. Severe cases of pandemic (H1N1) 2009 in children, Germany. Emerg Infect Dis 2011 Feb;17(2):186-92 [Full text]
Alvarez MM, Lopez-Pacheco F, Aguilar-Yanez JM, et al. Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method. PLoS ONE 2010 Apr 14;5(4):e10176 [Full text]
Amine IL, Bajjou T, Rhaffouli HEI, et al. Pandemic influenza A(H1N1) 2009 in Morocco: experience of the Mohammed V Military Teaching Hospital, Rabat, 12 June to 24 December 2009. Euro Surveill 2011 Jun 9;16(23):pii=19887 [Full text]
Amodio E, Anastasi G, Marsala MGL, et al. Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy). Vaccine 2011 Feb 4;29(7):1408-12 [Abstract]
Ampofo K, Herbener A, Blaschke AJ, et al. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization With parapneumonic empyema in children in Utah. Ped Infect Dis J 2010 Oct;29(10):905-9 [Abstract]
an der Heiden M, Buchholz U, Krause G, et al. Breaking the waves: modelling the potential impact of public health measures to defer the epidemic peak of novel influenza A/H1N1. PLoS One 2009 Dec 21;4(12):e8356 [Full text]
Andrews N, Stowe J, Salman RAS, et al. Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine 2011 Oct 19;29(45):7878-82 [Abstract]
Andrews N, Waight P, Yung CF, et al. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis 2011 Jan 1;203(1):32-9 [Abstract]
Andrews NJ, Walker WT, Finn A, et al. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Vaccine 2011 Oct 19;29(45):7913-9 [Abstract]
Ang B, Poh BF, Win MK, et al. Surgical masks for protection of health care personnel against pandemic novel swine-origin influenza A (H1N1)-2009: results from an observational study. Clin Infect Dis 2010 Apr 1;50(7):1011-4 [Abstract]
Ann Acad Med Singapore. Pandemic Influenzas. Special issue on 2009 H1N1 experience. Apr 2010 [Table of contents]
Antona A, Marcosa MA, Martinez MJ, et al. D225G mutation in the hemagglutinin protein found in 3 severe cases of 2009 pandemic influenza A (H1N1) in Spain. Diagn Microbiol Infect Dis 2010 Jun;67(2):207-8 [Full text]
ANZ ECMO influenza investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009 Nov 4;302(17):1888-95 [Full text]
ANZIC influenza investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ 2010 Mar 18;340:c1279 [Full text]
ANZIC influenza investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009 Nov 12;361(20):1925-34 [Full text]
Apisarnthanarak A, Mundy LM. Outbreak of influenza A (2009) H1N1 among Thai healthcare workers: is it time to integrate a vaccination program? Infect Control Hosp Epidemiol 2010 Aug;31(8):854-6 [Abstract]
Appuhamy RD, Beard FH, Phung HN, et al. The changing phases of pandemic (H1N1) 2009 in Queensland: an overview of public health actions and epidemiology. Med J Aust 2010 Jan 18;192(2):94-7 [Full text]
Arankalle VA, Lole KS, Arya RP, et al. Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS ONE 2010 Oct 1;5(10):e13099 [Full text]
Arda B, Durusoy R, Yamazhan T, et al. Did the pandemic have an impact on influenza vaccination attitude? A survey among health care workers. BMC Infect Dis 2011 Apr 7;11:87 [Abstract]
Arguedas A, Soley C, Lindert K. Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. (Letter) N Engl J Med 2010 Jan 28;362(4):370-2 [Full text]
Ariano RE, Sitar DS, Zelenitsky SA, et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 2010 Mar 9;182(4):357-63 [Abstract]
Arinaminpathy N, Raphaely N, Saldana L, et al. Transmission and control in an institutional pandemic influenza A(H1N1) 2009 outbreak. Epidemiol Infect 2011 (published online Aug 23) [Abstract]
Arjona MAO, Elaziz KMA, Lanzas JMC, et al. Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers. Vaccine 2011 Aug 26;29(37):6366-8 [Abstract]
Asner S, Peci A, Marchand-Austin A, et al. Respiratory viral infections in institutions from late stage of the first and second waves of pandemic influenza A (H1N1) 2009, Ontario, Canada. Influenza Other Respi Viruses 2012 May;6(3):e11-5 [Abstract]
ASPR/ECCC/ACEP. National strategic plan for emergency department management of outbreaks of novel H1N1 influenza. Joint ASPR/ECCC/ACEP document 2009 [Full text]
Association of Public Health Laboratories (APHL). Lessons from a virus: public health laboratories response to the H1N1 pandemic. Published online Sep 9 [Full text]
Athanasiou M, Baka A, Spala G, et al. Influenza surveillance during the post-pandemic influenza 2010/11 season in Greece, 04 October 2010 to 22 May 2011. Euro Surveill 2011 Nov 3;16(44):pii=20004 [Full text]
Atkins CY, Patel A, Taylor TH, et al. Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States. Emerg Infect Dis 2011 Sep;17(9):1591-8 [Full text]
Aviram G, Bar-Shai A, Sosna J, et al. H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology 2010 Apr;255(1):252-9 [Abstract]
Ayora-Talavera G, Cadavieco-Burgos JM, Canul-Armas AB. Serologic evidence of human and swine influenza. Emerg Infect Dis 2005 Jan;11(1):158-60 [Full text]
Azziz-Baumgartner E, Rahman M, Mamun AA, et al. Early detection of pandemic (H1N1) 2009, Bangladesh. Emerg Infect Dis 2012 Jan;18(1):146-9 [Full text]
Babin SM, Hsieh YH, Rothman RE, et al. A meta-analysis of point-of-care laboratory tests in the diagnosis of novel 2009 swine-lineage pandemic influenza A (H1N1). Diagn Microbiol Infect Dis 2011 Apr;69(4):410-8 [Abstract]
Babiuk S, Albrecht R, Berhane Y, et al. 1918 and 2009 H1N1 influenza viruses are not pathogenic in birds. J Gen Virol 2010 Feb;91(2):339-42 [Abstract]
Babiuk S, Masic A, Graham J, et al. An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine. Vaccine 2011 Apr 12;29(17):3118-23 [Abstract]
Baden LR, Drazen JM, Kritek PA, et al. H1N1 influenza A disease--information for health professionals. (Editorial) N Engl J Med 2010 Jun 18;360(25):2666-7 [Full text]
Bagdure D, Curtis DJ, Dobyns E, et al. Hospitalized children with 2009 pandemic influenza A (H1N1): comparison to seasonal influenza and risk factors for admission to the ICU. PLoS ONE 2010 Dec 15;5(12):e15173 [Full text]
Baguelin M, Hoschler K, Stanford E, et al. Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation. PLoS ONE 2011 Feb 23;6(2):e17074 [Full text]
Baillie GJ, Galiano M, Agapow PM, et al. Evolutionary dynamics of local pandemic H1N1/09 influenza lineages revealed by whole genome analysis. J Virol 2012 Jan;86(1):11-8 [Abstract]
Bajardi P, Poletto C, Ramasco JJ, et al. Human mobility networks, travel restrictions, and the global spread of 2009 H1N1 pandemic. PLoS ONE 2011 Jan 31;6(1):e16591 [Full text]
Baker AW, Enfield K, Mehring B, et al. Local influenza-like illness surveillance at a university health system during the 2009 H1N1 influenza pandemic. Am J Infect Control 2012 (published online Mar 14) [Abstract]
Baker MG, Thornley CN, Mills C, et al. Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study. BMJ 2010 May 21;340:c2424 [Abstract]
Baker MG, Wilson N, Huang QS, et al. Pandemic influenza A(H1N1) in New Zealand: the experience from April to August 2009. (Rapid communications) Eurosurveill 2009 Aug 27;14(34):pii=19319 [Full text]
Baker PRA, Sun J, Morris J, et al. Epidemiologic modeling with FluSurge for pandemic (H1N1) 2009 outbreak, Queensland, Australia. Emerg Infect Dis 2011 Sep;17(9):1608-14 [Full text]
Balanzat AM, Hertlein C, Apezteguia C, et al. An analysis of 332 fatalities infected with pandemic 2009 influenza A (H1N1) in Argentina. PLoS ONE 2012 Apr 10;7(4):e33670 [Full text]
Balasegaram S, Glasswell A, Cleary V, et al. From containment to community: trigger points from the London pandemic (H1N1) 2009 influenza incident response. Public Health 2011 Feb;125(2):72-8 [Abstract]
Balasegaram S, Ogilvie F, Glasswell A, et al. Patterns of early transmission of pandemic influenza in London--link with deprivation. Influenza Other Respi Viruses 2012 May;6(3):e35-41 [Abstract]
Balcan D, Hu H, Goncalves B, et al. Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. BMC Med 2009 Sep 10;7:45 [Abstract]
Balkhy HH, Abolfotouh MA, Al-Hathlool RH, et al. Awareness, attitudes, and practices related to the swine influenza pandemic among the Saudi public. BMC Infect Dis 2010 Feb 28;20:42 [Abstract]
Balkhy HH, El-Saed A, Sallah M. Epidemiology of H1N1 (2009) influenza among healthcare workers in a tertiary care center in Saudi Arabia: a 6-month surveillance study. Infect Control Hosp Epidemiol 2010 Oct;31(10):1004-10 [Abstract]
Balter S, Gupta LS, Lim S, et al. Pandemic (H1N1) 2009 surveillance for severe illness and response, New York, New York, USA, April-July 2009. Emerg Infect Dis 2010 Aug;16(8):1259-64 [Full text]
Baluch A, Humar A, Egli A, et al. Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients. PLoS ONE 2011 Dec 14;6(12):e28627 [Full text]
Bandaranayake D, Huang QS, Bissielo A, et al. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 2010 Oct 14;5(10):e13211 [Full text]
Bandaranayake D, Huang S, Bissielo A, et al. Seroprevalence of the 2009 influenza A (H1N1) pandemic in New Zealand. New Zealand Ministry of Health report released Jun 4, 2010 (but dated May) [Full text]
Bandaranayake D, Jacobs M, Baker M, et al. The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010. Euro Surveill 2011 Feb 10;16(6):pii=19788 [Full text]
Bansal S, Pourbohloul B, Hupert N, et al. The shifting demographic landscape of pandemic influenza. PLoS One 2010 Feb 26;5(2):e9360 [Full text]
Baras B, de Waal L, Stittelaar KJ, et al. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naive ferrets. Vaccine 2011 Mar 3;29(11):2120-6 [Abstract]
Barchi E, Prati F, Parmeggiani M, et al. Pandemic (H1N1) 2009 and HIV co-infection. (Letter) Emerg Infect Dis 2010 Oct;16(10):1643-4 [Full text]
Bardage C, Persson I, Ortqvist A, et al. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort in Stockholm, Sweden. BMJ 2011 Oct 12;343:d5956 [http://www.bmj.com/content/343/bmj.d5956.short]
Barr IG, Cui L, Komadina N, et al. A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill 2010 Oct 21;15(42):pii=19692 [Full text]
Barriere J, Vanjak D, Kriegel I, et al. Acceptance of the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer centers. Vaccine 2010 Oct 8;28(43):7030-4 [Full text]
Barry JM. How to bring about a best-case scenario for H1N1. (Commentary) Washington Post June 23, 2009 [Full text]
Barry JM. Pandemics: avoiding the mistakes of 1918. (Essay) Nature 2009 May 21;459(7245):324-5 [Full text]
Barry JM. White paper on novel H1N1. MIT Engineering Systems Division Working Paper Series ESD-WP-2009-07. 2009 Jul [Full text]
Bassetti M, Parisini A, Calzi A, et al. Risk factors for severe complications of the novel influenza A(H1N1): analysis of patients hospitalized in Italy. Clin Microbiol Infect 2010 Feb;17(2):247-50 [Abstract]
Bastien N, Bowness D, Burton L, et al. Parotitis in a child infected with triple reassortant influenza A, Canada, 2007. J Clin Microbiol 2009 Jun;47(6):1896-8 [Abstract]
Bate J, Yung CF, Hoschler K, et al. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. Clin Infect Dis 2010 Dec 15;51(12):e95-104 [Full text]
Baz M, Abed Y, Papenburg J, et al. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. (Letter) N Engl J Med 2009 Dec 3;361(23):2296-7 [Full text]
Bearden A, Friedrich TC, Goldberg TL, et al. An outbreak of the 2009 influenza A (H1N1) virus in a children's hospital. Influenza Other Respi Viruses 2012 (published online Jan 2) [Abstract]
Beaute J, Broberg E, Plata F, et al. Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries. Euro Surveill 2012 Mar 1;17(9):pii=20105 [Full text]
Beck ET, Jurgens LA, Kehl SC, et al. Development of a rapid automated influenza A, influenza B, and respiratory syncytial virus A/B multiplex real-time RT-PCR assay and its use during the 2009 H1N1 swine-origin influenza virus epidemic in Milwaukee, Wisconsin. J Molec Diagn 2010 Jan;12(1):74-81 [Abstract]
Belmont E, Leibold P, Osterholm M. Preparation will pay off: regardless of what happens with swine flu, pandemic bound to strike. (Commentary) Mod Healthc 2009 May 4;39(18):22 [Full text]
Belongia EA, Irving SA, Waring SC, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010 Sep 8;304(10):1091-8 [Abstract]
Belser JA, Gustin KM, Maines TR, et al. Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic. J Virol 2011 Feb;85(4):1563-72 [Abstract]
Belshe RB. Implications of the emergence of a novel H1 influenza virus. (Editorial) N Engl J Med 2009 Jun 18;360(25):2667-8 [Full text]
Bennett B, Carney T. Law, ethics and pandemic preparedness: the importance of cross-jurisdictional and cross-cultural perspectives. Aust N Z J Public Health 2010 Apr;34(2):106-12 [Abstract]
Bentley RA, Ormerod P. A rapid method for assessing social versus independent interest in health issues: a case study of 'bird flu' and 'swine flu'. Soc Sci Med 2010 Aug;71(3):482-5 [Abstract]
Berdal JE, Mollnes TE, Waehre T, et al. Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza. J Infect 2011 Oct;63(4):308-16 [Abstract]
Berhane Y, Kehler H, Handel K, et al. Molecular and antigenic characterization of reassortant H3N2 viruses from turkeys with a unique constellation of pandemic H1N1 internal genes. PLoS ONE 2012 Mar 21;7(3):e32858 [Full text]
Bettinger JA, Sauve LJ, Scheifele DW, et al. Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine 2010 Apr 19;28(18):3180-4 [Full text]
Bhoumik P, Hughes AL. Reassortment of ancient neuraminidase and recent hemagglutinin in pandemic (H1N1) 2009 virus. Emerg Infect Dis 2010 Nov;16(11):1748-50 [Full text]
Bi Y, Fu G, Chen J, et al. Novel swine influenza virus reassortants in pigs, China. Emerg Infect Dis 2010 Jul;16(7):1162-1164 [Full text]
Bin C, Xingwang L, Yuelong S, et al (National Influenza A Pandemic [H1N1] 2009 Clinical Investigation Group). Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus, People's Republic of China. Emerg Infect Dis 2009 Sep;15(9):1418-22 [Full text]
Birnkrant D, Cox E. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza. (Perspective) N Engl J Med 2009 Dec 3;361(23):2204-7 [Full text]
Birrell PJ, Ketsetzis G, Gay NJ, et al. Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London. Proc Natl Acad Sci 2011 (published online Oct 31) [Abstract]
Bish A, Yardley L, Nicoll A, et al. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 2011 Sep 2;29(38):6472-84 [Abstract]
Bishop JF, Murnane MP, Owen R. Australia's winter with the 2009 pandemic influenza A (H1N1) virus. (Perspective) N Engl J Med 2009 Dec 31;361(27):2591-4 [Full text]
Black S, Eskola J, Siegrist CA, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009 Dec 19;374(9707):2115-22 [Abstract]
Blasio BFD, Iversen BG, Tomba GS. Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing. PLoS ONE 2012 Jan 10;7(1):e30018 [Full text]
Blau DM, Denison AM, Bhatnagar J, et al. Fatal infectious diseases during pandemic (H1N1) 2009 outbreak. (Letter) Emerg Infect Dis 2011 Nov;17(11):2069-70 [Full text]
Block SL, Ruiz-Palacios GM, Lourdes GM, et al. A dose-range study of MF59(R)-adjuvanted versus non-adjuvanted monovalent A/H1N1 pandemic influenza vaccine in 6 to <36 month-old children. Pediatr Infect Dis J 2012 (published online Apr 4) [Abstract]
Blumental S, Huisman E, Cornet MC, et al. Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey. BMC Infect Dis 2011 Nov 7;11:313 [Abstract]
Blyth CC, Kelso A, McPhie KA, et al. The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. Euro Surveill 2010 Aug 5;15(31):pii=19631 [Full text]
Boelle PY, Bernillon P, Desencios JC. A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009. Euro Surveill 2009 May 14;14(19):pii=19205 [Full text]
Bogers H, Boer K, Duvekot JJ. Complications of the 2009 influenza A/H1N1 pandemic in pregnant women in the Netherlands: a national cohort study. Influenza Other Respi Viruses 2011 (published online Dec 15) [Abstract]
Bokhari SH, Pomeroy LW, Janies DA. Reassortment networks and the evolution of pandemic H1N1 swine-origin influenza. IEEE/ACM Tans Comput Biol Bioinform 2011 Oct;39(8):e49-51 [Abstract]
Bone A, Guthmann JP, Assal A, et al. Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France. PLoS ONE 2012 Mar 22;7(3):e33056 [Full text]
Bone A, Guthmann JP, Nicolau J, et al. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine 2010 Nov 29;28(51):8157-61 [Abstract]
Boon ACM, deBeauchamp J, Krauss S, et al. Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J Virol 2010 Aug;84(15):7662-7 [Abstract]
Borse RH, Behravesh CB, Dumanovsky T, et al. Closing schools in response to the 2009 pandemic influenza A H1N1 virus in New York City: economic impact on households. Clin Infect Dis 2011 Jan 1;52(suppl 1):S168-72 [Abstract]
Bosch BJ, Bodewes R, de Vries RP, et al. Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol 2010 Oct;84(19):10366-74 [Abstract]
Bose ME, Beck ET, Ledboer N, et al. Rapid semi-automated subtyping of influenza during the 2009 swine-origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin. J Clin Virol 2009 Sep;47(9):2779-86 [Abstract]
Boutolleau D, Houhou N, Deback C, et al. Detection of pandemic (H1N1) 2009 virus in patients treated with oseltamivir. (Letter) Emerg Infect Dis 2010 Feb;16(2):351-2 [Full text]
Bozzola E, Krysztofiak A, Lancella L, et al. Risk factors of complicated H1N1 influenza in hospitalized Italian children. Vaccine 2010 Jul 26;28(33):5387-8 [Abstract]
Bradley KC, Jones CA, Tompkins SM, et al. Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (novel 2009 H1N1). Virology 2011 May 10;413(2):169-82 [Abstract]
Bradt DA, Epstein D. The rational clinician in a pandemic setting. Med J Aust 2010 Jan 18;192(2):87-9 [Full text]
Brandsaeter BJ, Pillgram M, Berild D, et al. Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009. BMC Infect Dis 2011 Mar 24;11:75 [Abstract]
Brandt C, Rebenau HF, Bornmann S, et al. The impact of the 2009 influenza A(H1N1) pandemic on attitudes of healthcare workers toward seasonal influenza vaccination 2010/11. Euro Surveill 2011 Apr 28;16(17):pii=19854 [Full text]
Bratincsak A, El-Said HG, Bradley JS, et al. Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol 2010 Mar 2;55(9):928-9 [Feb 10 J Am Coll Cardiol letter]
Brett SJ, Myles P, Lim WS, et al. Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease. PLoS ONE 2011 Apr 25;6(4):e18120 [Full text]
Briand S, Mounts A, Chamberland M. Challenges of global surveillance during an influenza pandemic. Public Health 2011 May;125(5):247-56 [Abstract]
Brien S, Kwong JC, Buckeridge DL. The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review. Vaccine 2012 Feb 8;30(7):1255-64 [Abstract]
Britton AP, Sojnky KR, Scouras AP, et al. Pandemic (H1N1) 2009 in skunks, Canada. (Letter) Emerg Infect Dis 2010 Jun;16(6):1043-5 [Full text]
Broadbent AJ, Subbarao K. Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Curr Opin Virol 2011 Oct;1(4):254-62 [Abstract]
Brockwell-Staats C, Webster RG, Webby RJ. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Resp Viruses 2009 Sep;3(5):207-13 [Abstract]
Brookes SM, Nunez A, Choudhury B, et al. Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PLoS One 2010 Feb 5;5(2):e9068 [Full text]
Brooks-Pollock E, Tilston N, Edmunds WJ, et al. Using an online survey of healthcare-seeking behavior to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England. BMC Infect Dis 2011 Mar 16;11:68 [Abstract]
Broor S, Krishnan A, Roy DS, et al. Dynamic patterns of circulating seasonal and pandemic A(H1N1)pdm09 influenza viruses from 2007-2010 in and around Delhi, India. PLoS ONE 2012 Jan 3;7(1):e29129 [Full text]
Broos N, van Puijenbroek EP, van Grootheest K. Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands. Drug Safet 2010 Dec 1;33(12):1109-15 [Abstract]
Brouwers L, Cakici B, Camitz M, et al. Economic consequences to society of pandemic H1N1 influenza 2009: preliminary results for Sweden. Euro Surveill 2009 Sep 17;14(37):pii:19333 [Full text]
Brown KF, Kroll JS, Hudson MJ, et al. Omission bias and vaccine rejection by parents of healthy children: implications for the influenza A/H1N1 vaccination programme. Vaccine 2010 Jun 7;28(25):4181-5 [Abstract]
Brown LH, Aitken P, Leggat PA, et al. Self-reported anticipated compliance with physician advice to stay home during pandemic (H1N1) 2009: results from the 2009 Queensland Social Survey. BMC Public Health 2010 Mar 16;20:138 [Abstract]
Brown ST, Tai JHY, Bailey RR, et al. Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost? A computational simulation of Pennsylvania. BMC Public Health 2011 May 20;11:353 [Abstract]
Brownstein JS, Freifeld CC, Chan EH, et al. Information technology and global surveillance of cases of 2009 H1N1 influenza. N Engl J Med 2010 May 6;362(18):1731-5 [Full text]
Brownstein JS, Freifeld CC, Madoff LC. Digital disease detection--harnessing the Web for public health surveillance. (Perspective) N Engl J Med 2009 May 21;360(21):2153-7 [Full text]
Bryan P, Seabroke S, Davies C. H1N1 vaccine safety: real-time surveillance in the UK. Lancet 2010 Aug 7;376(0739):417-8 [Full text]
Bryant PA, Tebruegge M, Papadakis G, et al. Clinical and microbiologic features associated with novel swine-origin influenza A pandemic 2009 (H1N1) virus in children. Pediatr Infect Dis J 2010 Aug;29(8):694-8 [Abstract]
Bults M, Beaujean DJ, Richardus JH, et al. Pandemic influenza A (H1N1) vaccination in the Netherlands: parental reasoning underlying child vaccination choices. Vaccine 2011 Aug 26;29(37):6226-35 [Abstract]
Bults M, Beaujean DJMA, Zwart ODE, et al. Perceived risk, anxiety, and behavioural responses of the general public during the early phase of the influenza A (H1N1) pandemic in the Netherlands: results of three consecutive online surveys. BMC Public Health 2011 Jan 3;11:2 [Abstract]
Burgui R, Martines-Baz I, Guevara M, et al. Use of medical care during pandemic (H1N1) 2009, Navarre, Spain. Emerg Infect Dis 2011 Aug;17(8):1463-6 [Full text]
Burkom H, Kniss K, Meltzer M, et al. Investigating the effect of high spring incidence of pandemic influenza A(H1N1) on early autumn incidence. Epidemiol Infect 2012 (published online Feb 7) [Abstract]
Burmaa A, Tsatsral S, Odagiri T, et al. Cumulative incidence of pandemic influenza A (H1N1) 2009 by a community-based serological cohort study in Selenghe Province, Mongolia. Influenza Other Respi Viruses 2012 (published online Feb 13) [Abstract]
Calatayud L, Lackenby A, Reynolds A, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010. Emerg Infect Dis 2011 Oct;17(10):1807-15 [Full text]
Calistri A, Salata C, Cosentino M, et al. Report of two cases of influenza A/H1N1v and B co-infection during the 2010/2011 epidemics in the Italian Veneto region. Virol J 2011 Nov 3;8:502 [Abstract]
Campanini G, Piralla A, Paolucci S, et al. Genetic divergence of influenza A NS1 gene in pandemic 2009 H1N1 isolates with respect to H1N1 and H3N2 isolates from previous seasonal epidemics. Virol J 2010 Sep 1;7:209 [Abstract]
Campbell A, Rodin R, Kropp R, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010 Mar 9;182(4):349-55 [Abstract]
Campbell CNJ, Mytton OT, McLean EM, et al. Hospitalization in two waves of pandemic influenza A(H1N1) in England. Epidemiol Infect 2011 Oct;139(10):1560-9 [Abstract]
Canadian Institute for Health Information. H1N1 in Canada--a context for understanding patients and their use of hospital services. Feb 11, 2010 [Full text]
Canadian Institute for Health Information. The impact of the H1N1 pandemic on Canadian hospitals. Nov 23, 2010 [Full text]
Canadian Senate Committee on Social Affairs, Science and Technology. Canada's response to 2009's H1N1 influenza pandemic. Dec 29, 2010 [News release, with link to full report]
Canadian Standards Association. Voices from the H1N1 influenza pandemic front lines: a white paper about how Canada could do better next time. (Roundtable report on healthcare and emergency service sector pandemic preparedness) Jun 8, 2010 [Full text]
Cao B, Li XW, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009 Dec 24;361(26):2507-17 [Full text]
Capua I, Cattoli G. One Flu for One Health. (Letter) Emerg Infect Dis 2010 Apr;16(4):719 [Full text]
Carcione D, Giele C, Dowse GK, et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis 2010 Sep;16(9):1388-95 [Full text]
Carcione D, Giele CM, Goggin LS, et al. Secondary attack rate of pandemic influenza A(H1N1) 2009 in western Australian households, 29 May-7 Aug 2009. Euro Surveill 2011 Jan 20;16(3):pii=19765 [Full text]
Caress AL, Duxbury P, Woodcock A, et al. Exploring the needs, concerns and behaviours of people with existing respiratory conditions in relation to the H1N1 'swine influenza' pandemic: a multicentre survey and qualitative study. Health Technol Assess 2010 Jul; 14(34):1-108 [Abstract]
Carlson SJ, Dalton CB, Durrheim DN, et al. Online flutracking survey of influenza-like illness during pandemic (H1N1) 2009, Australia. Emerg Infect Dis 2010 Dec;16(12):1960-2 [Full text]
Carmona A, Omenaca F, Tejedor JC, et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Vaccine 2010 Aug 16;28(36):5837-44 [Abstract]
Carrillo-Santisteve P, Renard-Dubois S, Cheron G, et al. 2009 pandemic influenza A(H1N1) outbreak in a complex of schools in Paris, France, June 2009. Euro Surveill 2010 Jun 24;15(25):pii=19599 [Full text]
Carvajal A, Ortega PG, Sainz M, et al. Adverse events associated with pandemic influenza vaccines: comparison of the results of a follow-up study with those coming from spontaneous reporting. Vaccine 2011 Jan 10;29(3):519-22 [Abstract]
Casalegno JS, Bouscambert-Duchamp M, Caro v, et al. Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007-2009. Antiviral Res 2010 Aug;87(2):242-8 [Abstract]
Casalegno JS, Ottmann M, Duchamp MB, et al. Rhinoviruses delayed the circulation of pandemic influenza A(H1N1) 2009 virus in France. Clin Microbiol Infect 2010 Apr;16(4):326-9 [Abstract]
Castilla J, Moran J, Martinez-Artola V, et al. Effectiveness of the monovalent influenza A(H1N1) 2009 vaccine in Navarre, Spain, 2009-2010: cohort and case control study. Vaccine 2011 Aug 11;229(35):5919-24 [Abstract]
Castilla J, Moran J, Martinez-Artola V, et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1) 2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveill 2011 Feb 17;16(7):pii=19799 [Full text]
Catton M, Druce J, Papadakis G, et al. Reality check of laboratory service effectiveness during pandemic (H1N1) 2009, Victoria, Australia. Emerg Infect Dis 2011 Jun;17(6):963-8 [Full text]
Cauchemez S, Bhattarai A, Marchbanks TL, et al. Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc Natl Acad Sci 2011 Feb 15;108(7):2825-30 [Abstract]
Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009 Dec 31;361(27):2619-27 [Full text]
Cauchemez S, Ferguson NM, Wachtel C, et al. Closure of schools during an influenza pandemic. Lancet Infect Dis 2009 Aug;9(8):473-81 [Abstract]
CDC Health Alert Network (HAN) Info Service Message. Three reports of oseltamivir resistant novel influenza A (H1N1) viruses. July 9, 2009 [Full text]
CDC. 10 steps you can take: actions for novel H1N1 influenza planning and response for medical offices and outpatient facilities. July 14, 2009 [Full text]
CDC. 2009 H1N1 and seasonal flu and African American communities: questions and answers. Feb 17, 2010 [Full text]
CDC. 2009 H1N1 and seasonal influenza and Hispanic communities: questions and answers. Feb 16, 2010 [Full text]
CDC. 2009 H1N1 flu ("swine flu") and you. February 10, 2010 [Full text]
CDC. 2009 H1N1 flu (referred to as "swine flu" early on) and seasonal flu information for people with inflammatory arthritis or rheumatic disease. Jan 21, 2010 [Full text]
CDC. 2009 H1N1 flu (swine flu) and feeding your baby: what parents should know. Oct 23, 2009 [Full text]
CDC. 2009 H1N1 flu information for people with disabilities and their caregivers or personal assistants. April 8, 2010 [Full text]
CDC. 2009 H1N1 flu: international situation update. Aug 9, 2010 [Full text]
CDC. 2009 H1N1 flu: underlying health conditions among hospitalized adults and children. Feb 24, 2010 [Full text]
CDC. 2009 H1N1 influenza shots and pregnant women: questions and answers for patients. Dec 22, 2009 [Full text]
CDC. 2009 H1N1 influenza vaccine and pregnant women: information for healthcare providers. Jan 14, 2010 [Full text]
CDC. 2009 H1N1 influenza vaccine dose spacing and administration with seasonal influenza and other vaccines. Nov 20, 2009 [Full text]
CDC. 2009 H1N1 influenza vaccine supply status. Nov 10, 2009 [Full text]
CDC. 2009 H1N1 influenza vaccine with long-dated expiration (Q&A). Jul 23, 2010 [Full text]
CDC. 2009 H1N1 influenza vaccine--dose spacing for children 6 months through 9 years of age. Nov 23, 2009 [Full text]
CDC. 2009 H1N1 monovalent influenza vaccine dosage, administration, and storage. Dec 28, 2009 [Full text]
CDC. 2009 influenza (H1N1) monovalent vaccine Vaccine Provider Agreement Q&A. Oct 27, 2009 [Full text]
CDC. 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care--New York City, 2009. MMWR 2010 Mar 26;59(11):321-6 [Full text]
CDC. 2009 pandemic influenza A (H1N1) virus infections--Chicago, Illinois, April-July 2009. MMWR 2009 Aug 28;58(33):913-8 [Full text]
CDC. 2009-2010 Influenza season triage algorithm for children (< 18 years) with influenza-like illness. Oct 16, 2009 [Chart]
CDC. Abbreviated pandemic influenza plan template for primary care provider offices: guidance from stakeholders. Feb 9, 2010 [Full text]
CDC. Advice for parents on talking to children about novel H1N1 flu (formerly swine flu) concerns. Oct 23, 2009 [Full text]
CDC. Allocation and distribution Q & A. Nov 3, 2009 [Full text]
CDC. Antiviral drugs for the 2009-2010 influenza season. Oct 19, 2009 [Podcast]
CDC. Antiviral safety information. Dec 24, 2009 (updated regularly) [Full text]
CDC. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)--United States, May-August 2009. MMWR 2009 Sep 29;58(Early release):1-4 [Full text]
CDC. Behavioral Risk Factor Surveillance System (BRFSS) 2009 H1N1 flu modules for influenza-like illness (ILI) and vaccination. Q&A posted Feb 24, 2010 [Full text]
CDC. CDC 2009 H1N1 vaccination campaign planning checklist. Aug 31, 2009 [Full text]
CDC. CDC guidance for day and residential camps responses to influenza during the 2010 summer camp season. May 17, 2010 [Full text]
CDC. CDC guidance for responses to influenza for institutions of higher education during the 2009-2010 academic year. Feb 22, 2010 [Full text]
CDC. CDC guidance on helping child care and early childhood programs respond to influenza during the 2009-2010 influenza season. Feb 22, 2010 [Full text]
CDC. CDC health update: interim guidance--children and pregnant women who may be infected with swine-origin influenza virus: considerations for clinicians. Apr 28, 2009 [Full text]
CDC. CDC interim guidance for people who have close contact with pigs in non-commercial settings: preventing the spread of influenza A viruses, including the novel influenza A (H1N1) virus. Aug 5, 2009 [Full text]
CDC. CDC recommendations for state and local planning for a 2009 novel H1N1 influenza vaccination program. Jul 8, 2009 [Full text]
CDC. CDC recommendations for the amount of time persons with influenza-like illness should be away from others. Oct 23, 2009 [Full text]
CDC. Clinical data collection forms and templates for collection of information on patients infected with novel H1N1 influenza A (H1N1). May 12, 2009 [Full text]
CDC. Deaths and hospitalizations related to 2009 pandemic influenza A (H1N1) --- Greece, May 2009--February 2010. MMWR 2010 Jun 11;59(22):682-6 [Full text]
CDC. Deaths related to 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives--12 states, 2009. MMWR 2009 Dec 11;58(48):1341-4 [Full text]
CDC. DSAT guidance on CDC import permits for swine-originated flu. May 26, 2009 [Full text]
CDC. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1)--United States, May-June 2009. MMWR 2009 Nov 13;58(44):1241-5 [Full text]
CDC. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus--United States, 2009. MMWR 2009 Aug 7;58(30):826-9 [Full text]
CDC. Final estimates for 2009-10 seasonal influenza and influenza A (H1N1) 2009 monovalent vaccination coverage -- United States, August 2009 through May, 2010. Oct 7, 2010 [Full text]
CDC. Flu information for people with diabetes and caregivers of people with diabetes. Jan 6, 2010 [Full text]
CDC. Flu-related hospitalizations and deaths in the United States from April 2009 - January 30, 2010. (Q&A) Apr 16, 2010 [Full text]
CDC. Frequently asked questions on use of influenza A(H1N1) 2009 monovalent vaccines (2009 H1N1 monovalent influenza vaccines): practical considerations for immunization programs and providers. Nov 10, 2009 [Full text]
CDC. General questions and answers on Guillain-Barre syndrome (GBS). Dec 15, 2009 [Full text]
CDC. General questions and answers on thimerosal. Dec 15, 2009 [Full text]
CDC. Guidance for state and local public health officials and school administrators for school (K-12) responses to influenza during the 2009-2010 school year. Feb 22, 2010 [Full text]
CDC. Guidance from pediatric stakeholders: a coordinated approach to communicating pediatric-related information on pandemic influenza at the community level. Jan 27, 2010 [Full text]
CDC. Guidelines for the submission of tissue specimens for the pathologic evaluation of influenza virus infections. May 23, 2009 [Full text]
CDC. H1N1 clinicians questions and answers. Apr 8, 2010 [Full text]
CDC. H1N1 flu (swine flu): resources for K-12 schools. Dec 30, 2009 [Web page]
CDC. H1N1 flu (swine flu): resources for obstetric health care providers. Dec 14, 2009 [Full text]
CDC. H1N1 flu (swine flu): resources for people who are deaf and hard of hearing. Jun 2, 2009 [Full text]
CDC. H1N1 flu resources for businesses and employers. Aug 19, 2009 [Full text]
CDC. Healthcare providers and facilities: decision tree for 2009 H1N1 vaccination. Oct 5, 2009 [Full text]
CDC. Home care guidance: physician directions to patient/parent. Sep 24, 2009 [Full text]
CDC. Hospitalized patients with novel influenza A (H1N1) virus infection--California, April-May, 2009. MMWR 2009 May 18;58(Early Release):1-5 [Full text]
CDC. Influenza A (H1N1) 2009 monovalent vaccine safety monitoring: CDC planning recommendations for state, local, tribal, and territorial health officials. August 21, 2009 [Full text]
CDC. Influenza round table: warning signs. Released Nov 5, 2009 [Video for consumers]
CDC. Information for pregnant women working in education, child care, and health care settings concerning 2009 H1N1 influenza virus. Nov 9, 2009 [Full text]
CDC. Information on 2009 H1N1 impact by race and ethnicity. Q&A posted Feb 24, 2010 [Full text]
CDC. Intensive-care patients with severe novel influenza A (H1N1) virus infection--Michigan, June 2009. MMWR 2009 Jul 10;58(Dispatch):1-4 [Full text]
CDC. Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines--two counties, North Carolina, August 2009. MMWR 2009 Dec 25;58(50):1401-5 [Full text]
CDC. Interim biosafety guidance for all individuals handling clinical specimens or isolates containing 2009-H1N1 influenza A virus (novel H1N1), including vaccine strains. Aug 15, 2009 [Full text]
CDC. Interim guidance for correctional and detention facilities on novel influenza A (H1N1) virus. May 24, 2009 [Full text]
CDC. Interim guidance for emergency medical services (EMS) systems and 9-1-1 public safety answering points (PSAPs) for management of patients with confirmed or suspected swine-origin influenza A (H1N1) infection. Aug 5, 2009 [Full text]
CDC. Interim guidance for employers for protection of migrant and seasonal farmworkers from the novel H1N1 flu virus. May 5, 2009 [Full text]
CDC. Interim guidance for homeless and emergency shelters on the novel influenza A (H1N1) virus. Dec 21, 2009 [Full text]
CDC. Interim guidance for influenza surveillance: prioritizing RT-PCR testing in laboratories. Oct 9, 2009 [Full text]
CDC. Interim guidance for management of influenza-like illness aboard commercial aircraft during the 2009-10 influenza season. Nov 30, 2009 [Full text]
CDC. Interim guidance for public gatherings in response to human infections with novel influenza A (H1N1). Sep 23, 2009 [Full text]
CDC. Interim guidance for use of 23-valent pneumonococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak. Oct 26, 2009 [Full text]
CDC. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel. Jul 15, 2010 [Full text]
CDC. Interim guidance on specimen collection, processing, and testing for patients with suspected novel influenza A (H1N1) virus infection. May 13, 2009 [Full text]
CDC. Interim guidance: considerations regarding 2009 H1N1 influenza in intrapartum and postpartum hospital settings. Nov 10, 2009 [Full text]
CDC. Interim recommendations for facemask and respirator use to reduce novel influenza A (H1N1) virus transmission. Sep 24, 2009 [Full text]
CDC. Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination coverage among health-care personnel--United States, August 2009-January 2010. MMWR 2010 Apr 2;59(12):357-62 [Full text]
CDC. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage--United States, October-December 2009. MMWR 2010 Jan 15;59(Early release):1-5 [Full text]
CDC. Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage--United States, October 2009-January 2010. MMWR 2010 Apr 2;59(12):363-8 [Full text]
CDC. Introduction and transmission of 2009 pandemic influenza A (H1N1) virus--Kenya, June-July 2009. MMWR 2009 Oct 23;58(41):1143-6 [Full text]
CDC. Key issues for clinicians concerning antiviral treatments for 2009 H1N1. Health Alert Network (HAN) message released Nov 6, 2009 [Full text]
CDC. Key mental and behavioral health issues related to social distancing for state, local, and tribal health departments and community based organizations. May 5, 2009 [Full text]
CDC. Letter to providers promoting PPSV for adults. Nov 10, 2009 [Full text]
CDC. Limited human-to-human transmission of novel influenza A (H3N2) virus--Iowa, November 2011. MMWR 2011 Nov 23;60(Dispatch):1-3 [Full text]
CDC. Managing calls and call centers during a large-scale influenza outbreak: implementation tool. July 30, 2009 [Full text]
CDC. Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)--United States, April 2009-August 2010. MMWR 2011 Sep 9;60(35):1193-6 [Full text]
CDC. Monitoring influenza activity, including 2009 H1N1. (Q&A) May 28, 2010 [Full text]
CDC. Morbid obesity as a risk factor for hospitalization and death due to 2009 H1N1 (Q&A). Mar 16, 2010 [Full text]
CDC. Neurologic complications associated with novel influenza A (H1N1) virus infection in children--Dallas, Texas, May 2009. MMWR 2009 Jul 24;58(28):773-8 [Full text]
CDC. Non-safety-related voluntary recall of certain lots of Sanofi Pasteur H1N1 pediatric (0.25 mL, for 6-35 month olds) vaccine in pre-filled syringes questions & answers. Dec 15, 2009 [Full text]
CDC. Notice to readers: revised estimates of the public health impact of 2009 pandemic influenza A (H1N1) vaccination. MMWR 2011 Sep 30;60(38):1321 [Full text]
CDC. Novel H1N1 - creating a safe and healthy workplace. Podcast May 14, 2009 [Full text]
CDC. Novel H1N1 Flu Situation Update. Information about ongoing outbreak investigation. Jun 18, 2010 [Web page]
CDC. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. MMWR 2009 Sep 11;58(35):969-72 [Full text]
CDC. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients--Seattle, Washington, 2009. MMWR 2009 Aug 21;58(32):893-6 [Full text]
CDC. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March - April 2009. MMWR 2009 Apr 30;58(Dispatch):1-3 [Full text]
CDC. Pandemic influenza pediatric office plan template: product of a pediatric healthcare response to pandemic H1N1 influenza stakeholder meeting. Mar 3, 2010 [Full text]
CDC. Parental attitudes and experiences during school dismissals related to 2009 influenza A (H1N1)--United States, 2009. MMWR 2010 Sep 10;59(35):1131-4 [Full text]
CDC. Patients hospitalized with 2009 pandemic influenza A (H1N1)--New York City, May 2009. MMWR 2010 Jan 8;58(51&52):1436-40 [Full text]
CDC. Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection--Connecticut, 2009. MMWR 2009 Sep 25;58(37):1029-32 [Full text]
CDC. Planning guide for vaccinating pediatric patients against 2009 H1N1 influenza in primary healthcare settings. Nov 3, 2009 [Full text]
CDC. Post-mortem care and safe autopsy procedures for novel H1N1 influenza. May 28, 2009 [Full text]
CDC. Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine--United States, 2009-2010. MMWR 2010 Jun 2;59(Early release):1-5 [Full text]
CDC. Preparing for the flu: a communication toolkit for child care and early childhood programs. Mar 24, 2010 [Full text]
CDC. Preparing for the flu: a communication toolkit for institutions of higher education. Mar 25, 2010 [Full text]
CDC. Preparing for the flu: a communication toolkit for schools (grades K-12). Mar 24, 2010 [Full text]
CDC. Q & A: vaccine against 2009 H1N1 influenza virus. Oct 16, 2009 [Full text]
CDC. Questions & answers: Thimerosal and 2010-2011 seasonal flu vaccines. Oct 12, 2010 [Full text]
CDC. Questions and answers about updating guidance on infection control measures for influenza in healthcare settings. Jul 15, 2010 [Full text]
CDC. Receipt of A(H1N1)pdm09 vaccine by prisons and jails--United States, 2009-10 influenza season. MMWR 2012 Jan 6;60(51):1737-40 [Full text]
CDC. Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease. CDC Health Alert Network (HAN) info service message. Oct 19, 2009 [Full text]
CDC. Recommendations for use of antiviral medications for the management of influenza in children and adolescents for the 2009-2010 Season: pediatric supplement for health care providers. Dec 24, 2009 [Full text]
CDC. Regional influenza A (H1N1) 2009 monovalent vaccination campaign--Skokie, Illinois, October 16-December 31, 2009. MMWR 2010 Jul 30;59(29):909-13 [Full text]
CDC. Safety of influenza A (H1N1) 2009 monovalent vaccines--United States, October 1-November 24, 2009. MMWR 2009 Dec 4;58(Early release):1-6 [Full text]
CDC. Safety of thimerosal in vaccines against 2009 H1N1 flu. (Fact sheet) Jan 4, 2010 [Full text]
CDC. School-located vaccination planning materials and templates. Sep 13, 2009 [Full text]
CDC. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women--10 states, 2009-10 influenza season. MMWR 2010 Dec 3;59(47);1541-5 [Full text]
CDC. Self-reported influenza-like illness during the 2009 H1N1 influenza pandemic--United States, September 2009-March 2010. MMWR 2011 Jan 21;60(2):37-41 [Full text]
CDC. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 2009 May 22;58(19):521-4 [Full text]
CDC. Severe illness from 2009 pandemic influenza A (H1N1)--Utah, 2009-2010 influenza season. MMWR 2011 Sep 30;60(38):1310-4 [Full text]
CDC. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection--United States, April-August 2009. MMWR 2009 Sep 4;58(34):941-7 [Full text]
CDC. Surveillance for the 2009 pandemic influenza A (H1N1) virus and seasonal influenza viruses--New Zealand, 2009. MMWR 2009 Aug 28;58(33):918-21 [Full text]
CDC. Swine-origin influenza A (H3N2) virus infection in two children--Indiana and Pennsylvania, July-August 2011. MMWR 2011 Sep 2;60(Early release):1-4 [Full text]
CDC. Technical report for state and local public health officials and child care and early childhood providers on CDC guidance on helping child care and early childhood programs respond to influenza during the 2009-2010 influenza season. Feb 22, 2010 [Full text]
CDC. Technical report for state and local public health officials and school administrators on CDC guidance for school (K-12) responses to influenza during the 2009-2010 school year. Feb 22, 2010 [Full text]
CDC. Technical report on CDC guidance for responses to influenza for institutions of higher education during the 2009-2010 academic year. Feb 22, 2010 [Full text]
CDC. The 2009 H1N1 pandemic summary highlights, April 2009-April 2010. June 16, 2010 [Full text]
CDC. Update on influenza A (H1N1) 2009 monovalent vaccines. MMWR 2009 Oct 9;58(39):1100-1 [Full text]
CDC. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR 2009 Apr 28;58(Dispatch):1-3 [Full text]
CDC. Update: infections with a swine-origin influenza A (H1N1) virus--United States and other countries, April 28, 2009. MMWR 2009 Apr 28;58(Dispatch):1-3 [Full text]
CDC. Update: influenza activity--United States, 2009-10 season. MMWR 2010 Jul 30;59(29):901-8 [Full text]
CDC. Update: interim guidance - HIV-infected adults and adolescents: considerations for clinicians regarding novel influenza A(H1N1) virus. Oct 21, 2009 [Full text]
CDC. Update: novel influenza A (H1N1) virus infections--worldwide, May 6, 2009. MMWR 2009 May 8;58(17):453-8 [Full text]
CDC. Updated CDC Estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April, 2009 - April 10, 2010. May 14, 2010 [Full text]
CDC. Updated interim recommendations for obstetric health care providers related to use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Dec 29, 2009 [Full text]
CDC. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Dec 7, 2009 [Full text]
CDC. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 2009 Aug 21;58(Early release):1-8 [Full text]
CDC. What adults with HIV infection should know about 2009 H1N1 flu (formerly called swine flu). January 22, 2010 [Full text]
CDC. What should pregnant women know about 2009 H1N1 flu (swine flu). Oct 19, 2009 [Full text]
CDC. What to do if you get sick: 2009 H1N1 and seasonal. January 10, 2010 [Full text]
CDC/DHS. Guidance for businesses and employers to plan and respond to the 2009-2010 influenza season. Feb 22, 2010 [Full text]
Chakravarthy KV, Bonoiu A, Davis WG, et al. Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication. Proc Natl Acad Sci 2010 Jun 1;107(22):10172-7 [Abstract]
Chamberlain AT, Seib K, Wells K, et al. Perspectives of immunization program managers on 2009-10 H1N1 vaccination in the United States: a national survey. Biosecur Bioterror 2012 Mar 28;10(1):142-50 [Abstract]
Chan M, Chen MI, Chow A, et al. Pandemic (H1N1) 2009: clinical and laboratory findings of the first fifty cases in Singapore. Ann Acad Med Singapore 2010 Apr;39(4):267-72 [Full text]
Chan PP, Subramony H, Lai FYL, et al. Outbreak of novel influenza A (H1N1-2009) linked to a dance club. Ann Acad Med Singapore 2010 Apr;39(4):299-302 [Full text]
Chan TC, Hung IFN, Luk JKH, et al. Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: a one-year prospective cohort study. Vaccine 2011 Oct 13;29(44):7773-8 [Abstract]
Chanel O, Luchini S, Massoni S, et al. Impact of information on intentions to vaccinate in a potential epidemic: swine-origin influenza A (H1N1). Soc Sci Med 2011 Jan;72(2):142-8 [Abstract]
Chang LY, Chen WH, Lu CY, et al. Household transmission of pandemic (H1N1) 2009 virus, Taiwan. Emerg Infect Dis 2011 Oct;17(10):1928-31 [Full text]
Chang YS, van Hal SJ, Spencer PM, et al. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust 2010 Jan 18;192(2):90-3 [Full text]
Chao DL, Halloran ME, Longini IM. School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. J Infect Dis 2010 Sep 15;202(6):877-80 [Abstract]
Chao DL, Matrajt L, Basta NE, et al. Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. Am J Epidemiol 2011 May 15;173(10):1121-30 [Abstract]
Chao DY, Cheng KF, Hsieh YH, et al. Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine. Vaccine 2011 Jan 17;29(4):617-23 [Abstract]
Chao DY, Cheng KF, Li TC, et al. Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic. Int J Infect Dis 2011 Oct;15(10):e695-701 [Abstract]
Chao DY, Cheng KF, Li TC, et al. Serological evidence of subclinical transmission of the 2009 pandemic H1N1 influenza virus outside of Mexico. PLoS ONE 2011 Jan 18;6(1):e14555 [Full text]
Charania NA, Tsu LJS. A community-based participatory approach and engagement process creates culturally appropriate and community informed pandemic plans after the 2009 H1N1 influenza pandemic: remote and isolated First Nations communities of sub-arctic Ontario, Canada. BMC Public Health 2012 Apr 3;12:268 [Abstract]
Charu V, Chowell G, Mejia LSP, et al. Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis 2011 (published online Oct 5) [Abstract]
Checkley W. Extracorporeal membrane oxygenation as a first-line treatment strategy for ARDS. (Editorial) JAMA 2011 (published online Oct 5) [Full text]
Chen GL, Lau KF, Lamirande EW, et al. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proc Natl Acad Sci 2011 Jan 18;108(3):1140-5 [Abstract]
Chen GL, Min JY, Lamirande EW, et al. Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets. J Infect Dis 2011 Apr 1;203(7):930-6 [Abstract]
Chen H, Cheung CL, Tai H, et al. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis 2009 Dec;15(12):1970-2 [Full text]
Chen H, Wang Y, Liu W, et al. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. (Letter) Emerg Infect Dis 2009 Nov;15(11):1849-50 [Full text]
Chen H, Wen X, To KKW, et al. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis 2010 May 15;201:1517-21 [Abstract]
Chen LF, Dailey NJM, Rao AK, et al. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009. J Infect Dis 2011 Mar 15;203(6):838-46 [Abstract]
Chen LM, Rivailler P, Hossain J, et al. Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. Virology 2011 Apr 10;412(2):401-10 [Abstract]
Chen MI, Barr IG, Koh GCH, et al. Serological response in RT-PCR confirmed H1N1-2009 influenza A by hemagglutination inhibition and virus neutralization assays: an observational study. PLoS ONE 2010 Aug 30;5(8):e12474 [Full text]
Chen MIC, Lee VJM, Lim WY, et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 2010 Apr 14;303(14):1383-91 [Abstract]
Chen SC, Hawkins G, Aspinall E, et al. Factors influencing uptake of influenza A (H1N1) vaccine amongst healthcare workers in a regional pediatric centre: lessons for improving vaccination rates. Vaccine 2012 Jan 5;30(2):493-7 [Abstract]
Chen WC, Huang AS, Chuang JH, et al. Social and economic impact of school closure resulted from pandemic influenza A/H1N1. J Infect 2011 Mar;62(3):200-3 [Abstract]
Chen Z, Kim L, Subbarao K, et al. The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets. Vaccine 2012 Mar 28;30(15):2516-22 [Abstract]
Cheng AC, Kotsimbos T, Kelly HA, et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study. Vaccine 2011 Oct 6;29(43):7320-5 [Abstract]
Cheng VCC, Lau YK, Lee KL, et al. Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus. J Infect 2009 Nov;59(5):366-70 [Abstract]
Cheng VCC, To KKW, Tse H, et al. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 2012 Apr;25(2):223-63 [Abstract]
Chew C, Eysenbach G. Pandemics in the age of Twitter: content analysis of tweets during the 2009 H1N1 outbreak. PLoS ONE 2010 Nov 29;5(11):e14118 [Full text]
Chien JMF, Tan BH, Yang KS, et al. Severe infection with H1N1 requiring intensive care - lessons for preparedness programmes. Ann Acad Med Singapore 2010 Apr;39(4):328-32 [Full text]
Chien YS, Su CP, Tsai HT, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect 2010 Feb;60(2):168-74 [Abstract]
Chiu SS, Chan KH, Wong WHS, et al. Age-matched comparison of children hospitalized for 2009 pandemic H1N1 influenza with those hospitalized for seasonal H1N1 and H3N2. PLoS ONE 2011 Jul 20;6(7):e21837 [Full text]
Chlibek R, Anca I, Andre F, et al. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination. Vaccine 2010 May 14;28(22):3758-66 [Abstract]
Choe YJ, Cho H, Bae GR, et al. Guillain-Barre syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton collaboration case definition. Vaccine 2011 Mar 3;29(11):2066-70 [Abstract]
Choi SH, Chung JW, Jeon MH, et al. Risk factors for pandemic H1N1 2009 infection in healthcare personnel of four general hospitals. J Infect 2011 Oct;63(4):267-73 [Abstract]
Chopra T, Binienda J, Mohammed M, et al. A practical method for surveillance of novel H1N1 influenza using automated hospital data. Infect Control Hosp Epidemiol 2011 Jul;32(7):700-2 [Extract]
Chor JSY, Pada SK, Stephenson I, et al. Seasonal influenza vaccination predicts pandemic H1N1 vaccination uptake among healthcare workers in three countries. Vaccine 2011 Oct 6;29(43):7364-9 [Abstract]
Chou YY, Albrecht RA, Pica N, et al. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol 2011 Nov;85(21):11235-41 [Abstract]
Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009 Aug 13;361(7):674-9 [Full text]
Chowell G, Eschevarria-Zuno S, Viboud C, et al. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med 2011 May 24;8(5):e1000436 [Full text]
Chowell G, Viboud C, Munayco CV, et al. Spatial and temporal characteristics of the 2009 A/H1N1 influenza pandemic in Peru. PLoS ONE 2011 Jun 21;6(6):e21287 [Full text]
Chowell G, Viboud C, Simonsen L, et al. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico. BMC Infect Dis 2012 Apr 20;12:97 [Abstract]
Chu CY, Li CY, Zhang H, et al. Quarantine methods and prevention of secondary outbreak of pandemic (H1N1) 2009. Emerg Infect Dis 2010 Aug;16(8):1300-2 [Full text]
Chu TP, Li CC, Wang L, et al. A surveillance system to reduce transmission of pandemic H1N1 (2009) influenza in a 2600-bed medical center. PLoS ONE 2012 Mar 13;7(3):e32731 [Full text]
Chuang JH, Huang AS, Huang WT, et al. Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan. PLoS ONE 2012 Apr 24;7(4):e36120 [Full text]
Chutinimitkul S, Herfst S, Steel J, et al. Virulence-associated substitution D222G in hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol 2010 Nov;84(22):11802-13 [Abstract]
Cianchi G, Bonizzoli M, Pasquini A, et al. Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center. BMC Pulm Med 2011 Jan 11;11:2 [Abstract]
CIDRAP. H1N1 & higher ed lessons learned: pandemic influenza tools, tips, and takeaways from the Big 10+2 universities. Released Dec 7, 2010 [Full text]
Cilloniz C, Ewig S, Manendez R, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect 2012 (published online Apr 26) [Abstract]
Cilloniz C, Ewig S, Menendez R, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect 2012 (published online Apr 30) [Abstract]
Cinti S, Haas K, Paliani P, et al. Efficacy of surveillance for 2009 H1N1 pandemic within a healthcare system. Infect Control Hosp Epidemiol 2011 Aug;32(8):811-4 [Abstract]
Clark TW, Pareek M, Hoschler K, et al. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine. N Engl J Med 2009 Dec 17;361(125):2424-35 [Full text]
Clin Infect Dis editors. The 2009 H1N1 influenza pandemic: field and epidemiologic investigations. Clin Infect Dis 2011 Jan 1;52(suppl 1): special supplement published Dec 14, 2010 [Table of contents]
Cline TD, Karlsson EA, Freiden P, et al. Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin. J Virol 2011 Dec;85(23):12262-70 [Abstract]
Coburn BJ, Wagner BG, Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med 2009 Jun 22;7:30 [Abstract]
Cohen D, Carter P. WHO and the pandemic flu "conspiracies." BMJ 2010 Jun 3;340:c2912 [Excerpt]
Cohen NJ, Callahan DB, Gonzalez V, et al. Respiratory illness in households of school-dismissed students during influenza pandemic, 2009. (Letter) Emerg Infect Dis 2011 Sep;17(9):1756-7 [Full text]
Coleman BL, Kuster SP, Gubbay J, et al. Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort study. Eur J Clin Microbiol Infect Dis 2011 (published online Jul 28) [Abstract]
Coleman LA, Waring SC, Irving SA, et al. Evaluation of obesity as an independent risk factor for medically attended laboratory-confirmed influenza. Influenza Other Respi Viruses 2012 (published online May 14) [Abstract]
Collin N, de Radigues X, WHO H1N1 Vaccine Task Force. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 2009 Aug 20;27(38):5184-6 [Abstract]
Colombatti R, Perrotta S, Masera N, et al. Lessons learned from the H1N1 pandemic: the need to improve systematic vaccination in sickle cell disease children. A multi center survey in Italy. Vaccine 2011 Feb 1;29(6):1126-8 [Abstract]
Cook AR, Chen MIC, Lin RTP. Internet search limitations and pandemic influenza, Singapore. (Letter) Emerg Infect Dis 2010 Oct;16(10):1647-9 [Full text]
Cook S, Conrad C, Fowlkes AL, et al. Assessing Google flu trends performance in the United States during the 2009 influenza virus A (H1N1) pandemic. PLoS ONE 2011 Aug 19;6(8):e23610 [Full text]
Coory M, Grant K, Kelly H. Influenza-like illness surveillance using a deputizing medical service corresponds to surveillance from sentinel general practices. Euro Surveill 2009 Nov 5;14(44):pii:19387 [Full text]
Cordero E, Aydillo T, Farinas MC, et al. Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis 2011 (published online Jul 26) [Abstract]
Corti D, Suguitan AL Jr, Pinna D, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 2010 May 3;120(5):1663-73 [Full text]
Cotte L, Voirin N, Richard C, et al. Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients. Vaccine 2011 Aug 5;29(34):5638-44 [Abstract]
Couch RB, Atmar RL, Franco LM, et al. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults. Clin Infect Dis 2011 (published online Nov 10) [Abstract]
Council of the European Union. Council conclusions on lessons learned from the A/H1N1 pandemic: health security in the European Union. Sep 13, 2010 [Full text]
Courtney B, Morhard R, Bouri N, et al. Expanding practitioner scopes of practice during public health emergencies: experiences from the 2009 H1N1 pandemic vaccination efforts. Biosecur Bioterror 2010 Sep 8;8(3):223-31 [Abstract]
Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010 Jun 10;362(23):2175-84 [Full text]
Cowling BJ, LLH, Wu P, et al. Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis 2010 Mar 30;10:82 [Abstract]
Cowling BJ, Ng DMW, Ip DKM, et al. Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong. J Infect Dis 2010 Sep 15;202(6):867-76 [Abstract]
Cowling BJ, Ng S, Ma ESK, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010 Dec 15;51(12):1370-9 [Abstract]
Cox CM, Blanton L, Dhara R, et al. 2009 pandemic influenza A (H1N1) deaths among children--United States, 2009-2010. Clin Infect Dis 2011 Jan 1;52(suppl 1):S69-74 [Full text]
Cox CM, Goodin K, Fisher E, et al. Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009. PLoS ONE 2011 Dec 20;6(12):e29301 [Full text]
Cramer JP, Mac T, Hogan B, et al. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany. Euro Surveill 2012 Jan 12;17(2):pii=20052 [Full text]
Crawford JM, Stallone R, Zhang F, et al. Laboratory surge response to pandemic (H1N1) 2009 outbreak, New York City metropolitan area, USA. Emerg Infect Dis 2010 Jan;16(1):8-13 [Full text]
Creanga AA, Kamimoto L, Newsome K, et al. Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. Am J Obstet Gynecol 2011 Jun;204(6):S38-45 [Abstract]
Cristina C, Marco T, Pasquale P, et al. Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district. Vaccine 2011 Apr 18;29(18):3443-8 [Abstract]
Crossley B, Hietala S, Hunt T, et al. Pandemic (H1N1) 2009 in captive cheetah. Emerg Infect Dis 2012 Feb;18(2):315-7 [Full text]
CRS (Congressional Research Service). Potential farm sector effects of 2009 H1N1 'swine flu': questions and answers. Posted Jun 17, 2009 (but dated May 20) [Full text]
CRS (Congressional Research Service). The 2009 influenza A(H1N1) 'swine flu' outbreak: US response to global human cases. Posted Jun 17, 2009 (but dated May 26) [Full text]
CRS (Congressional Research Service). The 2009 influenza pandemic: an overview. First published Apr 30, 2009; updated regularly [Full text]
CRS (Congressional Research Service). The 2009 influenza pandemic: selected legal issues. First published May 6, 2009; updated regularly [Full text]
Crum-Cianflone NF, Iverson E, Defang G, et al. Durability of antibody responses after receipt of the monovalent 2009 influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine 2011 Apr 12;29(17):3183-91 [Abstract]
Cruz AT, Demmler-Harrison GJ, Caviness AC, et al. Performance of a rapid influenza test in children during the H1N1 2009 influenza A outbreak. Pediatrics 2010 Mar 3;125(3):645-50 [Abstract]
Cruz AT, Patel B, DiStefano MC, et al. Outside the box and into thick air: implementation of an exterior mobile pediatric emergency response team for North American H1N1 (Swine) influenza virus in Houston, Texas. Ann Emerg Med 2010 Jan;55(1):23-31 [Abstract]
Cruz-Pacheco G, Duran L, Esteva L, et al. Modelling of the influenza A(H1N1)v outbreak in Mexico City, April-May 2009, with control sanitary measures. (Rapid communications) Eurosurveill 2009 Jul 2;14(26):pii=19254 [Full text]
Cui W, Zhao H, Lu X, et al. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis 2010 May 31;10:145 [Abstract]
Cullen G, Martin J, O'Donnell J, et al. Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April-3 October 2009. Euro Surveill 2009 Nov 5;14(44):pii:19389 [Full text]
Cutler J, Schleifhauf E, Hatchette TF, et al. Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) in Canada. CMAJ 2009 Aug 4;181(3-4):159-63 [Full text]
Cutter JL, Ang LW, Lai FYL, et al. Outbreak of pandemic influenza A (H1N1-2009) in Singapore, May to September 2009. Ann Acad Med Singapore 2010 Apr;39(4):273-82 [Full text]
D'Ortenzio E, Do C, Renault P, et al. Enhanced influenza surveillance on Reunion island (Southern Hemisphere) in the context of the emergence of influenza A(H1N1)V. (Rapid communications) Eurosurveill 2009 Jun 11;14(23):pii=19239 [Full text]
Dalt LD, Calistri A, Chillemi C, et al. Oseltamivir-resistant pandemic (H1N1) 2009 treated with nebulized zanamivir. (Letter) Emerg Infect Dis 2010 Nov;16(11):1813-5 [Full text]
Daugherty EL, Carlson AL, Perl TM. Planning for the inevitable: preparing for epidemic and pandemic respiratory illness in the shadow of H1N1 influenza. Clin Infect Dis 2010 Apr 15;50(8):1145-54 [Abstract]
Dawood FS, Dong L, Liu F, et al. A pre-pandemic outbreak of triple-reassortant swine influenza virus infection among university students, South Dakota, 2008. J Infect Dis 2011 Oct 15;204(8):1165-71 [Abstract]
Dawood FS, Hope KG, Durrheim DN, et al. Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England, Northern New South Wales, Australia, 2009. PLoS ONE 2010 Mar 25;5(3):e9880 [Full text]
Dawood FS, Kamimoto L, D'Mello TA, et al. Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009. Pediatrics 2011 (published online Jun 6) [Abstract]
de Picoli Jr S, Teixeira JJV, Ribeiro HV, et al. Spreading patterns of the influenza A (H1N1) pandemic. PLoS ONE 2011 Mar 31;6(3):e17823 [Full text]
De Serres G, Rouleau I, Hamelin ME, et al. Contagious period for pandemic (H1N1) 2009. Emerg Infect Dis 2010 May;16(5):783-8 [Full text]
De Vleeschauwer A, Atanasova K, Van Borm S, et al. Comparative pathogenesis of an avian H5N2 and a swine H1N1 influenza virus in pigs. PLoS ONE 2009 Aug 17;4(8):e6662 [Full text]
Dee DL, Bensyl DM, Gindler J, et al. Racial and ethnic disparities in hospitalizations and deaths associated with 2009 pandemic influenza A (H1N1) virus infections in the United States. Ann Epidemiol 2011 Aug;21(8):623-30 [Abstract]
Dee S, Jayathissa S. Clinical and epidemiological characteristics of the hospitalised patients due to pandemic H1N1 2009 viral infection: experience at Hutt Hospital, New Zealand. N Z Med J 2010 Apr 9;123(1312):45-53 [Abstract]
Deeks SL, Lim GH, Simpson MA, et al. Estimating background rates of Guillain-Barre syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign. BMC Public Health 2011 May 17;11:329 [Abstract]
del Campo MT, Villamor JM, Caceres S, et al. 2009-2010 seasonal and pandemic A (H1N1) influenza vaccination among healthcare workers. Vaccine 2011 May 9;29(20):3703-7 [Full text]
Deng YM, Iannello P, Smith I, et al. Transmission of influenza A(H1N1) 2009 pandemic viruses in Australian swine. Influenza Other Respi Viruses 2012 Mar;6(3):e42-7 [Abstract]
Denholm JT, Gordon CL, Johnson PD, et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust 2010 Jan 18;192(2):84-6 [Full text]
Denney L, Aitken C, Li CKF, et al. Reduction of natural killer but not effector CD8 T Lymphoyctes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection. PLoS ONE 2010 May 18;5(5):e10675 [Full text]
Depoortere E, Mantero J, Lenglet A, et al. Influenza A(H1N1)v in the Southern Hemisphere - lessons to learn for Europe? (Editorial) Eurosurveill 2009 Jun 18;14(24):pii=19246 [Full text]
DeStefano F, Vellozzi C, Schonberger LB, et al. Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines. (Editorial) BMJ 2011 Jul 12;343:d4159 [Abstract]
Devaux I, Kreidl P, Penttinen P, et al. Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009. Euro Surveill 2010 Dec 9;15(49):pii=19740 [Full text]
DeVries A, Wotton J, Lees C, et al. Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection. Influenza Other Respi Viruses 2012 (published online Jan 14) [Abstract]
Dexler JF, Helmer A, Kirberg H, et al. Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis 2009 Oct;15(10):1662-4 [Full text]
Dhanireddy S, Harrington RD, Crane HM, et al. Pandemic (H1N1) 2009 and HIV infection. (Letter) Emerg Infect Dis 2011 Jun;17(6):1140-3 [Full text]
Dhanoa A, Fang NC, Hassan SS, et al. Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection. Virol J 2011 Nov 3;8:501 [Abstract]
DHS. Planning for 2009 H1N1 influenza: a preparedness guide for small business. Sep 14, 2009 [Full text]
Di Giambenedetto S, Verme LZD, Sali M, et al. Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection. Euro J Clin Microbiol Infect Dis 2011 Apr;30(4):541-9 [Abstract]
Diaz E, Martin-Loeches I, Canadell L, et al. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect 2012 Mar;64(3):311-8 [Abstract]
DiBiase LM, Davis SHE, Rosselli R, et al. Evaluation of the implementation of the H1N1 pandemic influenza vaccine in local health departments (LHDs) in North Carolina. Vaccine 2011 May 23;29(23):3969-76 [Abstract]
Dieleman J, Romio S, Johansen K, et al. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011 Jul 12;343:d3908 [Full text]
Dimitrov NB, Goll S, Hupert N, et al. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza. PLoS ONE 2011 Jan 19;6(1):e16094 [Full text]
Ding H, Santibanez TA, Jamieson DJ, et al. Influenza vaccination coverage among pregnant women--National 2009 H1N1 Flu Survey (NHFS). Am J Obstet Gynecol 2011 Jun;204(6 suppl):S96-106 [Abstract]
Dlugacz Y, Fleischer A, Carney MT, et al. 2009 H1N1 vaccination by pregnant women during the 2009-10 H1N1 influenza pandemic. Am J Obstet Gynecol 2012 Apr;206(4):339.e1-8 [Abstract]
Doerr HW, Allwinn R, Cinatl J. Against the new H1N1 influenza (swine influenza): vaccinate or don't vaccine (all)? That is currently the question! (Editorial) Infection 2009 Oct;37(5):379-80 [Full text]
Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009 Nov 4;302(17):1880-7 [Full text]
Donaldson LJ, Rutter PD, Ellis BM, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009 Dec 10;339:b5213 [Abstract]
Dorian A, Rottman SJ, Shoaf K, et al. The novel influenza A H1N1 epidemic of spring 2009: national after action workshop on a federal public health emergency: 21-22 September 2009 Torrance, California. Prehosp Disaster Med 2009 (published online Nov 18) [Full text]
Doshi S, Kamimoto L, Finelli L, et al. Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. J Infect Dis 2011 (published online Oct 19) [Abstract]
Doyle TJ, Hopkins RS. Low secondary transmission of 2009 pandemic influenza A (H1N1) in households following an outbreak at a summer camp: relationship to timing of exposure. Epidemiol Infect 2011 Jan;139(1):45-51 [Abstract]
Drago R, Miller K. Sick at work: infected employees in the workplace during the H1N1 pandemic. Institute for Women's Policy Research briefing paper. Feb 8, 2010 [Abstract]
Drysdale SB, Alcazar M, Wilson T, et al. Pandemic influenza A (H1N1) virus 2009 in a prospectively followed cohort of prematurely born infants. Pediatr Infect Dis J 2012 Jan;31(1):91-2 [Abstract]
Du N, Zhou J, Lin X, et al. Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol 2010 Aug;84(15):7822-31 [Abstract]
Du QS, Huang RB, Wang SQ, et al. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus. PLoS One 2010 Feb 23;5(2):e9388 [Full text]
Duan S, Boltz DA, Seiler P, et al. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog 2010 Jul 29;6(7):e1001022 [Full text]
Dubar G, Azria E, Tesniere A, et al. French experience of 2009 A/H1N1v influenza in pregnant women. PLoS ONE 2010 Oct 5;5(10):e13112 [Full text]
Dube E, Defay F, Gilca V, et al. A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians opinions before and after the beginning of the vaccination campaign. BMC Public Health 2011 Feb 22;11:128 [Abstract]
Dublineau A, Batejat C, Pinon A, et al. Persistence of the 2009 pandemic influenza A (H1N1) virus in water and on non-porous surface. PLoS ONE 2011 Nov 23;6(11):e28043 [Full text]
Ducatez MF, Fabrizio TP, Webby RJ. Evolution and adaptation of the pandemic A/H1N1 2009 influenza virus. Virus Adapt Treat 2011 Jul;3:45-53 [Abstract]
Ducatez MF, Hause B, Stigger-Rosser E, et al. Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis 2011 Sep;17(9):1624-9 [Full text]
Dudareva S, Schweiger B, Thamm M, et al. Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS ONE 2011 Jun 20;6(6):e21340 [Full text]
Dulek DE, Williams JV, Creech CB, et al. Use of intravenous zanamivir after development of oseltamivir resistance in a critically ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clin Infect Dis 2010 Jun 1;50:1493-6 [Abstract]
Dulyachai W, Makkoch J, Rianthavorn P, et al. Perinatal pandemic (H1N1) 2009 infection, Thailand. (Letter) Emerg Infect Dis 2010 Feb;16(2):343-4 [Full text]
Duncan C, Guthrie JL, Tijet N, et al. Analytical and clinical validation of novel real-time reverse transcriptase-polymerase chain reaction assays for the clinical detection of swine-origin H1N1 influenza viruses. Diagn Microbiol Infect Dis 2011 Feb;69(2):167-71 [Abstract]
Dundon WG, Benedictis PD, Viale E, et al. Serologic evidence of pandemic (H1N1) 2009 infection in dogs, Italy. (Letter) Emerg Infect Dis 2010 Dec;16(12):2019-21 [Full text]
Dupras C, Williams-Jones B. The expert and the lay public: reflections on influenza A (H1N1) and the risk to society. Am J Public Health 2012 Apr;102(4):591-5 [Abstract]
Durrwald R, Krumbholz A, Baumgarte S, et al Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity. (Letter) Emerg Infect Dis 2010 Jun;16(6):1029-30 [Full text]
Duwe SC, Wedde M, Birkner P, et al. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany. Antiviral Res 2011 Jan;89(1):115-8 [Abstract]
Dwyer DE, The INSIGHT Influenza Study Group. Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies. Vaccine 2011 Jul 22;29(suppl 2):B56-62 [Abstract]
Eames KT, Tilston NL, White PJ, et al. The impact of illness and the impact of school closure on social contact patterns. Health Technol Assess 2010 Jul; 14(34):267-312 [Abstract]
Earn DJD, He D, Loeb MB, et al. Effects of school closure on incidence of pandemic influenza in Alberta, Canada. Ann Intern Med 2012 Feb 7;156(3):173-81 [Abstract]
Eastwood K, Durrheim DN, Butler M, et al. Responses to pandemic (H1N1) 2009, Australia. Emerg Infect Dis 2010 Aug;16(8):1211-6 [Full text]
ECDC (European Centre for Disease Prevention and Control). ECDC interim guidance: use of specific pandemic influenza vaccines during the H1N1 2009 pandemic. Aug 2009 [Full text]
ECDC (European Centre for Disease Prevention and Control). Likely evolution of the epidemics/pandemic of a new A(H1N1) influenza. ECDC module, published May 11, updated periodically [PPT]
ECDC (European Centre for Disease Prevention and Control). Likely scenarios for influenza in 2010 and the 2010/2011 influenza season in Europe and the consequent work priorities. Mar 8, 2010 [Full text]
ECDC (European Centre for Disease Prevention and Control). Pandemic phase level 4: human cases of the novel influenza A/H1N1 strain confirmed in Scotland and Spain. Eurosurveill 2009 Apr 30;14(17):pi=19185 [Full text]
ECDC (European Centre for Disease Prevention and Control). Report on the association between the 2009 pandemic vaccine (Pamdemrix) and narcolepsy--Republic of Ireland. Apr 19, 2012 [Full text]
ECDC Influenza Team. Start of the influenza season 2010-11 in Europe dominated by 2009 pandemic influenza A(H1N1) virus. Euro Surveill 2010 Dec 16;15(50):pii=19753 [Full text]
ECDC Technical Emergency Team. Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). (Rapid communications) Eurosurveill 2009 May 7;14(18):pi=19204 [Full text]
ECDC Working Group on Influenza A(H1N1)V. Preliminary analysis of influenza A(H1N1)V individual and aggregated case reports from EU and EFTA countries. (Rapid communications) Eurosurveill 2009 Jun 11;14(23):pii=19238 [Full text]
ECDC. 2009 pandemic influenza A(H1N1) virus mutations reported to be associated with severe disease. Dec 23, 2009 [Full text]
ECDC. ECDC interim risk assessment: influenza A(H1N1) 2009 pandemic. Document released Dec 17, 2009 [Full text]
ECDC/WHO. Key changes to pandemic plans by member states of the WHO European Region based on lessons learnt from the 2009 pandemic. Apr 4, 2012 [Full text]
Echavarria M, Querci M, Marcone D, et al. Pandemic (H1N1) 2009 cases, Buenos Aires, Argentina. Emerg Infect Dis 2010 Feb;16(2):311-3 [Full text]
Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso AJ, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009 Dec 19;374(9707):2072-9 [Abstract]
Ede LC, Loeffelholz MJ, Alvarez-Fernandez P, et al. Effect of the 2009 influenza A/H1N1 pandemic on viral respiratory infections in the first year of life. Pediatr Infect Dis J 2012 (published online May 16) [Abstract]
Editorial Staff. Could swine flu tip the world into deflation? Oxford Econ 2009 (published online Jun 22) [Full text]
Effler PV, Carcione D, Giele C, et al. Household responses to pandemic (H1N1) 2009-related school closures, Perth, Western Australia. Emerg Infect Dis 2010 Feb;16(2):205-11 [Full text]
Ehrlich HJ, Muller MKollaritsch H, et al. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Vaccine 2012 (published online Apr 1) [Abstract]
Ekstrand JJ, Herbener A, Rawlings J, et al. Heightened neurologic complications in children with pandemic influenza. Ann Neurol 2010 Nov;68(5):762-6 [Abstract]
Elizondo-Montemayor L, Alvarez MM, Hernandez-Torre M, et al. Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method. Int J Infect Dis 2011 Nov;15(11):e781-6 [Abstract]
Ellebedy AH, Ducatez MF, Duan S, et al. Impact of prior seasonal influenza vaccination and infection on pandemic A(H1N1) influenza virus replication in ferrets. Vaccine 2011 Apr 12;29(17):3335-9 [Full text]
Ellington SR, Hartman LK, Acosta M, et al. Pandemic 2009 influenza A (H1N1) in 71 critically ill pregnant women in California. Am J Obstet Gynecol 2011 Jun;204(6):S21-30 [Abstract]
Elliot A. Syndromic surveillance: the next phase of public health monitoring during the H1N1 influenza pandemic? Euro Surveill 2009 Nov 5;14(44):pii:19391 [Full text]
Elliot AJ, Powers C, Thornton A, et al. Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS Direct. BMJ 2009 Aug 27;339:b3403 [Abstract]
Ellis J, Galiano M, Pebody R, et al. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill 2011 Jan 6;16(1):pii=19760 [Full text]
Ellis J, Iturriza M, Allen R, et al. Evaluation of four real-time assays for detection of influenza A (H1N1)V viruses. (Rapid communications) Eurosurveill 2009 Jun 4;14(22):pi=19230 [Full text]
Emam KE, Mercer J, Moreau K, et al. Physician privacy concerns when disclosing patient data for public health purposes during a pandemic influenza outbreak. BMC Public Health 2011 Jun 9;11:454 [Abstract]
Engelhard D, Bromberg M, Averbuch D, et al. Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal influenza among children, Israel. Emerg Infect Dis 2011 Sep;17(9):1740-3 [Full text]
Enstone JE, Myles PR, Openshaw PJM, et al. Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010. Emerg Infect Dis 2011 Apr;17(4):592-8 [Full text]
Eposito S, Pugni L, Daleno C, et al. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Pediatrics 2011 May;127(5):e1161-8 [Abstract]
Eppes CS, Garcia PM, Grobman WA. Telephone triage of influenza-like illness during pandemic 2009 H1N1 in an obstetric population. Am J Obstet Gynecol 2012 (published online Mar 2) [Abstract]
Epstein JM. Modelling to contain pandemics. (Opinion) Nature 2009 Aug 6;460(7256):687 [Full text]
Erden I, Erden EC, Ozhan H, et al. Echocardiographic manifestations of pandemic 2009 (H1N1) influenza A virus infection. J Infect 2010 Jul;61(1):60-5 [Abstract]
Eshaghi A, Patel AN, Sarabia A, et al. Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child. Emerg Infect Dis 2011 Aug;17(8):1472-4 [Full text]
Esper FP, Spahlinger T, Zhou L. Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect 2011 Oct;63(4):260-6 [Abstract]
Esposito S, Daleno C, Baldanti F, et al. Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus. Virol J 2011 Jul 13;8:349 [Abstract]
Esposito S, Daleno C, Tagliabue C, et al. Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus. Virol J 2011 Dec 30;8:563 [Abstract]
Esposito S, Molteni CG, Daleno C, et al. Impact of pandemic A/H1N1/2009 influenza on children and their families: comparison with seasonal A/H1N1 and A/H3N2 influenza viruses. J Infect 2011 Oct;63(4):300-7 [Abstract]
Esposito S, Tagliaferri L, Daleno C, et al. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. Vaccine 2011 Feb 11;29(8):1677-82 [Abstract]
Evans D, Cauchemez S, Hayden FG. "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. J Infect Dis 2009 Aug 1;200:321-8 [Abstract]
Fabbiani M, Giambenedetto SD, Sali M, et al. Immune response to influenza A (H1N1) monovalent MF59-adjuvanted vaccine in HIV-infected patients. Vaccine 2011 Apr 5;29(16):2836-9 [Abstract]
Fabry P, Gagneur A, Pasquier JC. Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec. Vaccine 2011 Feb 17;29(9):1824-9 [Abstract]
Faix DJ, Hawksworth AW, Myers CA, et al. Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses. PLoS ONE 2012 Apr 13;7(4):e34581 [Full text]
Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. (Letter) N Engl J Med 2009 Aug 13;361:728-9 [Full text]
Falagas ME, Cholevas NV, Kapaskelis AM, et al. Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis 2010 Nov;29(11):1327-47 [Abstract]
Falagas ME, Koletsi PK, Baskouta E, et al. Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience. Epidemiol Infect 2011 Jan;139(1):27-40 [Abstract]
Fan X, Zhu H, Zhou B, et al. Emergence and dissemination of a swine H3N2 reassortant with 2009 pandemic H1N1 genes in pigs in China. J Virol 2011 (published online Dec 14) [Abstract]
Fanella ST, Pinto MA, Bridger NA, et al. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave. Infect Control Hosp Epidemiol 2011 May;32(5):435-43 [Abstract]
Fang L, Lin J, Chai C, et al. Risk factors for severe cases of 2009 influenza A (H1N1): a case control study in Zhejiang province, China. PLoS ONE 2012 Mar 28;7(3):e34365 [Full text]
FAO. FAO guidelines for surveillance of pandemic H1N1/2009 and other influenza viruses in swine populations. Aug 11, 2009 [Full text]
FAO/WHO/OIE. Joint FAO/WHO/OIE statement of influenza A(H1N1) and the safety of pork. May 6, 2009 [Full text]
Farias DR, Raffo L, Bacigalupo S, et al. Data for decision making: strategic information tools for hospital management during a pandemic. Disaster Med Public Health Prep 2010 Oct;4:207-12 [Abstract]
Farnsworth A, Cyr TD, Li C, et al. Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain. Vaccine 2011 Feb 11;29(8):1529-33 [Abstract]
Fatiregun AA, Adeyemo AA, Olowookere SA. Willingness to receive pandemic influenza A (H1N1) vaccine among doctors and nurses in public health facilities in Ibadan, Nigeria. Vaccine 2012 Mar 16;30(13):2315-9 [Abstract]
Fawkner-Corbett DW, doCarmo MMBD, Rose K, et al. The impact of the H1N1 influenza pandemic on clinical presentations and viral epidemiology of acute respiratory infection in pre-school children in Brazil. Pediatr Infect Dis J 2012 Jun;31(6):653-5 [Abstract]
FDA. Dear Health Care Professionals: 2009 H1N1 flu virus. (Letter) (published online May 7, 2010) [Full text]
FDA. FDA approves vaccines for the 2010-2011 influenza season. Released Jul 30, 2010 [Full text]
FDA. Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. Released Mar 2, 2010 [Full text]
FDA. Letter from the commissioner to nation's healthcare professionals on H1N1 vaccine. Nov 10, 2009 [Full text]
FDA. Peramivir IV questions and answers for health care providers. Jun 24, 2010 [Full text]
FDA. Questions and answers on the 2009 H1N1 flu virus and the food industry. May 7, 2009 [Full text]
FDA/CDC. FDA and CDC information on potential "spot shortages" of supplies for treating and preventing novel influenza A (H1N1). May 4, 2009, news release [Full text]
Fell DB, Sprague AE, Liu N, et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 2012 (published online Apr 19) [Abstract]
Fereidouni SR, Beer M, Vahlenkamp T, et al. Differentiation of two distinct clusters among currently circulating influenza A(H1N1)v viruses, March-September 2009. Euro Surveill 2009 Nov 19;14(46):pii:19409 [Full text]
Ferguson M, Risi G, Davis M, et al. Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant. J Infect Dis 2012 Mar 1;205(5):733-44 [Abstract]
Ferrante G, Baldissera S, Moghadam PF, et al. Surveillance of perceptions, knowledge, attitudes and behaviors of the Italian adult population (18-69 years) during the 2009-2010 A/H1N1 influenza pandemic. Eur J Epidemiol 2011 Mar;26(3):211-9 [Abstract]
Fidler DP. Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. PLoS Med 2010 May 4;7(5):e1000247 [Full text]
Fielding JE, Grant KA, Garcia K, et al. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerg Infect Dis 2011 Jul;17(7):1181-7 [Full text]
Fietje EH, Philbert D, van Geffen ECG, et al. Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands. (Letter) Emerg Infect Dis 2012 Mar;18(3):534-5 [Full text]
Fiore AE, Neuzil KM. 2009 A(H1N1) monovalent vaccines for children. (Editorial) JAMA 2010 Jan 6;303(1):73-4 [Extract]
Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR 2010 Jul 29;59(Early release):1-62 [Full text]
Firstenberg MS, Blais D, Louis LB, et al. Extracorporeal membrane oxygenation for pandemic (H1N1) 2009. (Letter) Emerg Infect Dis 2009 Dec;15(12):2059-60 [Full text]
Fisher BM, Bockern JV, Hart J, et al. Pandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancy. PLoS ONE 2012 Mar 22;7(3):e33048 [Full text]
Fisher BM, Scott J, Hart J, et al. Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy. Am J Obstet Gynecol 2011 Jun;204(6 suppl):S107-11 [Abstract]
Fisher D, Hui D, Gao Z, et al. Pandemic response lessons from influenza H1N1 2009 in Asia. Respirology 2011 Aug;16(6):876-82 [Abstract]
Fisman DN, Savage R, Jackson P. Older age and a reduced likelihood of 2009 H1N1 virus infection. (Letter) N Engl J Med 2009 Nov 12;361(20):2000-1 [Full text]
Flahault A, Vergu E, Boelle PY. Potential for a global dynamic of influenza A (H1N1). BMC Infect Dis 2009 Aug 12;9:129 [Abstract]
Flynn PM, Nachman S, Muresan P, et al. Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1 infected children and youth. J Infect Dis 2012 (published online May 21) [Abstract]
Fogarty AS, Holland K, Imison M, et al. Communicating uncertainty -- how Australian television reported H1N1 risk in 2009: a content analysis. BMC Public Health 2011 Mar 24;11:181 [Abstract]
Foisy J, Quach S, Heidebrecht CL, et al. Perceptions of frontline staff regarding data collection methodologies used during the 2009 A H1N1 influenza immunization campaign in Canada. BMC Public Health 2010 Dec 30;10:796 [Abstract]
Folkenberg M, Callreus T, Svanstrom H, et al. Spontaneous reporting of adverse events following immunization against pandemic influenza in Denmark November 2009-March 2010. Vaccine 2011 Feb 1;29(6):1180-4 [Abstract]
Follin P, Lindqvist A, Nystrom K, et al. A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)v virus strain. (Rapid communications) Eurosurveill 2009 Jun 18;14(24):pii=19242 [Full text]
Forgie SE, Keenliside J, Wilkinson C, et al. Swine outbreak of pandemic influenza A virus on a Canadian research farm supports human-to-swine transmission. Clin Infect Dis 2011 Jan 1;52(1):10-8 [Abstract]
Fowlkes AL, Arguin P, Biggerstaff MS, et al. Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. Clin Infect Dis 2011 Jan 1;52(suppl 1):S60-8 [Abstract]
Foxwell AR, Roberts L, Lokuge K, et al. Transmission of influenza on international flights, May 2009. Emerg Infect Dis 2011 Jul;17(7):1188-94 [Full text]
Fraaij PLA, van der Vries E, Beersma MFC, et al. Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection. J Infect Dis 2011 Sep 1;204(5):777-82 [Abstract]
France AM, Jackson M, Schrag S, et al. Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. J Infect Dis 2010 Apr 1;201(7):984-92 [Abstract]
France MW, Tai S, Masel PJ, et al. The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis. BMC Pulm Med 2010 Feb 25;10:8 [Abstract]
Franco-Paredes C, Carraso P, Preciado JI. The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness. J Immune Based Ther Vaccines 2009 Aug 7;7:2 [Full text]
Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a novel strain of influenza A (H1N1): early findings. Science 2009 Jun 19;324(5934):1557-61 [Full text]
Freund R, Ray CL, Charlier C, et al. Determinants of non-vaccination against pandemic 2009 H1N1 influenza in pregnant women: a prospective cohort study. PLoS ONE 2011 Jun 14;6(6):e20900 [Full text]
Frew PM, Hixson B, del Rio C, et al. Acceptance of pandemic 2009 influenza A (H1N1) vaccine in a minority population: determinants and potential points of intervention. Pediatrics 2011 May;127(Suppl 1):S113-9 [Abstract]
Fridman D, Steinberg E, Azhar E, et al. Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol 2011 Feb;33(2):127-33 [Abstract]
Friesema IHM, Meijer A, van Gageldonk-Lafeber AB, et al. Course of pandemic influenza A(H1N1) 2009 virus infection in Dutch patients. Influenza Other Respi Viruses 2012 May;6(3):e16-20 [Abstract]
Fry AM, Gubareva LV. Understanding influenza virus resistance to antiviral agents; early warning signs for wider community. (Editorial) J Infect Dis 2012 (published online May 4) [Abstract]
Fry AM, Hancok K, Patel M, et al. The first cases of 2009 pandemic influenza A (H1N1) virus infection in the United States: a serologic investigation demonstrating early transmission. Influenza Other Respi Viruses 2012 May;6(3):e48-53 [Abstract]
Fry AM, Perez A, Finelli L. Use of intravenous neuraminidase inhibitors during the 2009 pandemic: results from population-based surveillance. JAMA 2011 Jul 13;306(2):160-2 [Extract]
Fuhrman C, Bonmarin I, Betar D, et al. Adult intensive-care patients with 2009 pandemic influenza A(H1N1) infection. Epidemiol Infect 2011;139(8):1202-9 [Abstract]
Fuhrman C, Bonmarin I, Paty AC, et al. Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July - 15 November 2009. Euro Surveill 2010 Jan 14;15(2):5 [Full text]
Fukase H, Furuie H, Yasuda Y, et al. Assessment of the immunogenicity and safety of varying doses of an MF59-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects. Vaccine 2012 (published online Mar 31) [Abstract]
Galante M, Garin O, Sicuri E, et al. Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study. PLoS ONE 2012 Feb 14;7(2):e31696 [Full text]
Galarce EM, Minsky S, Viswanath V. Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States. Vaccine 2011 Jul 18;29(32):5284-9 [Abstract]
GAO (Government Accountability Office). Influenza pandemic: lessons from the H1N1 pandemic should be incorporated into future planning. GAO-11-632. Jun 27, 2011 [Summary with link to full report]
GAO (US Government Accountability Office). Influenza pandemic: gaps in pandemic planning and preparedness need to be addressed. GAO 09-909T. July 29, 2009 [Full text]
Gao F, Loring C, Laviolette M, et al. Detection of 2009 pandemic influenza A(H1N1) virus infection in different age groups by using rapid influenza diagnostic tests. Influenza Other Respi Viruses 2011 (published online Nov 24) [Abstract]
Garcia MC, Moros MJS, Peralta PSO, et al. Clinical characteristics and outcomes of diabetes sufferers hospitalized from 2009 pandemic influenza A H1N1 infections. J Infect 2011 (published online Nov 25) [Abstract]
Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009 Oct 6;339:b3928 [Full text]
Garcia-Sicilia J, Gillard P, Carmona A, et al. Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. Vaccine 2011 Jun 10;29(26):4353-61 [Abstract]
Garcia-Vidal C, Barba P, Arnan M, et al. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis 2011 Sep 15;53(6):e16-9 [Abstract]
Garg S, Chaves SS, Perez A, et al. Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year following the 2009 pandemic. Clin Infect Dis 2012 (published online Apr 27) [Abstract]
Garigliany MM, Habyarimana A, Lambrecht B, et al. Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice. Emerg Infect Dis 2010 Apr;16(4):595-603 [Full text]
Garske T, Legrand J, Donnelly CA, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 2009 Jul 14;339:b2840 [Full text]
Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of a swine-origin 2009 A(H1N1) influenza virus circulating in humans. Science 2009 Jul 10;325(5937):197-201 [Abstract]
Gauger PC, Vincent Al, Loving CL, et al. Enhanced pneuomonia and disease in pigs vaccinated with an inactivated human-like (o-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 2011 Mar 24;29(15):2712-9 [Abstract]
Gaur AH, Bagga B, Barman S, et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. (Letter) N Engl J Med 2010 Jan 7;362(1):88-9 [Full text]
Gautret P, Parola P, Brouqui P. Risk factors for H1N1 influenza complications in 2009 Hajj pilgrims. (Letter) Lancet 2010 Jan 16;375(9710):199-200 [Full text]
Gauzere BA, Malvy D, Filleul L, et al. Intensive care unit admission for pandemic (H1N1) 2009, Reunion Island, 2009. Emerg Infect Dis 2011 Jan;17(1):140-1 [Full text]
Gaygisiz U, Gaygisiz E, Ozkan T, et al. Why were Turks unwilling to accept the A/H1N1 influenza-pandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic. Vaccine 2010 Dec 16;29(2):329-33 [Abstract]
Gerloff NA, Kremer JR, Charpentier E, et al. Swine influenza virus antibodies in humans, Western Europe, 2009. Emerg Infect Dis 2011 Mar;17(3):403-11 [Full text]
Gerrard J, Keijzers G, Zhang P, et al. Clinical diagnostic criteria for isolating patients admitted to hospital with suspected pandemic influenza. (Letter) Lancet 2009 Nov 14;374(9702):1673 [Full text]
Gershon RRM, Magda LA, Qureshi KA, et al. Factors associated with the ability and willingness of essential workers to report to duty during a pandemic. J Occup Environ Med 2010 Oct;52(10):995-1003 [Abstract]
Gesualdo F, Romano M, Pandolfi E, et al. Surfing the web during pandemic flu: availability of World Health Organization recommendations on prevention. BMC Public Health 2010 Sep 20;10:561 [Abstract]
Ghosh S, Heffernan J. Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study. PLoS ONE 2010 Dec 20;5(12):e14307 [Full text]
Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A, et al. Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 2009 Dec 23;4(12):e8393 [Full text]
Gibbs AJ, Armstrong JS, Downie JC. From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge? Virol J 2009 Nov 24;6(1):207 [Full text]
Gidengil CA, Parker AM, Zikmund-Fisher BJ. Trends in risk perceptions and vaccination intentions: a longitudinal study of the first year of the H1N1 pandemic. Am J Public Health 2012 Apr;102(4)672-9 [Abstract]
Giesecke J. Experiences of giving oseltamivir to school children during the 2009 influenza A(H1N1) pandemic. (Editorial) Euro Surveill 2010 May 13;15(19):pii=19570 [Full text]
Gift TL, Palekar RS, Sodha SV, et al. Household effects of school closure during pandemic (H1N1) 2009, Pennsylvania, USA. Emerg Infect Dis 2010 Aug;16(8):1315-7 [Full text]
Gilbert GL, Cretikos MA, Hueston L, et al. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE 2010 Sep 7;5(9):e12562 [Full text]
Gilca R, Deceuninck G, De Serres G, et al. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children. Pediatrics 2011 (published online Oct 10) [Abstract]
Gilca V, De Serres G, Hamelin ME, et al. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Vaccine 2011 Dec 9;30(1):35-41 [Abstract]
Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010 Feb;134(2):235-43 [Abstract]
Gilles I, Bangerter A, Clemence A, et al. Trust in medical organizations predicts pandemic (H1N1) 2009 vaccination behavior and perceived efficacy of protection measures in the Swiss public. Eur J Epidemiol 2011 Mar;26(3):203-10 [Abstract]
Gilman SL. Moral panic and pandemics. (Commentary) Lancet 2010 May 29;375(9729):1866-7 [Full text]
Gilsdorf A, Poggensee G, on behalf of the working pandemic influenza A(H1N1)V. Influenza A(H1N1)V in Germany: the first 10,000 cases. (Rapid communications) Eurosurveill 2009 Aug 27;14(34):pii=19318 [Full text]
Gindler J, Grohskopf LA, Biggerstaff M, et al. A model survey for assessing 2009 pandemic influenza A (H1N1) virus disease burden in the workplace. Clin Infect Dis 2011 Jan 1;52(suppl 1):S173-6 [Abstract]
Ginocchio CC, St George K. Likelihood that an unsubtypeable influenza A virus result obtained with the Luminex xTAG respiratory virus panel is indicative of infection with novel A/H1N1 (swine-like) influenza virus. J Clin Microbiol 2009 Jul;47(7):2347-8 [Full text]
Girard MP, Katz J, Pervikov Y, et al. Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 17-18 February 2010. Vaccine 2010 Oct 4;28(42):6811-20 [Abstract]
Girard MP, Tam JS, Assossou OM, et al. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010 Jul 12;28(31):4895-902 [Abstract]
Glaser C, Winter K, DuBray K, et al. A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California. Clin Infect Dis 2012 (published online May 9) [Abstract]
Glaser MS, Chui S, Webber MP, et al. Predictors of acceptance of H1N1 influenza vaccination by FDNY firefighters and EMS workers. Vaccine 2011 Aug 5;29(34):5675-80 [Abstract]
Godlee F. Conflicts of interest and pandemic flu. (Editorial) BMJ 2010 Jun 3;340:c2947 [Excerpts]
Goldfarb I, Panda B, Wylie B, et al. Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Am J Obstet Gynecol 2011 Jun;204(6 suppl):S112-5 [Abstract]
Goldkind SF, Sahin L, Gallauresi B. Enrolling pregnant women in research -- lessons from the H1N1 influenza pandemic. N Engl J Med 2010 Jun 17;362(24):2241-3 [Full text]
Goldsmith CS, Metcalfe MG, Rollin DC, et al. Ultrastructural characterization of pandemic (H1N1) 2009 virus. Emerg Infect Dis 2011 Nov;17(11):2056-9 [Full text]
Goldstein E, Cowling BJ, O'Hagan JJ, et al. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis 2010 Jul 20;10:211 [Abstract]
Gomez-Gomez A, Magana-Aquino M, Garcia-Sepulveda CA, et al. Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosi, Mexico. Emerg Infect Dis 2010 Jan;16(1):27-34 [Full text]
Goni N, Fajardo A, Moratorio G, et al. Modeling gene sequences over time in 2009 H1N1 influenza A virus populations. Virol J 2009 Dec 4;6:215 [Abstract]
Gonzalez-Candelas F, Astray J, Alonso J, et al. Sociodemographic factors and clinical conditions associated to hospitalization in influenza A (H1N1) 2009 virus infected patients in Spain, 2009-2010. PLoS ONE 2012 Mar 7;7(3):e33139 [Full text]
Goodwin R, Haque S, Neto F, et al. Initial psychological responses to influenza A, H1N1 ("swine flu"). BMC Infect Dis 2009 Oct 6;9:16 [Abstract]
Gordon A, Saborio S, Videa E, et al. Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. Clin Infect Dis 2010 Jun 1;50(11):1462-7 [Abstract]
Gordon CL, Johnson PDR, Permezel M, et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G2 subclass deficiency. Clin Infect Dis 2010 Mar 1;50(5):672-8 [Abstract]
Gosbell IB, Gottlieb T, Kesson AM, et al. Immunisation and multi-dose vials. Vaccine 2010 Sep 14;28(40):6556-61 [Abstract]
Gostin LO. Influenza A(H1N1) and pandemic preparedness under the rule of international law. (Commentary) JAMA 2009 Jun 10;301(22):2376-8 [Extract]
Goulia P, Mantas C, Dimitroula D, et al. General hospital staff worries, perceived sufficiency of information and associated psychological distress during the A/H1N1 influenza pandemic. BMC Infect Dis 2010 Nov 9;10:322 [Abstract]
Govorkova EA, Marathe BM, Prevost A, et al. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets. Antiviral Res 2011 Aug;91(2):81-8 [Abstract]
Graham M, Liang B, Domselaar GV, et al. Nationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2009. PLoS ONE 2011 Jan 7;6(1):e16087 [Full text]
Graitcer SB, Gubareva L, Kamimoto L, et al. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis 2011 Feb;17(2):255-7 [Full text]
Grandea III AG, Olsen OA, Cox TC, et al. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc Natl Acad Sci 2010 Jul 13;107(28):12658-63 [Abstract]
Gras S, Kedzierski L, Valkenburg SA, et al. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci 2010 Jul 13;107(28):12599-604 [Abstract]
Gray GC, Baker WS. The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther 2007 Dec;82(6):638-41 [Abstract]
Gray GC, Kayali G. Facing pandemic influenza threats: the importance of including poultry and swine workers in preparedness plans. Poult Sci 2009 Apr;88(4):880-5 [Abstract]
Gray GC, Trampel DW, Roth JA. Pandemic influenza planning: Shouldn't swine and poultry workers be included? Vaccine 2007 May 30;25(22):4376-81 [Abstract]
Gray L, MacDonald C, Mackie B, et al. Community responses to communication campaigns for influenza A (H1N1): a focus group study. BMC Public Health 2012 Mar 19;12:205 [Abstract]
Greatorex JS, Digard P, Curran MD, et al. Survival of influenza A(H1N1) on materials found in households: implications for infection control. PLoS ONE 2011 Nov 22;6(11):e27932 [Full text]
Greenbaum JA, Kotturi MF, Kim Y, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci 2009 Dec 1;106(48):20365-70 [Abstract]
Greenberg ME, Lai MH, Hartel GF, et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine--preliminary report. N Engl J Med 2009 Dec 17;361(25):2405-13 [Full text]
Greer AL, Tuite A, Fisman DN. Age, influenza pandemics and disease dynamics. (Commentary) Epidemiol Infect 2010 Nov;138(11):1542-9 [Abstract]
Greer LG, Sheffield JS, Rogers VL, et al. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol 2010 Apr;115(4):711-6 [Abstract]
Greninger AL, Chen EC, Sittler T, et al. A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS ONE 2010 Oct 18;5(10):e13381 [Full text]
Griffin MR, Monto AS, Belongia EA, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS ONE 2011 Aug 12;6(8):e23085 [Full text]
Griffiths SM, Wong AH, Kim JH, et al. Influence of country of study on student responsiveness to the H1N1 pandemic. Public Health 2010 Aug;84(15):7569-80 [Abstract]
Grijalva CG, Griffin MR. Unveiling the burden of influenza-associated pneumococcal pneumonia. (Editorial) J Infect Dis 2011 (published online Dec 7) [Abstract]
Grills N, Piers LS, Barr I, et al. A lower than expected adult victorian community attack rate for pandemic (H1N1) 2009. Aust N Z J Public Health 2010 Jun 1;34(3):228-31 [Abstract]
Grimaldi-Bensouda L, Alperovitch A, Besson G, et al. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011 (published online Jun 7) [Abstract]
Gu Y, Komiya N, Kamiya H, et al. Pandemic (H1N1) 2009 transmission during presymptomatic phase, Japan. Emerg Infect Dis 2011 Sep;17(9):1737-9 [Full text]
Gubbels S, Perner A, Valentiner-Branth P, et al. National surveillance of pandemic influenza A(H1N1) infection-related admissions to intensive care units during the 2009-10 winter peak in Denmark: two complementary approaches. Euro Surveill 2010 Dec 9;15(49):pii=19743 [Full text]
Guh A, Reed C, Gould LH, et al. Transmission of 2009 pandemic influenza A (H1N1) at a public university--Delaware, April-May 2009. Clin Infect Dis 2011 Jan 1;52(suppl 1):S131-7 [Full text]
Guinard A, Grout L, Durand C, et al. Outbreak of influenza A(H1N1)v without travel history in a school in the Toulouse district, France, June 2009. (Rapid communications) Eurosurveill 2009 Jul 9;14(27):pii=19265 [Full text]
Gunson RN, Carman WF. During the summer 2009 outbreak of "swine flu" in Scotland what respiratory pathogens were diagnosed as H1N1/2009? BMC Infect Dis 2011 Jul 13;11:192 [Full text]
Guo X, Chen Y, Li X, et al. Dynamic variations in the peripheral blood lymphocyte subgroup of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection. Virol J 2011 May 10;8:215 [Abstract]
Guthmann JP, Fonteneau L, Bonmarin I, et al. Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine 2012 Feb 1;30(6):995-7 [Abstract]
Guzman-Herrador B, Aavitsland P, Feiring B, et al. Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway. BMC Infect Dis 2012 Mar 20;12:63 [Abstract]
Gwini SM, Coupland CAC, Siriwardena AN. The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study. Vaccine 2011 Feb 1;29(6):1145-9 [Abstract]
Hadler JL, Baker TN, Papadouka V, et al. Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years. J Infect Dis 2012(published online May 2) [Abstract]
Hadler JL, Baker TN, Papadouka V, et al. Effectiveness of one dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children 7 months to 9 years of age. J Infect Dis 2012 (published online May 2) [Abstract]
Hadler JL, Konty K, McVeigh KH, et al. Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May--June 2009. PLoS ONE 2010 Jul 21;5(7):e11677 [Full text]
Hakim H, Allison KJ, Van De Velde LA, et al. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults. Vaccine 2012 Jan 20;30(5):879-85 [Abstract]
Hakim H, Gaur AH, McCullers JA. Motivating factors for high rates of influenza vaccination among healthcare workers. Vaccine 2011 Aug 11;29(35):5963-9 [Abstract]
Halder N, Kelso JK, Milne GJ. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic. BMC Public Health 2010 Mar 29;10:168 [Abstract]
Halder N, Kelso JK, Milne GJ. Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics. PLoS ONE 2011 Jul 8;6(7):e22087 [Full text]
Hale MJ, Hoskins RS, Baker MG. Screening for influenza A(H1N1)pdm09, Auckland International Airport, New Zealand. Emerg Infect Dis 2012 May;18(5):866-8 [Full text]
Hamelin ME, Baz M, Abed Y, et al. Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog 2010 Jul 22;6(7):e1001015 [Full text]
Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011 Sep;70(3):410-7 [Abstract]
Han K, Ma H, An X, et al. Early use of glucocorticoids as a risk factor for critical disease and death from pH1N1 infection. Clin Infect Dis 2011 Aug 15;53(4):326-33 [Abstract]
Han K, Zhu X, He F, et al. Lack of airborne transmission during outbreak of pandemic (H1N1) 2009 among tour group members, China, June 2009. Emerg Infect Dis 2009 Oct;15(10):1578-81 [Full text]
Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009 Nov 12;361:1945-52 [Full text]
Hanquet G, Damme PV, Brasseur D, et al. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine 2011 Jan 10;29(3):370-7 [Abstract]
Hara M, Hanaoka T, Mizushima T, et al. Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability. Vaccine 2011 Oct 26;29(46):8323-9 [Abstract]
Harcourt SE, Smith GE, Elliot AJ, et al. Use of a large general syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK. Epidemiol Infect 2012 Jan;140(1):100-5 [Abstract]
Hardelid P, Andrews N, Pebody R. Excess mortality monitoring in England and Wales during the influenza A(H1N1) 2009 pandemic. Epidemiol Infect 2011 Sep;139(9):1431-9 [Abstract]
Hardelid P, Fleming DM, Andrews N, et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice. Vaccine 2012 Feb 8;30(7):1371-8 [Abstract]
Hardelid P, Fleming DM, McMenamin J, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1) 2009 infection in England and Scotland 2009-2010. Euro Surveill 2011 Jan 13;16(2):pii=19763 [Full text]
Harder KM, Andersen PH, Baehr I, et al. Electronic real-time surveillance for influenza-like illness: experience from the 2009 influenza A(H1N1) pandemic in Denmark. Euro Surveill 2011 Jan 20;16(3):pii=19767 [Full text]
Harmark L, Hunsel FV, Hak E, et al. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring. Vaccine 2011 Feb 24;29(10):1941-7 [Abstract]
Harms PW, Schmidt LA, Smith LB, et al. Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol 2010 Jul;134(1):27-35 [Abstract]
Harris K, Maurer J, Black C, et al. Workplace efforts to promote influenza vaccination among healthcare personnel and their association with uptake during the 2009 pandemic influenza A (H1N1). Vaccine 2011 Apr 5;29(16):2978-85 [Abstract]
Harter G, Zimmermann O, Maier L, et al. Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus. Clin Infect Dis 2010 May 1;50(9):1249-51 [Abstract]
Hartley DM, Nelson NP, Perencevich EN. Antiviral drugs for treatment of patients with pandemic (H1N1) 2009 virus. (Letter) Emerg Infect Dis 2009 Nov;15(11):1851-2 [Full text]
Harvala H, Gunson R, Simmonds P, et al. The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December 2009. Euro Surveill 2010 Apr 8;15(14):pii=19536 [Full text]
Harvard Opinion Research Program (Harvard School of Public Health). Employers took many measures to protect employees and avoid business impact of H1N1 flu outbreak. Poll results released Jun 22, 2010 [Press release]
Harvey R, Guilfoyle KA, Roseby S, et al. Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric haemagglutinin molecules. J Virol 2011 Jun;85(12):6086-90 [Abstract]
Hasegawa M, Inamo Y, Fuchigami T, et al. Bronchial casts and pandemic (H1N1) 2009 virus infection. (Letter) Emerg Infect Dis 2010 Feb;16(2):344-5 [Full text]
Hasegawa M, Okada T, Sakata H, et al. Pandemic (H1N1) 2009-associated pneumonia in children, Japan. Emerg Infect Dis 2011 Feb;17(2):279-82 [Full text]
Hatta Y, Hatta M, Bilsel P, et al. An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus. Vaccine 2011 Mar 9;29(12):2308-12 [Abstract]
Hatz C, Cramer JP, Vertuyen A, et al. A randomized, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. Vaccine 2012 (published online May 21) [Abstract]
Hatz C, Sonnenburg FV, Casula D, et al. A randomized clinical trial to identify the optimal antigen and MF59 adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. Vaccine 2012 May 14;30(23):3470-7 [Abstract]
Hawkes M, Richardson SE, Ipp M, et al. Sensitivity of rapid influenza diagnostic testing for swine-origin 2009 A (H1N1) influenza virus in children. Pediatrics 2010 Mar;125(3):e639-44 [Abstract]
Hayden FG, de Jong MD. Emerging influenza antiviral resistance threats. (Editorial) J Infect Dis 2010 Jan 1;203(1):6-10 [Full text]
He CQ, Ding NZ, Mou X, et al. Identification of three H1N1 influenza virus groups with natural recombinant genes circulating from 1918 to 2009. Virology 2012 May 25;427(1):60-6 [Abstract]
Health Protection Agency and Health Protection Scotland New Influenza A(H1N1) Investigation Teams. Epidemiology of new influenza A(H1N1) in the United Kingdom, April-May 2009. Euro Surveill 2009 May 14;14(19):pii=19213 [Full text]
Health Protection Agency West Midlands H1N1v Investigation Team. Preliminary descriptive epidemiology of a large school outbreak of influenza A(H1N1)v in the West Midlands, United Kingdom, May 2009. (Rapid communications) Eurosurveill 2009 Jul 9;14(27):pii=19264 [Full text]
Hebert PC, MacDonald N. Preparing for pandemic (H1N1) 2009. (Editorial) CMAJ 2009 Sep 15;181(6-7):E102-3 [Full text]
Hebert PC, MacDonald N. The H1N1 vaccine race: can we beat the pandemic? (Editorial) CMAJ 2009 Oct 13:181(8):e125-7 [Full text]
Heidebrecht CL, Foisy J, Pereira JA, et al. Perceptions of immunization information systems for collecting pandemic H1N1 immunization data within Canada's public health community: a qualitative study. BMC Public Health 2010 Aug 31;10:523 [Abstract]
Helferty M, Vachon J, Tarasuk J, et al. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 2010 Dec 14;182(18):1981-7 [Abstract]
Hellyer JMH, DeVries AS, Jenkins SM, et al. Attitudes toward and uptake of H1N1 vaccine among health care workers during the 2009 H1N1 pandemic. PLoS ONE 2011 Dec 22;6(12):e29478 [Full text]
Henrich N, Holmes B. The public's acceptance of novel vaccines during a pandemic: a focus group study and its application to influenza H1N1. Emerg Health Threats J 2009 Aug 21;2:e8 [Full text]
Henrich N, Holmes B. What the public was saying about the H1N1 vaccine: perceptions and issues discussed in on-line comments during the 2009 H1N1 pandemic. PLoS ONE 2011 Apr 18;6(4):e18479 [Full text]
Hens N, Ranst MV, Aerts M, et al. Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: a multi-country analysis for influenza A/H1N1v 2009. Vaccine 2011 Jan 29;29(5):896-904 [Abstract]
Herberg JA, Jones KDJ, Paulus S, et al. Comparison of pandemic and seasonal influenza reveals higher mortality and increased prevalence of shock in children with severe H1N1/09 infection. Pediatric Infect Dis J 2011 May;30(5):438-40 [Abstract]
Hernandez JE, Adiga R, Armstrong R, et al. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an emergency IND program in the United States. Clin Infect Dis 2011 Mar 15;52(6):695-706 [Abstract]
Hernandez JE, Grainger J, Simonsen L, et al. Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza Other Respi Viruses 2011 (published online Nov 16) [Abstract]
Hersh AL, Stafford RS. Antiviral prescribing by office-based physicians during the 2009 H1N1 pandemic. (Letter) Ann Intern Med 2011 Jan 3;154(1):74-6 [Extract]
Hersh DL, Herigon JC, Ampofo K, et al. Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. Pediatr Infect Dis J 2011 Oct;30(10):895-7 [Abstract]
Hessel A, Schwendinger M, Fritz D, et al. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations. PLoS ONE 2010 Aug 16;5(8):e12217 [Full text]
Hewagama S, Walker SP, Stuart RL, et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis 2010 Mar 1;50(5):686-90 [Abstract]
HHS. Assessment of the 2009 influenza A (H1N1) outbreak on selected countries in the southern hemisphere. Aug 26, 2009 [Full text]
HHS. H1N1 flu: a guide for community and faith-based organizatons. Sep 24, 2009 [Full text]
Hidiroglu S, Ay P, Topuzoglu A, et al. Resistance to vaccination: the attitudes and practices of primary healthcare workers confronting the H1N1 pandemic. Vaccine 2010 Nov 29;28(51):8120-4 [Full text]
Hien TT, Boni MF, Bryant JE, et al. Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis. PLoS Med 2010 May 18;7(5):e1000277 [Full text]
Higgins AD, Shaw CJ, Johnson JG, et al. A monoclonal antibody kit for identification of the novel 2009 H1N1 influenza A virus. J Clin Microbiol 2010 Aug;48(8):2677-82 [Abstract]
Hill-Cawthorn GA, Schelenz S, Lawes M, et al. Oseltamivir-resistant pandemic (H1N1) 2009 in patient with impaired immune system. (Letter) Emerg Infect Dis 2010 Jul;1185-6 [Full text]
Hillaire MLB, van Trierum SEV, Bodewes R, et al. Characterization of the human CD8+ T cell response following infection with 2009 pandemic influenza H1N1 virus. J Virol 2011 Nov;85(22):12057-61 [Abstract]
Hoen AG, Buckeridge DL, Chan EH, et al. Characteristics of US public schools with reported cases of novel influenza A (H1N1). Int J Infec Dis 2010 Sep;14(3):e6-8 [Abstract]
Holmes EC, Ghedin E, Halpin RA, et al. Extensive geographical mixing of human H1N1/09 influenza A virus in a single university community. J Virol 2011 Jul;85(14):6923-9 [Abstract]
Homaira N, Luby SP, Alamgir ASM, et al. Influenza-associated mortality in 2009 in four sentinel sites in Bangladesh. Bull World Health Organ 2012 Apr;90(4):272-8 [Full text]
Hombrouck A, Sabbe M, Van Casteren V, et al. Viral aetiology of influenza-like illness in Belgium during the influenza A(H1N1) 2009 pandemic. Eur J Clin Microbiol Infect Dis 2011 (published online Sep 8) [Abstract]
Horney JA, Moore Z, Davis M, et al. Intent to receive pandemic influenza A (H1N1) vaccine, compliance with social distancing and sources of information in NC, 2009. PLoS ONE 2010 Jun 18;5(6):e11226 [Full text]
Houlihan CF, Patel S, Price DA, et al. Life threatening infections labelled swine flu. (Letter) BMJ 2010 Jan 13;340:c137 [Extract]
Houng HSH, Garner J, Zhou Y, et al. Emergent 2009 influenza A(H1N1) viruses containing HA D222N mutation associated with severe clinical outcomes in the Americas. J Clin Virol 2012 Jan;53(1):12-5 [Abstract]
House T, Baguelin M, Van Hoek AJ, et al. Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proc R Soc Med 2011 Sep 22;278(1719):2753-60 [Abstract]
Howard WA, Essen SC, Strugnell BW, et al. Reassortant pandemic (H1N1) 2009 virus in pigs, United Kingdom. Emerg Infect Dis 2011 Jun;17(6):1049-52 [Full text]
HPA (Health Protection Agency), HPAS (Health Protection Agency Scotland), NPHSW (National Public Health Service for Wales), et al. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April - June 2009. (Rapid communications) Eurosurveill 2009 Jun 4;14(22):pi=19232 [Full text]
Hsann YM, Thang SP, Salam ZHA, et al. Clinical characteristics and outcomes of hospitalized patients with 2009 H1N1 influenza in a large acute tertiary hospital, Singapore. Am J Infect Control 2011 Oct;39(8):e49-51 [Abstract]
Hsieh YH, Cheng KF, Wu TN, et al. Transmissibility and temporal changes of 2009 pH1N1 pandemic during summer and fall/winter waves. BMC Infect Dis 2011 Dec 2;11:332 [Abstract]
Hsieh YH, Ma S, Hernandez JXV, et al. Early outbreak of 2009 influenza A (H1N1) in Mexico prior to identification of pH1N1 virus. PLoS ONE 2011 Aug 31;6(8):e23853 [Full text]
Hsueh PR, Lee PI, Chiu AWH, et al. Pandemic (H1N1) 2009 vaccination and class suspensions after outbreaks, Taipei City, Taiwan. Emerg Infect Dis 2010 Aug;16(8):1309-11 [Full text]
Huang DTN, Shao PL, Huang KC, et al. Serologic status for pandemic (H1N1) 2009 virus, Taiwan. Emerg Infect Dis 2011 Jan;17(1):76-8 [Full text]
Huang WT, Chen WC, Teng HJ, et al. Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women--Taiwan, November 2009-August 2010. PLoS ONE Aug 5;6(8):e23049 [Full text]
Huang WT, Chen WW, Yang HW, et al. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan. Vaccine 2010 Oct 18;28(44):7161-6 [Abstract]
Huang WT, Chuang JH, Kuo SHS. Monitoring the safety of pandemic H1N1 vaccine. (Letter) Lancet 2010 Apr 3;375(9721):1164 [Full text]
Huang WT, Hsu CC, Lee PI, et al. Mass psychogenic illness in nationwide in-school vaccination for pandemic influenza A(H1N1) 2009, Taiwan, November 2009-January 2010. Euro Surveill 2010 May 27;15(21):pii=19575 [Full text]
Huang WT, Hsu YF, Kuo TW, et al. Complicated pandemic (H1N1) 2009 during pregnancy, Taiwan. (Letter) Emerg Infect Dis 2011 Oct;17(10):1958-60 [Full text]
Huang WT, Huang WI, Huang YW, et al. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis. Vaccine 2012 Mar 9;30(12):2168-72 [Abstract]
Hulth A, Rydevik G. Web query-based surveillance in Sweden during the influenza A(H1N1) 2009 pandemic, April 2009 to February 2010. Euro Surveill 2011 May 5;16(18):pii=19856 [Full text]
Hung IFN, To KKW, Lee CK, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011 Feb 15;52(4):447-56 [Abstract]
Hung IFN, To KKW, Lee CK, et al. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis 2010 Aug 1;51(3):274-9 [Full text]
Hunter JC, Rodriguez DC, Aragon TJ, et al. Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California. BMC Public Health 2012 Jan 25;12:82 [Abstract]
Huo X, Qi X, Tang F, et al. Seroprevalence of pandemic (H1N1) 2009 in pregnant women in China: an observational study. PLoS ONE 2011 Mar 18;6(3):e17995 [Full text]
Hurt AC, Chotpitayasunondh T, Cox NJ, et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis 2011 (published online Dec 19) [Abstract]
Hurt AC, Deng YM, Ernest J, et al. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill 2011 Jan 20;16(3):pii=19770 [Full text]
Hurt AC, Hardie K, Wilson NJ, et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 2012 (published online May 4) [Abstract]
Hurt AC, Hardie K, Wilson NJ, et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med 2011 Dec 29;365:2541-2 [Full text]
Hurt AC, Leang SK, Speers DJ, et al. Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses. Emerg Infect Dis 2012 Jan;18(1):109-12 [Full text]
Hurt AC, Lee RT, Leang SK, et al. Increased detection in Australia and Singapore of a novel influenza A(H1N1) 2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill 2011 Jun 9;16(23):pii=19884 [Full text]
Ibuka Y, Chapman GB, Meyers LA, et al. The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infect Dis 2010 Oct 14;10:296 [Abstract]
Idrovo AJ, Fernandez-Nino JA, Bojorquez-Chapela I, et al. Performance of public health surveillance systems during the influenza A(H1N1) pandemic in the Americas: testing a new method based on Benford's Law. Epidemiol Infect 2011 Dec;139(12):1827-34 [Abstract]
Iglesias ALH, Kudo K, Manabe T, et al. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico. PLoS ONE 2011 Jul 8;6(7):e21838 [Full text]
Ikonen N, Haanpaa M, Ronkko E, et al. Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland. PLoS ONE 2010 Oct 20;5(10):e13329 [Full text]
Ilyushina NA, Ducatez MF, Rehg JE, et al. Does pandemic A/H1N1 virus have the potential to become more pathogenic? mBio 2010 Nov 16;1(5):e00249-10 [Full text]
Ilyushina NA, Khalenkov AM, Seiler JP, et al. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol 2010 Sep;84(17):8607-16 [Abstract]
Ilyushina NA, Kim JK, Negovetich NJ, et al. Extensive mammalian ancestry of pandemic (H1N1) 2009 virus. Emerg Infect Dis 2010 Feb;16(2):314-7 [Full text]
Imai H, Matsuishi K, Ito A, et al. Factors that reduce the conflicts of health professionals about working during a public crisis: a cross sectional study of motivation and hesitation of hospital workers in Japan during the pandemic (H1N1) 2009. BMC Public Health 2010 Nov 4;10:672 [Abstract]
Inglis TJJ, Merritt AJ, Levy A, et al. Deployable laboratory response to influenza pandemic; PCR assay field trials and comparison with reference methods. PLoS ONE 2011 Oct 12;6(10):e25526 [Abstract]
Inoue M, Barkham T, Leo YS, et al. Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours. Emerg Infect Dis 2010 Oct;16(10):1633-6 [Full text]
IOM (Institute of Medicine). Respiratory protection for healthcare workers in the workplace against novel H1N1 influenza A. Sep 3, 2009 [Full text]
IOM (Institute of Medicine). The domestic and international impacts of the 2009-H1N1 influenza A pandemic: global challenges, global solutions. Dec 29, 2009 [Links to full text]
Isaac-Renton JL, Chang Y, Prystajecky N, et al. Use of Lean response to improve pandemic influenza surge in public health laboratories. Emerg Infect Dis 2012 Jan;18(1):57-62 [Full text]
Isakova I, Davis CT, Rivailler P, et al. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 2011 Feb 17;29(9):1836-43 [Abstract]
Ismail HIM, Tan KK, Lee YL, et al. Characteristics of children hospitalized for pandemic (H1N1) 2009, Malaysia. Emerg Infect Dis 2011 Apr;17(4):708-10 [Full text]
Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009 Aug 20;460(7258):1021-5 [Abstract]
Iulian AD, Dawood FS, Silk BJ, et al. Investigating 2009 pandemic influenza A (H1N1) in US schools: what have we learned? Clin Infect Dis 2011 Jan 1;52(suppl 1):S161-7 [Abstract]
Iwasenko JM, Cretikos M, Paterson DL, et al. Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza. Clin Infect Dis 2010 Jul 1;51(1):70-2 [Abstract]
Jackson C, Mangtani P, Vynnycky E, et al. School closures and student contact patterns. Emerg Infect Dis 2011 Feb;17(2):245-7 [Full text]
Jackson ML, France AM, Hancock K, et al. Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009. Clin Infect Dis 2011 Sep 1;53(5):455-62 [Abstract]
Jaeger JL, Patel M, Dharan N, et al. Transmission of 2009 pandemic influenza A (H1N1) virus among healthcare personnel--Southern California, 2009. Infect Control Hosp Epidemiol 2011 Dec;32(12):1149-57 [Abstract]
Jagger BW, Memoli MJ, Sheng ZM, et al. The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymerase. mBio 2010 May 18;1(1):e00067-10 [Full text]
Jain S, Fry AM. Peramivir: another tool for influenza treatment? (Editorial) Clin Infect Dis 2011 Mar 15;52(6):707-9 [Extract]
Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009 Nov 12;361(20):1935-44 [Full text]
Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009 Aug 8;374(9688):451-8 [Abstract]
Janies DA, Voronkin IO, Studer J, et al. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages. Int J Health Geogr 2010 Feb 24;9(1):13 [Abstract]
Janjua NZ, Skowronski DM, Hottes TS, et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010 Nov 1;51(9):1017-27 [Abstract]
Janjua NZ, Skowronski DM, Hottes TS, et al. Transmission dynamics and risk factors for pandemic H1N1-related illness: outbreak investigation in a rural community of British Columbia, Canada. Influenza Other Respi Viruses 2012 May;6(3):e54-62 [Abstract]
Janusz KB, Cortes JE, Serdarevic F, et al. Influenza-like illness in a community surrounding a school-based outbreak of 2009 pandemic influenza A (H1N1) virus--Chicago, Illinois, 2009. Clin Infect Dis 2011 Jan 1;52(suppl 1):S94-101 [Abstract]
Jarquin VG, Callahan DB, Cohen NJ, et al. Effect of school closure from pandemic (H1N1) 2009, Chicago, Illinois, USA. (Letter) Emerg Infect Dis 2011 Apr;17(4):751-3 [Full text]
Javelle E, Soulier B, Brosset C, et al. Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine. Vaccine 2011 Feb 1;29(6):1123-5 [Abstract]
Jayaraman A, Pappas C, Raman R, et al. A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS ONE 2011 Mar 2;6(3):e17616 [Full text]
Jean C, Louie JK, Glaser CA, et al. Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza. Clin Infect Dis 2010 May 15;50(10):e59-62 [Abstract]
Jefferies S, Earl D, Berry N, et al. Effectiveness of the 2009 seasonal influenza vaccine against influenza A(H1N1) 2009 in healthcare workers in New Zealand, June-August 2009. Euro Surveill 2011 Jan 13;16(2):pii=19761 [Full text]
Jenlink CH, Kuehnert P, Mazyck D. H1N1 vaccinations, fall 2009: model school-located vaccination clinics. J Sch Nurs 2010 Aug;26(4 Suppl):7S-13 [Abstract]
Jeon MH, Chung JW, Choi SH, et al. Pneumonia risk factors and clinical features of hospitalized patients older than 15 years with pandemic influenza A (H1N1) in South Korea: a multicenter study. Diagn Microbiol Infect Dis 2011 Jun;70(2):230-5 [Abstract]
Jeong I, Lee CH, Kim DK, et al. Mild form of 2009 H1N1 influenza infection detected by active surveillance: implications for infection control. Am J Infect Control 2010 Aug;38(6):482-5 [Abstract]
Jhung MA, Swerdlow D, Olsen SJ, et al. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis 2011 Jan 1;52(suppl 1):S12-26 [Abstract]
Johns MC, Eick AA, Blazes DL, et al. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS ONE 2010 May 19;5(5):e10722 [Full text]
Johnson S, Ilhekweazu C, Hardelid P, et al. Seroepidemiologic study of pandemic (H1N1) 2009 during outbreak in boarding school, England. Emerg Infect Dis 2011 Sep;17(9):1670-7 [Full text]
Jones FR, Gabitzsch ES, Xu Y, et al. Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine. Vaccine 2011 Sep 16;29(40):7020-6 [Abstract]
Jones JH, Salathe M. Early assessment of anxiety and behavioral response to novel swine-origin influenza A(H1N1). PLoS One 2009 Dec 3;4(12):e8032 [Full text]
Jones TF, McMillian M, Boothe E, et al. Hospital discharge data for Guillain-Barre syndrome and influenza A (H1N1) vaccine adverse events. Emerg Infect Dis 2010 Sep;16(9):1500-1 [Full text]
Joseph KS, Liston RM. H1N1 influenza in pregnant women. (Editorial) BMJ 2011 Jun 14;342:d3237 [Abstract]
Jules A, Grijalva CG, Zhu Y, et al. Estimating age-specific influenza-related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN. Influenza Other Respi Viruses 2012 May;6(3):e63-71 [Abstract]
Jutel A, Baker MG, Stanley J, et al. Self-diagnosis of influenza during a pandemic: a cross-sectional survey. BMJ Open 2011 Sep 12;1(2):e000234 [Full text]
Kaboli F, Astrakianakis G, Li G, et al. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study. Infect Control Hosp Epidemiol 2010 Oct;31(10):1017-24 [Abstract]
Kaiser HE, Barnett DJ, Hayanga AJ, et al. Medical student's participation in the 2009 novel H1N1 influenza vaccination administration: policy alternatives for effective student utilization to enhance surge capacity in disasters. Disaster Med Public Health Prep 2011 Jun;5(2):150-3 [Abstract]
Kalthoff D, Grund C, Harder TC, et al. Limited susceptibility of chickens, turkeys, and mice to pandemic (H1N1) 2009 virus. Emerg Infect Dis 2010 Apr;16(4):703-5 [Full text]
Kamigaki T, Oshitani H. Influenza pandemic preparedness and severity assessment of pandemic (H1N1) 2009 in South-east Asia. Public Health 2010 Jan;124(1):5-9 [Full text]
Kamp C, Heiden M, Henseler O, et al. Management of blood supplies during an influenza pandemic. Transfusion 2010 Jan;50(1):231-9 [Abstract]
Kanchana S, Kanchana S, Chuntrakul C, et al. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after oseltamivir treatment. J Infect 2011 Oct;63(4):295-9 [Abstract]
Kandeel A, Deming M, Kereem EA, et al. Pandemic (H1N1) 2009 and Hajj pilgrims who received predeparture vaccination, Egypt. Emerg Infect Dis 2011 Jul;17(7):1266-8 [Full text]
Kang XP, Jiang T, Li YQ et al. A duplex real-time RT-PCR assay for detecting H5N1 avian influenza virus and pandemic H1N1 influenza virus. Virol J 2010 Jun 2;7:113 [Abstract]
Kantele A, Kanerva M, Seppanen M, et al. Do as I say, not as I do: handwashing compliance of infectious diseases experts during influenza pandemic. Am J Infect Control 2010 Sep;38(7):579-80 [Full text]
Kao CL, Chan TC, Tsai CH, et al. Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-2010. PLoS ONE 2012 Feb 6;7(2):e31162 [Full text]
Kao TM, Hsieh SM, Kung HC, et al. Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly. Vaccine 2010 Aug 31;28(38):6159-63 [Abstract]
Kao TM, Wu UI, Chen YC. Rapid diagnostic tests and severity of illness in pandemic (H1N1) 2009, Taiwan. (Letter) Emerg Infect Dis 2010 Jul;16(7):1181-3 [Full text]
Kaposy C. The influence of the stigma of obesity on H1N1 influenza vaccine sequencing in Canada in 2009. Vaccine 2011 Dec 6;29(52):9607-10 [Abstract]
Kappes MA, Sandbulte MR, Platt R, et al. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine 2012 Jan 5;30(2):280-8 [Abstract]
Kar-Purkayastha I, Ingram C, Maguire H, et al. The importance of school and social activities in the transmission of influenza A(H1N1)V: England, April - June 2009. (Rapid communications) Eurosurveill 2009 Aug 20;14(33):pii=19311 [Full text]
Kara EO, Elliot AJ, Bagnall H, et al. Absenteeism in schools during the 2009 influenza A(H1N1) pandemic: a useful tool for early detection of influenza activity in the community? Epidemiol Infect 2011 (published online Oct 21) [Abstract]
Karageorgopoulos DE, Vouloumanou EK, Korbila IP, et al. Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS ONE 2011 Jul;6(7):e21690 [Full text]
Kash JC, Qi L, Dugan VG, et al. Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus. Influenza Other Respi Viruses 2010 Jun;67(2):207-8 [Abstract]
Kash JC, Walters KA, Davis AS, et al. Lethal synergism of 2009 pandemic H1N1 influenza virus and streptococcus pneumonia coinfection is associated with loss of murine lung repair responses. mBio 2011 Sep 20;2(5):e00172-11 [Full text]
Kashyap AK, Steel J, Rubrum A, et al. Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog 2010 Jul 8;6(7):e1000990 [Full text]
Katriel G, Stone L. Pandemic dynamics and the breakdown of herd immunity. PLoS One 2010 Mar 15;5(3):e9565 [Full text]
Katz R. Use of revised international health regulations during influenza A (H1N1) epidemic, 2009. Emerg Infect Dis 2009 Aug;15(8):1165-70 [Full text]
Kavanagh AM, Bentley RJ, Mason KE, et al. Sources, perceived usefulness and understanding of information disseminated to families who entered home quarantine during the H1N1 pandemic in Victoria, Australia: a cross-sectional study. BMC Infect Dis 2011 Jan 4;11:2 [Abstract]
Kavanagh K, Robertson C, McMenamin J. Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach. PLoS ONE 2011 Dec 21;6(12):e28743 [Full text]
Kawaguchi R, Miyazono M, Noda T, et al. Influenza (H1N1) 2009 outbreak and school closure, Osaka Prefecture, Japan. (Letter) Emerg Infect Dis 2009 Oct;15(10):1685 [Full text]
Kay M, Zerr DM, Englund JA, et al. Shedding of pandemic (H1N1) 2009 virus among health care personnel, Seattle, Washington, USA. Emerg Infect Dis 2011 Apr;17(4):639-44 [Full text]
Keijzers GB, Vossen CNKL, Zhang P, et al. Predicting influenza A and 2009 H1N1 influenza in patients admitted to hospital with acute respiratory illness. Emerg Med J 2011 (published online Mar 25) [Abstract]
Kelly H, Barr I. Large trials confirm immunogenicity of H1N1 vaccines. (Commentary) Lancet 2010 Jan 2;375(9708):6-9 [Full text]
Kelly H, Barry S, Laurie K, et al. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Euro Surveill 2010 Nov 25;15(47):pii=19722 [Full text]
Kelly H, Carcione D, Dowse G, et al. Authors' reply: benefit and risks of trivalent 2010 seasonal influenza vaccine in Australian children. (Letter reply) Euro Surveill 2010 Oct 7;15(40):pii=19681 [Full text; see Lopert R, below, for letter]
Kelly H, Carcione D, Dowse G, et al. Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010. Euro Surveill 2010 Sep 16;15(37):pii=19661 [Full text]
Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. (Rapid communications) Eurosurveill 2009 Aug 6;14(31):pii=19288 [Full text]
Kelly H, Mercer GN, Cheng AC. Quantifying the risk of pandemic influenza in pregnancy and indigenous people in Australia in 2009. Eurosurveill 2009 Dec 17;14(50):pii=19441 [Full text]
Kelly H, Peck HA, Laurie KL, et al. The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination. PLoS ONE 2011 Aug 5;6(8):e21828 [Full text]
Kelly HA, Cowling BJ. Insights from Europe related to pandemic influenza A(H1N1) 2009 have international relevance. (Editorial) Euro Surveill 2011 Jun 30;16(26):pii=19899 [Full text]
Kelly HA, Grant KA, Fielding JE, et al. Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine 2011 Aug 26;29(37):6419-26 [Abstract]
Kelly HA, Mercer GN, Fielding JE, et al. Pandemic (H1N1) 2009 influenza community transmission was established in one Australian state when the virus was first identified in North America. PLoS ONE 2010 Jun 28;5(6):e11341 [Full text]
Kelly HA, Priest PC, Mercer GN, et al. We should not be complacent about our population-based public health response to the first influenza of the 21st century. (Commentary) BMC Public Health 2011 Feb 3;11:78 [Abstract]
Kelso JK, Halder N, Milne GJ. The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009. PLoS ONE 2010 Nov 3;5(11):e13797 [Full text]
Keramarou M, Cottrell S, Evans MR, et al. Two waves of pandemic influenza A(H1N1) 2009 in Wales--the possible impact of media coverage on consultation rates, April-December 2009. Euro Surveill 2011 Jan 20;16(3):pii=19772 [Full text]
Keynan Y, Juno J, Meyers A, et al. Chemokine receptor 5-delta-32 allele in patients with severe pandemic (H1N1) 2009. Emerg Infect Dis 2010 Oct;16(10):1621-2 [Full text]
Khan G, Al-Mutawa J, Hashim MJ. Pandemic (H1N1) 2009, Abu Dhabi, United Arab Emirates, May 2009-March 2010. Emerg Infect Dis 2011 Feb;17(2):292-5 [Full text]
Khan K, Arino J, Hu W, et al. Spread of a novel influenza A (H1N1) virus via global airline transportation. (Letter) N Engl J Med 2009 Jul 9;361(2):212-4 [Full text]
Khandaker G, Lester-Smith D, Zurynski Y, et al. Pandemic (H1N1) 2009 and seasonal influenza A (H3N2) in children's hospital, Australia. (Letter) Emerg Infect Dis 2011 Oct;17(10):1960-2 [Full text]
Kharbanda EO, Vargas CY, Castano PM, et al. Exploring pregnant women's views on influenza vaccination and educational text messages. Prev Med 2011 Jan;52(1):75-7 [Abstract]
Khatri M, Dwivedi V, Krakowka S, et al. Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus. J Virol 2010 Nov;84(21):11210-8 [Abstract]
Khiabanian H, Farrell GM, St George K, et al. Differences in patient age distribution between influenza A subtypes. PLoS ONE 2009 Aug 31;4(8):e6832 [Full text]
Khiabanian H, Hokmes AB, Kelly BJ, et al. Signs of the 2009 influenza pandemic in the New York-Presbyterian Hospital electronic health records. PLoS ONE 2010 Sep 9;5(9):e12658 [Full text]
Khurana S, Verma S, Verma N, et al. Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus. PLoS ONE 2010 Jul 12;5(7):e11548 [Full text]
Kiertiburanakul S, Malathum K, Watcharananan SP, et al. High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand. Am J Infect Control 2011 Aug;39(6):525-8 [Abstract]
Kilander A, Rykkvin R, Dudman SG, et al. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 2010 Mar 4;15(9):pii=19499 [Full text]
Kim HS, Choi HC, Cho B, et al. Effect of the H1N1 influenza pandemic on the incidence of epidemic keratoconjunctivitis and on hygiene behavior: a cross-sectional study. PLoS ONE 2011 Aug 16;6(8):e23444 [Full text]
Kim S, Pinkerton T, Ganesh N. Assessment of H1N1 questions and answers posted on the web. Am J Infect Control 2011 (published online Aug 16) [Abstract]
Kim, CO, Nam CM, Lee DC, et al. Is abdominal obesity associated with the 2009 influenza A (H1N1) pandemic in Korean school-aged children? Influenza Other Respi Viruses 2011 (published online Dec 8) [Abstract]
Kimble JB, Sorrell E, Shao H, et al. Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model. Proc Natl Acad Sci 2011 Jul 19;108(29):12084-8 [Abstract]
Kingsford C, Nagarajan N, Salzberg SL. 2009 swine-origin influenza A (H1N1) resembles previous influenza isolates. PLoS ONE 2009 Jul 28;4(7):e6402 [Full text]
Kiso M, Shinya K, Shimojima M, et al. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog 2010 Aug 26;6(8):e1001079 [Full text]
Kistner O, Crowe BA, Wodal W, et al. A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models. PLoS One 2010 Feb 23;5(2):e9349 [Full text]
Kitcharoen S, Pattapongsin M, Sawanyawisuth K, et al. Neurologic manifestations of pandemic (H1N1) 2009 virus infection. (Letter) Emerg Infect Dis 2010 Mar;16(3):569-70 [Full text]
Kitching A, Roche A, Balasegaram S, et al. Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)V, May 2009 - an internet-based cross-sectional survey. (Rapid communications) Eurosurveill 2009 Jul 30;14(30):pii=19287 [Full text]
Kitikoon P, Vincent AL, Gauger PC, et al. Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J Virol 2012 (published online Apr 4) [Abstract]
Kiviniemi MT, Ram PK, Kozlowski LT, et al. Perceptions of and willingness to engage in public health precautions to prevent 2009 H1N1 influenza transmission. BMC Public Health 2011 Mar 8;11:152 [Abstract]
Klaiman T, Kraemer JD, Stoto MA. Variability in school closure decisions in response to 2009 H1N1: a qualitative systems improvement analysis. BMC Public Health 2011 Feb 1;11:73 [Abstract]
Klenk HD, Garten W, Mikhail M. Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: lessons from the 2009 pandemic. BioEssays 2011 Mar;33(3):180-8 [Abstract]
Knight M, Lim B. Immunization against influenza during pregnancy. (Editorial) BMJ 2012 (published online May 2) [Extract]
Kobinger GP, Meunier I, Patel A, et al. Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J Infect Dis 2010 Apr 1;201(7):1000-6 [Abstract]
Kok J, Dywer DE. How common was 2009 pandemic influenza A H1N1? (Commentary) Lancet Infect Dis 2011 Jun;11(6):423-4 [Extract]
Komiya N, Gu Y, Kamiya H, et al. Clinical features of cases of influenza A (H1N1) in Osaka prefecture, Japan, May 2009. Eurosurveill 2009 Jul 23;14(29):pii=19272 [Full text]
Komiya N, Gu Y, Kamiya H, et al. Household transmission of pandemic 2009 influenza A (H1N1) virus in Osaka, Japan in May 2009. J Infect 2010 Oct;61(4):284-8 [Abstract]
Kong WL, Huang LZ, Qi HT, et al. Genetic characterization of H1N2 influenza A viruses isolated from sick pigs in southern China in 2010. Virol J 2011 Oct 13;8:469 [Abstract]
Koon K, Sanders CM, Green J, et al. Co-detection of pandemic (H1N1) 2009 virus and other respiratory pathogens. Emerg Infect Dis 2010 Dec;16(12):1976-8 [Full text]
Kopel E, Amitai Z, Grotto I, et al. Patients with pandemic (H1N1) 2009 in intensive care units, Israel. (Letter) Emerg Infect Dis 2010 Apr;16(4):720-1. [Full text]
Kopel E, Mandelboim M, Amitai Z, et al. Possible recurrent pandemic (H1N1) 2009 infection, Israel. (Letter) Emerg Infect Dis 2010 Aug;16(8):1321-2 [Full text]
Koster F, Gouveia K, Zhou Y, et al. Exhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferret. PLoS ONE 2012 Apr 3;7(4):e3311 [Full text]
Koutsonanos DG, Martin MDP, Zarnitsyn VG, et al. Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination. J Infect Dis 2011 Aug 15;204(4):582-91 [Abstract]
Kraigher A, Ucakar V. Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10. Vaccine 2010 Jul 26;28(33):5467-72 [Abstract]
Krause R. Swine flu and the fog of epidemics. Emerg Infec Dis 2006 Jan;12(1):40-3 [Full text]
Kraut A, Graff L, McLean D. Behavioral change with influenza vaccination: factors influencing increased uptake of the pandemic H1N1 versus seasonal influenza vaccine in health care personnel. Vaccine 2011 Oct 26;29(46):8357-63 [Abstract]
Kropp RY, Bogaert LE, Barber R, et al. Pandemic (H1N1) 2009 outbreak at Canadian forces cadet camp. Emerg Infect Dis 2010 Dec;16(12):1986-9 [Full text]
Kubiak RJ, McLean AR. Why was the 2009 influenza pandemic in England so small? PLoS ONE 2012 Feb 10;7(2):e30223 [Full text]
Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009 Nov 4;302(17):1872-9 [Full text]
Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010 Aug;10(8):521-6 [Abstract]
Kumar S, Henrickson KJ. Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev 2012 Apr;25(2):344-61 [Abstract]
Kumar S, Quinn SC, Kim KH, et al. The impact of workplace policies and other social factors on self-reported influenza-like illness incidence during the 2009 H1N1 pandemic. Am J Public Health 2012 Jan;102(1):134-40 [Abstract]
Kung HC, Huang KC, Kao TM, et al. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza. Vaccine 2010 Oct 21;28(45):7337-43 [Full text]
Kuo CY, Huang YC, Huang CG, et al. Symptomatic predictors for 2009 influenza A virus (H1N1) infection with an emphasis for patients with a negative rapid diagnostic test. PLoS ONE 2011 Dec 2;6(12):e28102 [Full text]
Kuroda M, Katano H, Nakajima N, et al. Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS ONE 2010 Apr 23;5(4):e10256 [Full text]
Kurz X, Domergue F, Slattery J, et al. Safety monitoring of influenza A/H1N1 pandemic vaccines in EudraVigilance. Vaccine 2011 Jun 10;29(26):4378-87 [Abstract]
Kwon Y, Cho HY, Lee YK, et al. Relationship between intention of novel H1N1 influenza A (H1N1) vaccination and vaccination coverage rate. Vaccine 2010 Dec 16;29(2):161-5 [Abstract]
La Torre G, Di Thiene D, Cadeddu C, et al. Behaviours regarding preventive measures against pandemic H1N1 influenza among Italian healthcare workers, October 2009. Eurosurveill 2009 Dec 10;14(49):pii=19432 [Full text]
Labrosse B, Tourdjman M, Porcher R, et al. Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 influenza viruses using a pseudotype neutralization assay. PLoS ONE 2010 Jun 9;5(6):e11036 [Full text]
Lackenby A, Gilad JM, Pebody R, et al. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1) 2009 virus, United Kingdom, winter 2010/11. Euro Surveill 2011 Feb 3;16(5):pii=19784 [Full text]
Lafeber RABVG, Riesmeijer RM, Friesema IHM, et al. Case-based reported mortality associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection in the Netherlands: the 2009-2010 pandemic season versus the 2010-2011 influenza season. BMC Public Health 2011 Oct 4;11:758 [Abstract]
Lagasse LP, Rimal RN, Smith KC, et al. How accessible was information about H1N1 flu? Literacy assessments of CDC guidance documents for different audiences. PLoS ONE 2011 Oct 25;6(10);e23583 [Full text]
Lagler H, Grabmeier-Pfistershammer K, Touzeau-Romer V, et al. Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals. PLoS ONE 2012 May 21;7(5):e36773 [Full text]
Lagler H, Wenisch JM, Tobudic S, et al. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination. Vaccine 2011 Sep 16;29(40):6888-93 [Abstract]
Laguna-Torres VA, Benavides JG. Infection and death from influenza A H1N1 virus in Mexico. (Editorial) Lancet 2009 Dec 19;374(9707):2032-3 [Full text]
Laguna-Torres VA, Gomez J, Aguilar PV, et al. Changes in the viral distribution pattern after the appearance of the novel influenza A H1N1 (pH1N1) virus in influenza-like illness patients in Peru. PLoS ONE 2010 Jul 27;5(7):e11719 [Full text]
Lai YC, Yang KC, Hsieh SM, et al. Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers. Clin Vaccine Immunol 2012 Mar;19(3):429-35 [Abstract]
Lajous M, Danon L, Lopez-Ridaura R, et al. Mobile messaging as surveillance tool during pandemic (H1N1) 2009, Mexico. (Letter) Emerg Infect Dis 2010 Aug;16(9):1488-9 [Full text]
Lakdawala SS, Lamirande EW, Suguitan AL, et al. Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog 2011 Dec 29;7(12):e1002443 [Full text]
Lam TTY, Zhu H, Wang J, et al. Reassortment events among swine influenza A viruses in China: implications for the origin of the 2009 influenza pandemic. J Virol 2011 Oct;85(19):10279-85 [Abstract]
Lamaitre M, Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis 2010 Jun 9;10:162 [Full text]
Lancet Editors. Pandemic influenza--(some) reasons to be cheerful? (Editorial) Lancet 2010 Aug 21;376(9741):565 [Full text]
Lancet Staff. Supply and safety issues surrounding an H1N1 vaccine. (Editorial) Lancet 2009 Aug 1;374(9687):358 [Full text]
Lancet Staff. Swine influenza: how much of a global threat? (Editorial) Lancet 2009 May 2;373(9674):1495 [Full text - free access with registration]
Landaverde JM, Danovaro-Holliday C, Trumbo SP, et al. Guillain-Barre syndrome in children aged <15 years in Latin America and the Caribbean: baseline rates in the context of the influenza A (H1N1) pandemic. J Infect Dis 2010 Mar 1;201(5):746-50 [Abstract]
Lange E, Kalthoff D, Blohm U, et al. Pathogenesis and transmission of the novel swine origin influenza virus A/H1N1 after experimental infection of pigs. (Short communication) J Gen Virol 2009 Sep;90(9):2119-23 [Full text]
Lapinsky SE. Critical illness as a result of influenza A/H1N1 infection in pregnancy. (Editorial) BMJ 2010 Mar 18;340:c1235 [Extract]
Lapphra K, Dobson S, Bettinger J. Acceptability of Internet adverse event self-reporting for pandemic and seasonal influenza immunization among health care workers. Vaccine 2010 Agu 31;28(38):6199-202 [Abstract]
Larson EL, Cohen B, Baxter KA. Analysis of alcohol-based hand sanitizer delivery systems: efficacy of foam, gel, and wipes against influenza A (H1N1) virus on hands. Am J Infect Control 2012 (published online Feb 12) [Abstract]
Larson HJ, Heymann DL. Public health response to influenza A(H1N1) as an opportunity to build public trust. (Commentary) JAMA 2010 Jan 20;303(3):271-2 [Extract]
Lat A, Bhadelia N, Miko B, et al. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis 2010 Jun;16(6):971-3 [Full text]
Lau JTF, Griffiths S, Au DWH, et al. Changes in knowledge, perceptions, preventive behaviours and psychological responses in the pre-community outbreak phase of the H1N1 epidemic. Epidemiol Infect 2011 Jan;139(1):80-90 [Abstract]
Lau JTF, Griffiths S, Choi KC, et al. Avoidance behaviors and negative psychological responses in the general population in the initial stage of the H1N1 pandemic in Hong Kong. BMC Infect Dis 2010 May 28;10:139 [Abstract]
Lau JTF, Griffiths S, Choi KC, et al. Prevalence of preventive behaviors and associated factors during early phase of the H1N1 influenza epidemic. Am J Infect Control 2010 Jun;38(5):374-80 [Abstract]
Lau JTF, Griffiths S, Choi KC, et al. Widespread public misconception in the early phase of the H1N1 influenza epidemic. J Infect 2009 Aug;59(2):122-7 [Abstract]
Lau JTF, Yeung NCY, Choi KC, et al. Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population. Vaccine 2010 Jun 23;28(29):4632-7 [Full text]
Lau SKP, Chan KH, Yip CCY, et al. Confirmation of the first Hong Kong case of human infection by novel swine origin influenza A (H1N1) virus diagnosed using ultrarapid, real-time reverse transcriptase PCR. (Fast track communications) J Clin Microbiol 2009 Jul;47(7):2344-6 [Full text]
Launay E, Ovetchkine P, Saint-Jean M, et al. Novel influenza A (H1N1): clinical features of pediatric hospitalizations in two successive waves. Int J Infect Dis 2011 Feb;15(2):e122-30 [Abstract]
Launay O, Desaint C, Durier C, et al. Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. J Infect Dis 2011 Jul 1;204(1):124-34 [Abstract]
Launes C, Garcia-Garcia JJ, Jordan I, et al. 2009 influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease. Pediatr Infect Dis J 2010 Jul;30(7):622-5 [Abstract]
Launes C, Garcia-Garcia JJ, Jordan I, et al. Viral load at diagnosis and influenza A H1N1 (2009) disease severity in children. Influenza Other Respi Viruses 2012 (published online May 24) [Abstract]
Laurie KL, Carolan LA, Middleton D, et al. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis 2010 Oct 1;202(7):1011-20 [Abstract]
Lautenbach E, Saint S, Henderson DK, et al. Initial response of health care institutions to emergence of H1N1 influenza: experiences, obstacles, and perceived future needs. Clin Infect Dis 2010 Feb 15;50(4):523-7 [Abstract]
Lavallade HD, Garland P, Sekine T, et al. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica 2011 Feb;96(2):307-14 [Abstract]
Lavelle TA, Meltzer MI, Gebremariam A, et al. Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events. PLoS ONE 2011 (published online Dec 19) [Full text]
Ledesma J, Pozo F, Reina G, et al. Genetic diversity of influenza A(H1N1) 2009 virus circulating during the season 2010-2011 in Spain. J Clin Virol 2011 (published online Nov 8) [Abstract]
Lee A, Chuh AAT. Facing the threat of influenza pandemic: roles of and implications to general practitioners. BMC Public Health 2010 Nov 2;10:661 [Abstract]
Lee BY, Bacon K, Donohue JM, et al. From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine 2011 Mar 3;29(11):2149-58 [Abstract]
Lee BY, Brown ST, Korch G, et al. A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Vaccine 2010 Jul 12;28(31):4875-9 [Abstract]
Lee CK, Lee HK, Loh TP, et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza viral loads, Singapore. Emerg Infect Dis 2011 Feb;17(2):287-91 [Full text]
Lee EH, Wu C, Lee EU, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York City. Clin Infect Dis 2010 Jun 1;50(11):1498-504 [Abstract]
Lee GC, Jeon ES, Kim WS, et al. Evaluation of a rapid diagnostic test, NanoSign(R) influenza A/B antigen, for detection of the 2009 pandemic influenza A/H1N1 viruses. Virol J 2010 Sep 20;7:244 [Abstract]
Lee SS, Wong NS. Reconstruction of epidemic curves for pandemic influenza A (H1N1) 2009 at city and sub-city levels. Virol J 2010 Nov 16;7:321 [Abstract]
Lee SS, Wong NS. The clustering and transmission dynamics of pandemic influenza A (H1N1) 2009 cases in Hong Kong. J Infect 2011 Oct;63(4):274-80 [Abstract]
Lee VJ, Tay JK, Chen MIC, et al. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 2010 Oct 4;28(42):6852-7 [Abstract]
Lee VJ, Yap J, Cook AR, et al. Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study. J Infect Dis 2010 Nov 1;202(9):1319-26 [Abstract]
Lee VJ, Yap J, Cook AR, et al. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med 2010 Jun 10;362(23):2166-74 [Full text]
Lee VJ, Yap J, Tay JK et al. Seroconversion and asymptomatic infections during oseltamivir prophylaxis against influenza A H1N1 2009. BMC Infect Dis 2010 Jun 10;10(1):164 [Jun 10 BMC Infectious Disease report]
Lee YK, Kwon Y, Kim DW, et al. 2009-2010 novel influenza A (HN1) vaccination coverage in the Republic of Korea. Am J Infect Control 2011 (published online Aug 26) [Abstract]
Lees CH, Avery C, Asherin R, et al. Pandemic (H1N1) 2009-associated deaths detected by unexplained death and medical examiner surveillance. Emerg Infect Dis 2011 Aug;17(8):1479-83 [Full text]
Lefevre EA, Carr BV, Inman CF, et al. Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes. PLoS ONE 2012 Mar 9;7(3):e32400 [Full text]
Legriel S, Merceron S, Tattevin P, et al. Favorable outcome after life-threatening meningococcal disease complicating influenza A(H1N1) infection. Infection 2011 Oct;39(5):477-80 [Abstract]
Lehmann HC, Hartung HP, Kieseier BC, et al. Guillain-Barre syndrome after exposure to influenza virus. Lancet Infect Dis 2010 Sep;10(9):643-51 [Abstract]
Lemaitre M, Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis 2010 Jun 9;10(1):162 [Abstract]
Lerdsamran H, Pittayawonganon C, Pooruk P, et al. Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population. PLoS ONE 2011 Jan 25;6(1):e16164 [Full text]
Leroux-Roels G, Leroux-Roels I. Head-to-head comparison of pandemic influenza vaccines. (Commentary) Lancet Infect Dis 2011 Feb;11(2):74-5 [Extract]
Lertdumrongluk P, Changsirikulchai S, Limkunakul C, et al. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients. Vaccine 2012 Feb 1;30(6):1108-14 [Abstract]
Lessler J, Reich NG, Cummings DAT, et al. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med 2009 Dec 31;361(27):2628-36 [Full text]
Leung GM, Nicoll A. Reflections on pandemic (H1N1) 2009 and the international response. PLoS Med 2010 Oct 5;7(10):e1000346 [Full text]
Leung YH, Li MP, Chuang SK. A school outbreak of pandemic (H1N1) 2009 infection: assessment of secondary household transmission and the protective role of oseltamivir. Epidemiol Infect 2011 Jan;139(1):41-4 [Abstract]
Leung YH, Lim WL, Wong MH, et al Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus. Epidemiol Infect 2011 (published online Jul 29) [Abstract]
Li CC, Wang L, Eng HL, et al. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis 2010 Aug;16(8):1265-72 [Full text]
Li GM, Chiu C, Wrammert J, et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci 2012 (published online May 21) [Abstract]
Li P, Su DJ, Zhang JF, et al. Pneumonia in novel swine-origin influenza A (H1N1) virus infection: high-resolution CT findings. Eur J Radiol 2011 Nov;80(2):e146-52 [Abstract]
Li T, Fu C, Di B, et al. A two-year surveillance of 2009 pandemic influenza A (H1N1) in Guangzhou, China: from pandemic to seasonal influenza? PLoS ONE 2011 Nov 18;6(11):e28027 [Full text]
Li W, Shi W, Qiao H, et al. Positive selection on hemagglutinin and neuraminidase genes of H1N1 influenza viruses. Virol J 2011 Apr 22;8:183 [Abstract]
Li Y, Shi J, Zhong G, et al. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry and humans in China from 2004 to 2009. J Virol 2010 Sep;84(17):8389-97 [Abstract]
Liang XF, Li L, Liu DW, et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011 Feb 17;364(7):638-47 [Full text]
Liang XF, Wang HQ, Wang JZ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010 Jan 2;375(9708):56-66 [Full text]
Liao Q, Cowling B, Lam WT, et al. Situational awareness and health protective responses to pandemic influenza A (H1N1) in Hong Kong: a cross-sectional study. PLoS ONE 2010 Oct 12;5(10):e13350 [Full text]
Liao Q, Cowling BJ, Lam WWT, et al. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS ONE 2011 Mar 11;6(3):e17713 [Full text]
Libster R, Bugna J, Coviello S, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010 Jan 7;362(1):45-55 [Full text]
Lichtner M, Mastroianni CM, Rossi R, et al. Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection. PLoS ONE 2011 May 19;6(5):e19872 [Full text]
Lillie PJ, Duncan CJA, Sheehy SH, et al. Distinguishing malaria and influenza: early clinical features in controlled human experimental infection studies. Travel Med Infect Dis 2012 (published online Apr 23) [Abstract]
Lim HC, Cutter J, Lim WK, et al. The influenza A (H1N1-2009) experience at the inaugural Asian Youth Games Singapore 2009: mass gathering during a developing pandemic. Br J Sports Med 2010 Jun;44(7):528-32 [Abstract]
Lim ML, Lim WY, Tee NWS, et al. Obstetric outcomes of influenza A H1N1 (2009) infection in pregnancy, - experience of a Singapore tertiary hospital. Ann Acad Med Singapore 2010 Apr;30(4):295-8 [Full text]
Lim SH, Lee JH, Kim BC, et al. Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns. (Editorial) Vaccine 2010 Nov 3;28(47):7455-6 [Abstract]
Lin TH, Lin SY, Lin CH, et al. AdimFlu-S influenza A (H1N1) vaccine during pregnancy: the Taiwanese pharmacovigilance survey. Vaccine 2012 Mar 30;30(16):2671-5 [Abstract]
Lin Y, Huang L, Nie S, et al. Knowledge, attitudes and practices (KAPS) related to the pandemic (H1N1) 2009 among Chinese general population: a telephone survey. BMC Infect Dis 2011 May 16;11:128 [Abstract]
Lina B, Bouscambert M, Enouf V, et al. S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. Euro Surveill 2011 Dec 15;16(50):pii=20039 [Full text]
Lindblade KA, Arvelo W, Gray J, et al. A comparison of the epidemiology and clinical presentation of seasonal influenza A and 2009 pandemic influenza A (H1N1) in Guatemala. PLoS ONE 2010 Dec 30;5(12):e15826 [Full text]
Lindstrom S, Garten R, Balish A, et al. Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg Infect Dis 2012 May;18(5):834-7 [Full text]
Ling LM, Chow AL, Lye DC, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010 Apr 1;50(7):963-9 [Abstract]
Lipsitch M, Finelli L, Heffernan RT, et al. Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. Biosecur Bioterror 2011 May 25;9(2):89-115 [Abstract]
Lipsitch M, Hayden FG, Cowling, et al. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet 2009 Oct 3;374(9696):1209-11 [Abstract]
Lipsitch M, Riley S, Cauchemez S, et al. Managing and reducing uncertainty in an emerging influenza pandemic. (Perspective) N Engl J Med 2009 Jul 9;361(2):112-5 [Full text]
Liu C, Schwartz BS, Vallabhaneni S, et al. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis 2010 Dec;16(12):1910-7 [Full text]
Liu H, Bungener L, ter Veer W, et al. Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines. Vaccine 2011 Mar 3;29(11):2037-43 [Abstract]
Liu J, Bi Y, Qin K, et al. Emergence of European avian-like H1N1 swine influenza A viruses in China. J Clin Microbiol 2009 Aug;47(8):2643-6 [Abstract]
Liu Q, Ma J, Liu H, et al. Emergence of novel reassortant H3N2 swine influenza viruses with the 2009 pandemic H1N1 genes in the United States. Arch Virol 2012 Mar;157(3):555-62 [Abstract]
Liu W, de Vlas SJ, Tang F, et al. Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination. Clin Infect Dis 2010 Nov 1;51(9):1028-32 [Abstract]
Liu W, Jiang T, Li XF, et al. Community transmission of pandemic influenza A (H1N1) in China. Infect Control Hosp Epidemiol 2010 Sep;31(9):961-3 [Abstract]
Liu W, Li ZD, Tang F, et al. Mixed infections of pandemic H1N1 and seasonal H3N2 viruses in 1 outbreak. Clin Infect Dis 2010 May 15;50(10):1359-65 [Abstract]
Liu W, Ma MJ, Tang F, et al. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects. Vaccine 2012 (published online May 24) [Abstract]
Liu Y, Childs RA, Matrosovich T, et al. Altered receptor specificity and cell tropism of D222G haemagglutinin mutants from fatal cases of pandemic A(H1N1) 2009 influenza. J Virol 2010 Nov;84(22):12069-74 [Abstract]
Liu Y, Ji J, Xie Q, et al. Isolation and complete genomic characterization of H1N1 subtype swine influenza viruses in southern China through the 2009 pandemic. Virol J 2011 Mar 20;8:129 [Abstract]
Liu Y, Liu X, Fang J, et al. Characterization of antibodies specific for hemagglutinin and neuraminidase proteins of the 1918 and 2009 pandemic H1N1 viruses. Vaccine 2010 Dec 16;29(2):183-90 [Abstract]
Ljungman P. Solid-organ transplants and the risks of pandemic influenza. (Commentary) Lancet Infect Dis 2010 Aug;10(8):506-7 [Extract]
Lockman JL, Fischer WA, Perl TM, et al. The critically ill child with novel H1N1 influenza A: a case series. Ped Crit Care Med 2010 Mar;11(2):173-8 [Abstract]
Loeb M, Earn DJD, Smieja M, et al. Pandemic (H1N1) 2009 risk for nurses after trivalent vaccination. (Letter) Emerg Infect Dis 2010 Apr;16(4):719-20 [Full text]
Loeffen WLA, de Vries RP, Stockhofe N, et al. Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus. Vaccine 2011 Feb 11;29(8):1545-50 [Abstract]
Loncarevic G, Payne L, Kon P, et al. Public health preparedness for two mass gathering events in the context of pandemic influenza (H1N1) 2009 - Serbia, July 2009. (Rapid communications) Eurosurveill 2009 Aug 6;14(31):pii=19296 [Full text]
Lopert R. Benefit and risks of trivalent 2010 seasonal influenza vaccine in Australian children. (Letter) Euro Surveill 2010 Oct 7;15(40):pii=19679 [Full text; see Kelly H, above, for response]
Lopez-Macias C, Ferat-Osorio E, Tenorio-Calvol A, et al. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vacine in a blinded, randomized, placebo-controlled trial of adults in Mexico. Vaccine 2011 Oct 13;29(44):7826-34 [Abstract]
Louie JK, Acosta M, Jamieson DJ, et al. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010 Jan 7;362(1):27-35 [Full text]
Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011 Feb 1;52(3):301-12 [Abstract]
Louie JK, Guevara H, Boston E, et al. Rapid influenza antigen test for diagnosis of pandemic (H1N1) 2009. Emerg Infect Dis 2010 May;16(5):824-6 [Full text]
Louie JK, Jamieson DJ, Rasmussen SA. 2009 pandemic influenza A (H1N1) virus infection in postpartum women in California. Am J Obstet Gynecol 2011 Feb;204(2):144.e1-6 [Abstract]
Louie JK, Jean C, Acosta M, et al. A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California. PLoS ONE 2011 Apr 5;6(4):e18221 [Full text]
Loustalot F, Silk BJ, Gaither A, et al. Household transmission of 2009 pandemic influenza A (H1N1) and nonpharmaceutical interventions among households of high school students in San Antonio, Texas. Clin Infect Dis 2011 Jan 1;52(suppl 1):S146-53 [Full text]
Lovato-Salas F, Matienzo-Serment L, Monjaras-Avila C, et al. Pandemic influenza A(H1N1) 2009 and respiratory syncytial virus associated hospitalizations. J Infect 2010 Nov;61(5):382-90 [Abstract]
Low CL, Chan PP, Cutter JL, et al. International health regulations: lessons from the influenza pandemic in Singapore. Ann Acad Med Singapore 2010 Apr;39(4):325-7 [Full text]
Lu CC, Wang YC, Lai JH, et al. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine 2011 Jan 10;29(3):444-50 [Abstract]
Lu CY, Shao PL, Chang LY, et al. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Vaccine 2010 Aug 16;28(36):5864-70 [Abstract]
Lu L, Yin Y, Sun Z, et al. Genetic correlation between current circulating H1N1 swine and human influenza viruses. J Clin Virol 2010 Nov;49(3):186-91 [Abstract]
Lum ME, McMillan AJ, Brook CW, et al. Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med J Aust 2009 Nov 2;191(9):502-6 [Full text]
Lurie N. H1N1 influenza, public health preparedness, and health care reform. (Perspective) N Engl J Med 2009 Aug 27;361(9):843-5 [Full text]
Luteijn JM, Dolk H, Marnoch GJ. Differences in pandemic influenza vaccination policies for pregnant women in Europe. BMC Public Health 2011 Oct 20;11:819 [Abstract]
Lyytikainen O, Kuusi M, Snellman M, et al. Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010. Eurosurveillance 2011 Jul 7;16(27):pii=19908 [Full text]
Ma W, Belisle SE, Mosier D, et al. 2009 pandemic H1N1 virus causes disease and upregulation of genes related to inflammatory and immune response, cell death and lipid metabolism in pigs. J Virol 2011 Nov;85(22):11626-37 [Abstract]
Ma W, Lager KM, Vincent AL, et al. The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 2009 Aug;56(6-7):326-37 [Abstract]
Ma X, He Z, Wang Y, et al. Knowledge and attitudes of healthcare workers in Chinese intensive care units regarding 2009 H1N1 influenza pandemic. BMC Infect Dis 2011 Jan 25;11:24 [Abstract]
MacDonald N. H1N1 influenza vaccine: global access for a global problem. (Editorial) CMAJ 2009 Aug 4;181(3-4):124 [Full text]
Madhun AS, Akselsen PE, Sjursen H, et al. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 2010 Dec 16;29(2):266-73 [Abstract]
Magill SS, Black SR, Wise ME, et al. Investigation of an outbreak of 2009 pandemic influenza A virus (H1N1) infections among healthcare personnel in a Chicago hospital. Infect Control Hosp Epidemiol 2011 Jun;32(6):611-5 [Full text]
Mahmud SM, Caeseele PV, Hammond G, et al. No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada. Emerg Infect Dis 2012 May;18(5):801-10 [Full text]
Mahmud SM, Hammond G, Elliott L, et al. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. Vaccine 2011 Oct 19;29(45):7975-81 [Abstract]
Mai LQ, Wertheim HFL, Duong TN, et al. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. (Letter) N Engl J Med 2010 Jan 7;362(1):86-7 [Full text]
Maines TR, Jayaraman A, Belser JA, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009 Jul 24;325(5939):484-7 [Abstract]
Mak DB, Daly AM, Armstrong PK, et al. Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia. Med J Aust 2010 Oct 4;193(7):401-4 [Full text]
Mak GC, Chow PWW, Lee WY, et al. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. J Med Virol 2010 Nov;82(11):1816-8 [Abstract]
Mak GC, Leung CK, Cheng KC, et al. Evolution of the haemagglutinin gene of the influenza A(H1N1)2009 virus isolated in Hong Kong, 2009-2011. Euro Surveill 2011 Mar 3;16(9):pii=19807 [Full text]
Mak GC, Wong AH, Ho WYY, et al. The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009-2011. Influenza Other Respi Viruses 2012 May;6(3):e6-10 [Abstract]
Mak KK, Lai CM. Knowledge, risk perceptions, and preventive precautions among Hong Kong students during the 2009 influenza A (H1N1) pandemic. Am J Infect Control 2012 Apr;40(3):273-5 [Abstract]
Mak PWY, Wong CKS, Li OTW, et al. Rapid genotyping of swine influenza viruses. Emerg Infect Dis 2011 Apr;17(4):691-4 [Full text]
Malato L, Llavador V, Marmier E, et al. Pandemic influenza A(H1N1) 2009: molecular characterization and duration of viral shedding in intensive care patients in Bordeaux, South-West France, May 2009 to January 2010. Euro Surveill 2011 Jan 27;16(4):pii=19776 [Full text]
Mallory RM, Malkin E, Ambrose CS, et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE 2010 Oct 29;5(10):e13755 [Full text]
Maltezou HC, Dedoukou X, Patrinos S, et al. Determinants of intention to get vaccinated against novel (pandemic) influenza A H1N1 among health-care workers in a nationwide survey. J Infect 2010 Sep;61(3):252-8 [Abstract]
Maltezou HC, Drakoulis N, Siahanidou T, et al. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1. Pediatr Infect Dis J 2012 May;31(5):527-9 [Abstract]
Maltezou HC, Katerelos P, Mavrouli M, et al. Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece. Vaccine 2011 Sep 2;29(38):6664-9 [Abstract]
Mandelboim M, Hindyieh M, Segman-Meningher T, et al. Possible transmission of pandemic (HIN1) 2009 virus with oseltamivir resistance. (Letter) Emerg Infect Dis 2010 May;16(5):873-4 [Full text]
Manicassamy B, Medina RA, Hai R, et al. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 2010 Jan 29;6(1):e1000745 [Full text]
Manuel O, Pascual M, Hoschler K, et al. Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis 2011 Jan 15;52(2):248-56 [Abstract]
Marcelin G, Bland HM, Negovetich NJ, et al. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-depedent manner. J Infect Dis 2010 Dec 1;202(11):1634-8 [Abstract]
Marcelin G, DuBois R, Rubrum A, et al. A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus. PLoS ONE 2011 Oct 24;6(10):e26335 [Full text]
Marshal H, Tooher R, Collins J, et al. Awareness, anxiety, compliance: community perceptions and response to the threat and reality of an influenza pandemic. Am J Infect Control 2011 (published online Jul 22) [Abstract]
Marshall C, Kelso A, McBryde E, et al. Pandemic (H1N1) 2009 risk for frontline health care workers. Emerg Infect Dis 2011 Jun;17(6):1000-6 [Full text]
Martin A, Reade EP. Acute necrotizing encephalopathy progressing to brain death in a pediatric patient with novel influenza A (H1N1) infection. Clin Infect Dis 2010 Apr 15;50(8):e50-2 [Abstract]
Martin SD. Nurses' ability and willingness to work during pandemic flu. J Nurs Manag 2011 Jan;19(1):98-108 [Abstract]
Martin-Loeches I, Diaz E, Vidaur L, et al. Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Crit Care 2011 (published online Nov 28) [Full text]
Martinez-Hernandez F, Jimenez-Gonzalez DE, Martinez-Flores A, et al. What happened after the initial global spread of pandemic human influenza A (H1N1)? A population genetics approach. Virol J 2010 Aug 20;7:196 [Abstract]
Martirosyan L, Page WJ, Jorgensen P, et al. The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries. BMC Infect Dis 2012 Feb 10;12:36 [Abstract]
Masia M, Padilla S, Antequera P, et al. Predictors of pneumococcal co-infection for patients with pandemic (H1N1) 2009. Emerg Infect Dis 2011 Aug;17(8):1475-8 [Full text]
Mathieu C, Moreno V, Retamal P, et al. Pandemic (H1N1) 2009 in breeding turkeys, Valparaiso, Chile. Emerg Infect Dis 2010 Apr;16(4):709-11 [Full text]
Matsumoto C, Sobata R, Uchida S, et al. Risk for transmission of pandemic (H1N1) 2009 virus by blood transfusion. (Letter) Emerg Infect Dis 2010 Apr;16(4):722-3 [Full text]
Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Resp Crit Care Med 2010 Jan 1;181(1):72-9 [Abstract]
Maurer J, Uscher-Pines L, Harris KM. Awareness of government seasonal and 2009 H1N1 influenza vaccination recommendations among targeted US adults: The role of provider interactions. Am J Infect Control 2010 Aug;38(6):489-90 [Abstract]
Maurer J, Uscher-Pines L, Harris KM. Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter? Prev Med 2010 Aug;51(2):185-7 [Abstract]
Maurer-Stroh S, Ma J, Lee RTC, et al. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. Biology Direct 2009 May 20;4:18 [Abstract]
Mavrouli MD, Routsias JG, Maltezou HC, et al. Estimation of seroprevalence of the pandemic H1N1 2009 influenza virus using a novel virus-free ELISA assay for the detection of specific antibodies. Viral Immunol 2011 Jun 13;24(3):221-6 [Abstract]
May L, Katz R, Johnston L, et al. Assessing physicians' in training attitudes and behaviors during the 2009 H1N1 influenza season: a cross-sectional survey of medical students and residents in an urban academic setting. Influenza Other Respi Viruses 2010 Sep;4(5):267-75 [Full text]
Mayet A, Duron S, Nivoix P, et al. Novel influenza A(H1N1) outbreak among French armed forces in 2009: results of military influenza surveillance system. Public Health 2011 Aug;125(8):494-500 [Abstract]
Mayet A, Ligier C, Gache K, et al. Adverse event following pandemic influenza vaccine Pandemrix reported in the French military forces--2009-2010. Vaccine 2011 Mar 21;29(14):2576-81 [Abstract]
McCarthy NL, Gee J, Weintraub E, et al. Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza. Vaccine 2011 Jul 12;29(31):4891-6 [Abstract]
McCormick JB, Yan C, Ballou J, et al. Response to H1N1 in a U.S.-Mexico border community. Biosecur Bioterror 2010 Sep 8;8(3):233-42 [Abstract]
McCullers JA, Van De Velde LA, Allison KJ, et al. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis 2010 Jun 1;50(11):1487-92 [Abstract]
McEwen RE, Scriven JE, Green CA, et al. Chest radiography findings in adults with pandemic H1N1 2009 influenza. Br J Radiol 2010 Jun;83(990):499-504 [Abstract]
McLean E, Pebody RG, Campbell C, et al. Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect 2010 Nov;138(11):1531-41 [Abstract]
McLeish NJ, Simmonds P, Robertson C, et al. Sero-prevalence and incidence of A/H1N1 2009 influenza infection in Scotland in winter 2009-2010. PLoS ONE 2011 Jun 8;6(6):e20358 [Full text]
McNeil MM, Arana J, Stewart B, et al. A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination--possible stimulated reporting? Vaccine 2012 Mar 23;30(14):2421-6 [Abstract]
McVernon J, Laurie K, Nolan T, et al. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009. Euro Surveill 2010 Oct 7;15(40):pii=19678 [Full text]
McVernon J, Mason K, Petrony S, et al. Recommendations for and compliance with social restrictions during implementation of school closures in the early phase of the influenza A (H1N1) 2009 outbreak in Melbourne, Australia. BMC Infect Dis 2011 Sep 30;11:257 [Abstract]
McVernon J, McCaw JM, Nolan TM. Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response. Aust N Z J Public Health 2010 Apr;34(2):113-9 [Abstract]
Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science 2009 Sep 25;325(5948):1705-8 [Abstract]
Mehle A, Doudna JA. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci 2009 Dec 15;106(50):21312-6 [Abstract]
Meier S, Bel M, L'Huillier A, et al. Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. Vaccine 2011 Apr 27;29(19):3548-57 [Abstract]
Meites E, Farias D, Raffo L, et al. Hospital capacity during an influenza pandemic--Buenos Aires, Argentina, 2009. Infect Control Hosp Epidemiol 2011 Jan;32(1):87-90 [Abstract]
Melzi H, Wenzel JJ, Feierabend K, et al. First sequence-confirmed case of infection with the new influenza A(H1N1) strain in Germany. (Rapid communications) Eurosurveill 2009 May 7;14(18):pi=19203 [Full text]
Memish ZA, McNabb SJN, Mahoney F, et al. Establishment of public health security in Saudi Arabia for the 2009 Hajj in response to pandemic influenza A H1N1. Lancet 2009 Nov 21;374(9703):1786-91 [Abstract]
Memoli MJ, Bristol T, Proudfoot KE, et al. In vivo evaluation of pathogenicity and transmissibility of influenza A(H1N1)pdm09 hemagglutinin receptor binding domain 222 intrahost variants isolated from a single immunocompromised patient. Virology 2012 June 20;428(1):21-9 [Abstract]
Memoli MJ, Davis AS, Proudfoot K, et al. Multidrug-resistant 2009 pandemic influenza A (H1N1) viruses maintain fitness and transmissibility in ferrets. J Infect Dis 2011 Feb 1;203(3):348-57 [Abstract]
Memoli MJ, Hrabal RJ, Hassantoufighi A, et al. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis 2010 May 1;50(9):1252-5 [Abstract]
Mendez-Figueroa H, Raker C, Anderson BL. Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic. Am J Obstet Gynecol 2011 Jun;204(6 suppl):S58-63 [Abstract]
Mereckiene J, Cotter S, Weber JT, et al. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. (Commentary) Euro Surveill 2012 Jan 26;17(4):pii=20064 [Full text]
Mermel LA. Preventing the spread of influenza A H1N1 2009 to health-care workers. Lancet Infect Dis 2009 Dec;9(12):723-4 [Full text]
Meschi S, Selleri M, Lalle E, et al. Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect Dis 2011 May 23;11:140 [Abstract]
Metzger KE, Black SR, Jones RC, et al. Identification, management , and clinical characteristics of hospitalized patients with influenza-like illness during the 2009 H1N1 influenza pandemic, Cook County, Illinois. Infect Control Hosp Epidemiol 2011 Oct;32(10):998-1002 [Abstract]
Meunier I, Embury-Hyatt C, Stebner S, et al. Virulence differences of closely related pandemic 2009 H1N1 isolates correlate with increased inflammatory responses in ferrets. Virology 2012 Jan 5;422(1):125-31 [Abstract]
Michaan N, Amzallag S, Laskov I, et al. Maternal and neonatal outcome of pregnant women infected with H1N1 influenza virus (swine flu). J Matern Fetal Neonatal Med 2011 (published online Apr 8) [Abstract]
Michaelis M, Doerr HW, Cinatl J Jr. An influenza A H1N1 virus revival--pandemic H1N1/09 virus. Infection 2009 Oct;37(5):381-9 [Abstract]
Microsoft. H1N1 Swine Flu Response Center. Decision tree for patients launched Oct 7, 2009 [Web page]
Miller AC, Safi F, Hussain D, et al. Novel influenza A(H1N1) virus among gravid admissions. Arch Intern Med 2010 May 24;170(10):868-73 [Full text]
Miller E, Hoschler K, Hardelid P, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010 Mar 27;375(9720):1100-8 [Abstract]
Miller JC, Danon L, O'Hagan JJ, et al. Student behavior during a school closure caused by pandemic influenza A/H1N1. PLoS ONE 2010 May 5;5(5):e10425 [Full text]
Miller MA, Viboud C, Balinska M, et al. The signature features of influenza pandemics -- implications for policy. (Perspective) N Engl J Med 2009 Jun 18;360(25):2595-8 [Full text]
Miller RR III, Markewitz BA, Rolfs RT, et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest 2010 Apr;137(4):752-8 [Full text]
Miller RS, MacLean AR, Gunson RN, et al Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the west of Scotland, United Kingdom, 2009-10. (Letter) Euro Surveill 2010 Apr 22;15(16):4 [Full text]
Min JY, Chen GL, Santos C, et al. Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets. Virology 2010 Dec 5;408(1):128-33 [Full text]
Minor PD. Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production. Clin Infect Dis 2010 Feb 15;50(4):560-5 [Abstract]
Miraglia JL, Abdala E, Hoff PM, et al. Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. PLoS ONE 2011 Nov 8;6(11):e27214 [Full text]
Mishra AC, Chadha MS, Choudhary ML, et al. Pandemic influenza (H1N1) 2009 is associated with severe disease in India. PLoS ONE 2010 May 7;5(5):e10540 [Full text]
Mitchell H, Levin D, Forrest S, et al. Higher replication efficiency of 2009 (H1N1) pandemic influenza than seasonal and avian strains: kinetics from epithelial cell culture and computational modeling. J Virol 2011 Jan;85(2):1125-35 [Abstract]
Mitchell MD, Mikkelsen ME, Umscheid CA, et al. A systemic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med 2010 Jun;38(6):1398-404 [Abstract]
Mitchell R, Ogunremi T, Astrakianakis G, et al. Impact of the 2009 influenza A (H1N1) pandemic on Canadian health care workers: a survey on vaccination, illness, absenteeism, and personal protective equipment. Am J Infect Control 2012 (published online May 11) [Abstract]
Mitchell T, Dee DL, Phares CR, et al. Non-pharmaceutical interventions during an outbreak of 2009 pandemic influenza A (H1N1) virus infection at a large public university, April-May 2009. Clin Infect Dis 2011 Jan 1;52(suppl 1):S138-45 [Abstract]
Moghadas SM, Bowman CS, Rost G, et al. Post-exposure prophylaxis during pandemic outbreaks. BMC Med 2009 Dec 2;7:73 [Abstract]
Mohamed AG, BinSaeed AA, Al-Habib H, et al. Communicability of H1N1 and seasonal influenza among household contacts of cases in large families. Influenza Other Respi Viruses 2011 (published online Nov 26) [Abstract]
Molbak K, Widgren K, Jensen KS, et al. Burden of illness of the 2009 pandemic of influenza A (H1N1) in Denmark. Vaccine 2011 Jul 22;29(suppl 2):B63-9 [Abstract]
Mollura DJ, Asnis DS, Conetta R, et al. Imaging findings in a fatal case of pandemic swine-origin influenza A (H1N1). AJR Am J Roentgenol 2009 Dec;193(6):1500-3 [Full text]
Monash MD, Stephenson N. Compliant, complacent or panicked? Investigating the problematisation of the Australian general public in pandemic influenza control. Soc Sci Med 2011 Mar;72(6):912-8 [Abstract]
Monsalvo AC, Batalle JP, Lopez MF, et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. (Letter) Nat Med 2011 Feb;17(2):195-9 [Abstract]
Monto AS, Black S, Plotkin SA, et al. Response to the 2009 pandemic: effect on influenza control in wealthy and poor countries. (Commentary) Vaccine 2011 Sep 2;29(38):6427-31 [Abstract]
Moon SM, Kim SH, Jeong MH, et al. Acute encephalopathy and pandemic (H1N1) 2009. (Letter) Emerg Infect Dis 2010 Nov;16(11):1811-3 [Full text]
Moore C, Galiano M, Lackenby A, et al. Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. J Infect Dis 2010 Jan 1;203(1):18-24 [Full text]
Mora M, Rodriguez-Castellano E, Pano-Pardo JR, et al. Influenza A pandemic (H1N1) 2009 virus and HIV. (Letter) Emerg Infect Dis 2010 Jul;16(7):1175-6 [Full text]
Morens DM, Taubenberger JK, Fauci AS. The 2009 H1N1 pandemic influenza virus: what next? mBio 2010 Sep 28;1(4):e00211-10 [Abstract]
Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. (Perspective) N Engl J Med 2009 Jul 16;361(3):225-9 [Full text]
Morens DM, Taubenberger JK. Understanding influenza backward. (Commentary) JAMA 2009 Aug 12;302(6):679-80 [Extract]
Morgan OW, Bramley A, Fowlkes A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010 Mar 15;5(3):e9694 [Full text]
Morlighem JE, Aoki S, Kishima M, et al. Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic. PLoS ONE 2011 Apr 29;6(4):e18956 [Full text]
Moro PL, Broder K, Zheteyeva Y, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2011 Nov;205(5):473 [Abstract]
Morrison C, Maurtua-Neumann P, Myint MT, et al. Pandemic (H1N1) 2009 outbreak at camp for children with hematologic and oncologic conditions. Emerg Infect Dis 2011 Jan;17(1):87-9 [Full text]
Mostaco-Guidolin LC, Greer A, Sander B, et al. Variability in transmissibility of the 2009 H1N1 pandemic in Canadian communities. BMC Res Notes 2011 Dec 13;4:537 [Abstract]
Mota NVVP, Lobo RD, Toscano CM, et al. Cost-effectiveness of sick leave policies for health care workers with influenza-like illness, Brazil, 2009. Emerg Infect Dis 2011 Aug;17(8):1421-9 [Full text]
Mouchtouri VA, Black N, Nichols G, et al. Preparedness for the prevention and control of influenza outbreaks on passenger ships in the EU: the SHIPSAN Trainet project communication. (Perspectives) Eurosurveill 2009 May 28;14(21):pi=19219 [Full text]
Mukherjee P, Lim PL, Chow A, et al. Epidemiology of travel-associated pandemic (H1N1) 2009 infection in 116 patients, Singapore. Emerg Infect Dis 2010 Jan;16(1):21-6 [Full text]
Mulrennan S, Tempone SS, Ling ITW, et al. Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable. PLoS ONE 2010 Sep 21;5(9):e12849 [Full text]
Munoz MP, Soldevila N, Martinez A, et al. Influenza vaccine coverage, influenza-associated morbidity and all-cause mortality in Catalonia (Spain). Vaccine 2011 Jul 12;29(31):5047-52 [Abstract]
Munster VJ, de Wit E, van den Brand JM, et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009 Jul 24;325(5939):481-3 [Abstract]
Murray M, Grant J, Bryce E, et al. Facial protective equipment, personnel, and pandemics: impact of the pandemic (H1N1) 2009 virus on personnel and use of facial protective equipment. Infect Control Hosp Epidemiol 2010 Oct;31(10):1011-6 [Abstract]
Murray RJ, Robinson JO, White JN, et al. Community-acquired pneumonia due to pandemic A(H1N1) 2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection. PLoS One 2010 Jan 14;5(1):e8705 [Full text]
Muscatello DJ, Barr M, Thackway SV, et al. Epidemiology of influenza-like illness during pandemic (H1N1) 2009, New South Wales, Australia. Emerg Infect Dis 2011 Jul;17(7):1240-7 [Full text]
Muscatello DJ, Cretikos MA, MacIntyre CR. All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009. Emerg Infect Dis 2010 Sep;16(9):1381-7 [Full text]
Myers CA, Kasper MR, Yasuda CY, et al. Dual infection of novel influenza viruses A/H1N1 and A/H3N2 in a cluster of Cambodian patients. Am J Trop Med Hyg 2011 Nov;85(5):961-3 [Abstract]
Mytton OT, Rutter PD, Donaldson LJ. Influenza A(H1N1)pdm09 in England, 2009 to 2011: a greater burden of severe illness in the year after the pandemic than in the pandemic year. Euro Surveill 2012 Apr 5;17(14):pii=20139 [Full text]
Mytton OT, Rutter PD, Mak M, et al. Mortality due to pandemic (H1N1) 2009 influenza in England: a comparison of the first and second waves. Epidemiol Infect 2011 (published online Nov 1) [Abstract]
Nasrullah M, Breiding MJ, Smith W, et al. Response to 2009 pandemic influenza A H1N1 among public schools of Georgia, United States--fall 2009. Int J Infect Dis 2012 May 2;9(5):431-41 [Abstract]
Nassim C, Christensen S, Henry D, et al. Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to one year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. Pediatr Infect Dis 2012 (published online Feb 1) [Abstract]
Nature editors. A pandemic of hindsight? (Editorial). Nature 2010 Jun 24;465(7301):985 [Full text]
Nature editors. After the pandemic. Nature 2010 Aug 19;466:903 [Full text]
Nature editors. Lessons from a pandemic. (Editorial) Nature 2010 Jan 14;463(7278):135-6 [Full text]
Nava GM, Attene-Ramos MS, Ang JK, et al. Origins of the new influenza A(H1N1) virus: time to take action. (Rapid communications) Eurosurveill 2009 Jun 4;14(22):pi=19228 [Full text]
Nelson CA, France EK, Shetterly SM, et al. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection. Pediatr Infect Dis J 2011 Jul;30(7):562-5 [Abstract]
Nelson GE, Gershman KA, Swerdlow DL, et al. Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA. Emerg Infect Dis 2012 Feb;18(2):208-16 [Full text]
Nelson MI, Tan Y, Ghedin E, et al. Phylogeography of the spring and fall waves of the H1N1/09 pandemic influenza virus in the United States. J Virol 2011 Jan;85(2):828-34 [Abstract]
Nelson NP, Brownstein JS, Hartley DM, et al. Event-based biosurveillance of respiratory disease in Mexico, 2007-2009: connection to the 2009 influenza A(H1N1) pandemic? Euro Surveill 2010 Jul 29;15(30):pii=19626 [Full text]
Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009 Jun 18;459(7249):931-9 [Abstract]
Neuzil KM. Influenza vaccines: more options and more opportunities. (Editorial) J Infect Dis 2012 Mar 1;205(5):700-1 [Abstract]
Neuzil KM. Pandemic influenza vaccine policy--considering the early evidence. (Editorial) N Engl J Med 2009 Dec 17;361(25):e59 [Full text]
New Influenza A(H1N1) Investigation teams. New influenza A(H1N1) virus infections in France, April - May 2009. (Rapid communications) Eurosurveill 2009 May 28;14(21):pi=19221 [Full text]
Nfon CK, Berhane Y, Hisanaga T, et al. Characterization of H1N1 swine influenza viruses circulating in Canadian pigs in 2009. J Virol 2011 Sep;85(17):8667-79 [Abstract]
Ng S, Wu P, Nishiura H, et al. An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11. BMC Infect Dis 2011 Aug 26;11:230 [Abstract]
Ngaosuwankul N, Noisumdaeng P, Komolsiri P, et al. Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses. Virol J 2010 Apr 20;7:75 [Abstract]
Nguyen HH, Tumpey TM, Park HJ, et al. Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS ONE 2010 Apr 13;5(4):e10152 [Full text]
Nguyen JT, Hoopes JD, Le MH, et al. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PLoS One 2010 Feb 22;5(2):e9332 [Full text]
Nguyen-Van-Tam JS, Openshaw PJM, Hashim A, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010 Jul;65(7):645-51 [Full text]
Nicholson KG, Abrams KR, Batham S, et al. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomized, multicentre, age-stratified, head-to-head trial. Lancet Infect Dis 2011 Feb;11(2):91-101 [Abstract]
Nicoll A, Ammona A, Amato A, et al. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health 2010 Jan;124(1):14-23 [Abstract]
Nicoll A, Coulombier D. Europe's intial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices. Eurosurveill 2009 Jul 23;14(29):pii=19279 [Full text]
Nicoll A, McKee M. Moderate pandemic, not many dead--learning the right lessons in Europe from the 2009 pandemic. (Commentary) Eur J Public Health 2010 Oct;20(5):486-8 [Abstract]
Nicoll A, Sprenger M. Learning lessons from the 2009 pandemic: putting infections in their proper place. (Commentary) Eur J Epidemiol 2011 Mar;26(3):191-4 [Full text]
Nicoll A, Sprenger M. The end of the pandemic--what will be the pattern of influenza in the 2010-11 European winter and beyond? (Editorial) Euro Surveill 2010 Aug 12;15(32):pii=19637 [Full text]
Nikolopoulos G, Bagos P, Lytras T, et al. An ecological study of the determinants of differences in 2009 pandemic influenza mortality rates between countries in Europe. PLoS ONE 2011 May 11;6(5):e19432 [Full text]
Ninove L, Gazin C, Gould EA, et al. A simple method for molecular detection of swine-origin and human-origin influenza A virus. Vector-Borne Zoonotic Dis 2010 Apr;10(3):237-40 [Full text]
Nishiura H, Castillo-Chavez C, Safan M, et al. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. (Rapid communications) Eurosurveill 2009 Jun 4;14(22):pi=19227 [Full text]
Nishiura H, Chowell G, Castillo-Chavez C. Did modeling overestimate the transmission potential of pandemic (H1N1-2009)? Sample size estimation for post-epidemic seroepidemiological studies. PLoS ONE 2011 Mar 24;6(3):e17908 [Full text]
Nishiura H, Kamiya K. Fever screening during the influenza (H1N1-2009) pandemic at Narita International Airport, Japan. BMC Infect Dis 2011 May 3;11:111 [Abstract]
Nishiura H, Klinkenberg D, Roberts M, et al. Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. PLoS ONE 2009 Aug 31;4(8):e6852 [Full text]
Nishiura H, Oshitani H. Effects of vaccination against pandemic (H1N1) 2009 among Japanese children. (Letter) Emerg Infect Dis 2011 Apr;17(4):746-7 [Full text]
Nishiyama M, Yoshida Y, Sato M, et al. Characteristics of paediatric patients with 2009 pandemic influenza A(H1N1) and severe, oxygen-requiring pneumonia in the Tokyo region, 1 September-31 October 2009. Euro Surveill 2010 Sep 9;15(36):pii=19659 [Full text]
Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011 (published online Oct 5) [Abstract]
Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 2012 Mar 28;7(3):e33536 [Full text]
Nokleby H, Nicoll A. Risk groups and other target groups: preliminary ECDC guidance for developing influenza vaccination recommendations for the season 2010-11. Euro Surveill 2010 Mar 25;15(12):pii=19525 [Full text]
Nolan T, McVernon J, Skeljo M, et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2009 Jan 6;303(1):37-46 [Abstract]
Norgaard O, Lazarus JV. Searching PubMed during a pandemic. PLoS ONE 2010 Apr 7;5(4):e10039 [Full text]
North F, Varkey P, Bartel GA, et al. Can an office practice telephonic response meet the needs of a pandemic? Telemed J E Health 2010 Dec;16(10):1012-6 [Abstract]
Nougairede A, Lagier JC, Ninove L, et al. Likely correlation between sources of information and acceptability of A/H1N1 swine-origin influenza virus vaccine in Marseille, France. PLoS ONE 2010 Jun 25;5(6):e11292 [Full text]
Nougairede A, Ninove L, Zandotti C, et al. Novel virus influenza A (H1N1sw) in south-eastern France, April-August 2009. PLoS One 2010 Feb 17;5(2):e9214 [Full text]
Nougairede A, Ninove L, Zandotti C, et al. Point of care strategy for rapid diagnosis of novel A/H1N1 influenza virus. PLoS One 2010 Feb 17;5(2):e9215 [Full text]
Novel Swine-Origin Influenza (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009 Jun 18;360(25):2605-15 [Full text]
O'Riordan S, Barton M, Yau Y, et al. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010 Jan 12;182(1):39-44 [Full text]
Octaviani CP, Goto H, Kawaoka Y. Reassortment between seasonal H1N1 and pandemic (H1N1) 2009 influenza viruses is restricted by limited compatibility among polymerase subunits. J Virol 2011 Aug;85(16):8449-52 [Abstract]
Octaviani CP, Ozawa M, Yamada S, et al. High genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol 2010 Oct;84(20):10918-22 [Abstract]
Odaira F, Takahashi H, Toyokawa T, et al. Assessment of secondary attack rate and effectiveness of antiviral prophylaxis among household contacts in an influenza A(H1N1)V outbreak in Kobe, Japan, May-June 2009. (Rapid communications) Eurosurveill 2009 Sep 3;14(35):pii=19320 [Full text]
Ofri D. The emotional epidemiology of H1N1 influenza vaccination. (Perspective) N Engl J Med 2009 Dec 31;361(27):2594-5 [Full text]
Oh CE, Lee J, Kang JH, et al. Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial. Vaccine 2010 Aug 16;28(36):5857-63 [Abstract]
Ohfuji S, Fukushima W, Deguchi M, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 2011 May 1;203(9):1301-8 [Abstract]
Ohio Department of Health. Ohio Department of Health H1N1 vaccine impact study. 2011 (published Apr 20) [Full text]
Okike IO, Yung C, Ladhani S, et al. The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. Vaccine 2011 Sep 2;29(38):6636-40 [Abstract]
Okumura A, Nakagawa S, Kawahima H, et al. Deaths associated with pandemic (H1N1) 2009 among children, Japan, 2009-2010. Emerg Infect Dis 2011 Nov;17(11):1993-2000 [Full text]
Olalla J, Marcos M, Fernandez F, et al. Screening for pandemic (H1N1) 2009 virus among hospital staff, Spain. (Letter) Emerg Infect Dis 2011 Jun;17(6):1139-40 [Full text]
Omon E, Damase-Michel C, Hurault-Delarue C, et al. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine 2011 Dec 6;29(52):9649-54 [Abstract]
Ong AK, Chen MI, Lin L, et al. Improving the clinical diagnosis of influenza--a comparative analysis of new influenza A (H1N1) cases. PLoS One 2009 Dec 29;4(12):e8453 [Full text]
Ong JBS, Chen MIC, Cook AR, et al. Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore. PLoS ONE 2010 Apr 14;5(4):e10036 [Full text]
Ooi PL, Lai FYL, Low CL, et al. Clinical and molecular evidence for transmission of novel influenza A(H1N1/2009) on a commercial airplane. (Letter) Arch Intern Med 2010 May 24;170(10):913-5 [Extract]
Opatowski L, Fraser C, Griffin J, et al. Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 Southern Hemisphere countries. PLoS Pathog 2011 Sep 1;7(9):e1002225 [Full text]
Oppermann M, Fritzsche J, Weber-Schoendorfer C, et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012 (published online May 6) [Abstract]
Opstelten W, van Essen GA, Heijnen ML, et al. High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice. Vaccine 2010 Aug 31;28(38):6164-8 [Abstract]
Orellano PW, Reynoso JI, Carlino O, et al. Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine 2010 Jul 19;28(32):5288-91 [Abstract]
Ortiz JR, Sotomayor V, Uez OC, et al. Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis 2009 Aug;15(8):1271-8 [Full text]
Ortqvist A, Berggren I, Insulander M, et al. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clin Infect Dis 2011 May 15;52(10):1203-11 [Abstract]
OSHA. OSHA statement re: H1N1-related inspections. Oct 14, 2009 [News release]
Osoro EM, Munyua P, Muthoka P, et al. Hospitalized patients with pandemic (H1N1) 2009, Kenya. Emerg Infect Dis 2011 Sep;17(9):1744-6 [Full text]
Ostovar GA, Kohn N, Yu KOA, et al. Nosocomial influenza in a pediatric hospital: comparison of rates of seasonal and pandemic 2009 influenza A/H1N1 infection. Infect Control Hosp Epidemiol 2012 (published online Jan 6) [Abstract]
Oughton M, Dascal A, Laporta D, et al. Evidence of viremia in 2 cases of severe pandemic influenza A H1N1/09. Diagn Microbiol Infect Dis 2011 Jun;70(2):213-7 [Abstract]
Owayed AF, Husain EH, Al-Khabaz A, et al. Epidemiology and clinical presentation of pandemic influenza A (H1N1) among hospitalized children in Kuwait. Med Princ Pract 2012 Apr;21(3):254-8 [Abstract]
Pabbaraju K, Wong S, Wong AA, et al. Design and validation of real-time RT-PCR assays for detection of pandemic (H1N1) 2009 virus. J Clin Microbiol 2009 Nov;47(11):3454-60 [Abstract]
Paine S, Mercer GN, Kelly PM, et al. Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influenza of age, ethnicity and importations. Euro Surveill 2010 Jun 17;15(24):pii=19591 [Full text]
Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS ONE 2009 Dec 31;4(12):8540 [Full text]
Pan C, Cheung B, Tan S, et al. Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus. PLoS One 2010 Mar 8;5(3):e954 [Full text]
Pan-infORM (Pandemic Influenza Outbreak Research Modelling Team). Modelling an influenza pandemic: a guide for the perplexed. CMAJ 2009 Aug 4;181(3-4):171-3 [Full text]
Panagiotopoulos T, Bonovas S, Danis K, et al. Cluster of new influenza A(H1N1) cases in travellers returning from Scotland to Greece - community transmission within the European Union? (Rapid communications) Eurosurveill 2009 May 28;14(21):pii=19226 [Full text]
Pandemic guide for HR professionals released A guide for human resource (HR) managers looking for ways to quickly plan for and respond to the H1N1 pandemic has been issued by the University of Minnesota Center for Infectious Disease Research and Policy, publisher of CIDRAP News, and the Society for Human Resource Management. The free 42-page guide was prepared with support from the Centers for Disease Control and Prevention. It includes lessons learned by HR professionals whose response skills were tested in the early days of the pandemic. [Pandemic toolkit]
Pang X, Yang P, Li S, et al. Pandemic (H1N1) 2009 among quarantined close contacts, Beijing, People's Republic of China. Emerg Infect Dis 2011 Oct;17(10):1824-30 [Full text]
Papenburg J, Baz M, Hamelin ME, et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis 2010 Nov 1;51(9):1033-41 [Abstract]
Pariani E, Boschini A, Amendola A, et al. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. Vaccine 2011 Nov 15;29(49):9209-13 [Abstract]
Park JH, Cheong HK, Son DY, et al. Perceptions and behaviors related to hand hygiene for the prevention of H1N1 influenza transmission among Korean university students during the peak pandemic period. BMC Infect Dis 2010 Jul 28;10:222 [Abstract]
Park SW, Lee JH, Kim ES, et al. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers. Am J Infect Control 2011 Feb;39(1):69-71 [Abstract]
Parmet WE. Pandemic vaccines--the legal landscape. N Engl J Med 2010 May 27;362(21):1949-52 [Full text]
Parretta E, Ianniello B, Ferrazin F, et al. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. Vaccine 2011 May 9;29(20):3708-13 [Abstract]
Parry HM, Damery S, Fergusson A, et al. Pandemic influenza A (H1N1) 2009 in a critical care and theatre setting: beliefs and attitudes towards staff vaccination. J Hosp Infect 2011 Aug;78(4):302-7 [Abstract]
Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 2012 Mar 28;7(3):e33723 [Full text]
Partridge J, Kieny MP, World Health Organization H1N1 Influenza Vaccine Task Force. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 2010 Jul 5;28(30):4709-12 [Abstract]
Pascua PNQ, Song MS, Lee JH, et al. Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. PLoS One 2009 Dec 23;4(12):e8431 [Full text]
Pasma T, Joseph T. Pandemic (H1N1) 2009 infection in swine herds, Manitoba, Canada. Emerg Infect Dis 2010 Apr;16(4):706-8 [Full text]
Pasternak B, Svanstrom H, Molgaard-Nielsen D, et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 2012 (published online May 2) [Abstract]
Patel A, Gorman SE. Stockpiling antiviral drugs for the next influenza pandemic. (Opinion) Clin Pharmacol Therapeutics 2009 Sep;86(3):241-3 [Abstract]
Pavia AT. What did we learn from the emergency use authorization of peramivir in 2009? (Editorial) Clin Infec Dis 2012 (published online Apr 5) [Abstract]
Peacey M, Hall RJ, Sonnberg S, et al. Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009. Emerg Infect Dis 2010 Oct;16(10):1618-20 [Full text]
Pearce MB, Jayaraman A, Pappas C, et al. Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci 2012 (published online Feb 21) [Abstract]
Pebody R, Andrews N, Waight P, et al. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine 2011 Mar 21;29(14):2613-8 [Abstract]
Pebody R, Hardelid P, Fleming DM, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill 2011 Feb 10;16(6):pii=19791 [Full text]
Pebody RG, Harris R, Kafatos G, et al. Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom. Emerg Infect Dis 2011 Jun;17(6):990-9 [Full text]
Pebody RG, McLean E, Zhao H, et al. Pandemic influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill 2010 May 20;15(20):pii=19571 [Full text]
Pelat C, Falchi A, Carrat F, et al. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS ONE 2011 May 10;6(5):e19621 [Full text]
Pelletier I, Rousset D, Enouf V, et al. Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France. Euro Surveill 2011 Oct 27;16(43):pii=19999 [Full text]
Pena L, Vincent AL, Ye J, et al. Modifications in the polymerase genes of swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol 2011 Jan;85(1):456-69 [Abstract]
Peralta PSO, Cortes-Garcia M, Vicente-Herrero M, et al. Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April - December 2009. Euro Surveill 2010 Sep 23;15(38):pii=19667 [Full text]
Pereda A, Cappuccio J, Quiroga MA, et al. Pandemic (H1N1) 2009 outbreak on a pig farm, Argentina. Emerg Infect Dis 2010 Feb;16(2):304-7 [Full text]
Perera RAPM, Riley S, Ma SK, et al. Seroconversion to pandemic (H1N1) 2009 virus and cross-reactive immunity to other swine influenza viruses. Emerg Infect Dis 2011 Oct;17(10):1897-9 [Full text]
Perez CM, Ferres M, Labarca JA. Pandemic (H1N1) 2009 reinfection, Chile. (Letter) Emerg Infect Dis 2010 Jan;16(1):156-7 [Full text]
Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009 Aug 13;361(7):680-9 [Full text]
Perez-Padilla R, Fernandez R, Garcia-Sancho C, et al. Pandemic (H1N1) 2009 virus and Down syndrome patients. Emerg Infect Dis 2010 Aug;16(8):1312-4 [Full text]
Perio MAD, Brueck SE, Mueller CA, et al. Evaluation of 2009 pandemic influenza A (H1N1) exposures and illness among physicians in training. Am J Infect Control 2012 (published online May 24) [Abstract]
Pfeifer D, Alfonso C, Wood D. Defining the safety profile of pandemic influenza vaccines. (Commentary) Lancet 2010 Jan 2;375(9708):9-11 [Full text]
Phelps R. Lessons from H1N1's first wave. Risk Manage 2009 Nov 1;56:27-32 [Full text]
Phongsamart W, Sirisanthana V, Wittawatmongkol O, et al. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children. Vaccine 2011 Nov 3;29(47):8705-11 [Abstract]
Pierce M, Kurinczuk JJ, Spark P, et al. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011 Jun 14;342:d3214 [Full text]
Piralla A, Pariani E, Rovida F, et al. Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic. PLoS ONE 2011 Dec 14;6(12):e28332 [Full text]
Piso RJ, Albrecht Y, Handschin P, et al. Low transmission rate of 2009 H1N1 influenza during a long-distance bus trip. Infection 2011 Apr;39(2):149-53 [Abstract]
Plagianos MG, Wu WY, McCullough C, et al. Syndromic surveillance during pandemic (H1N1) 2009 outbreak, New York, New York, USA. Emerg Infect Dis 2011 Sep;17(9):1724-6 [Full text]
Plennevaux E, Blatter M, Cornish MJ, et al. Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial. Vaccine 2011 Feb 11;29(8):1569-75 [Abstract]
Plennevaux E, Sheldon E, Blatter M, et al. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010 Jan 2;375(9708):41-8 [Full text]
Plough A, Bristow B, Fielding J, et al. Pandemics and health equity: lessons learned from the H1N1 response in Los Angeles County. J Public Health Manage Pract 2011 Jan/Feb;17(1):20-7 [Abstract]
Poeppl W, Hell M, Herkner H, et al. Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria. Infection 2011 Aug;39(4):341-52 [Abstract]
Poeppl W, Herkner H, Burgmann H, et al. Performance of the QuickVue Influenza A+B rapid test for pandemic H1N1 (2009) virus infection in adults. PLoS ONE 2011 Dec 1;6(12):e28089 [Full text]
Poggensee G, Gilsdorf A, Buda S, et al. The first wave of pandemic influenza (H1N1) 2009 in Germany: from initiation to acceleration. BMC Infect Dis 2010 Jun 7;10(1):155 [Abstract]
Poland GA. The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 2010 Sep 7;28(4):D3-13 [Abstract]
Poletti P, Ajelli M, Merler S. The effect of risk perception on the 2009 H1N1 pandemic influenza dynamics. PLoS ONE 2011 Feb 7;6(2):e16460 [Full text]
Pollock NR, Duong S, Cheng A, et al. Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing. Clin Infect Dis 2009 Sep 15;49(6):e66-8 [Abstract]
Pongthanapisith V, Sukasem C, Premchaiporn K, et al. Clinical performance of three rapid diagnostic tests for influenza virus in nasopharyngeal specimens to detect novel swine-origin influenza viruses. Infection 2011 Apr;39(2):105-11 [Abstract]
Poon LLM, Mak PWY, Li OTW, et al. Rapid detection of reassortment of pandemic H1N1/2009 influenza virus. Clin Chem 2010 Aug;56(8):1340-4 [Abstract]
Potdar VA, Chadha MS, Jadhav SM, et al. Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS One 2010 Mar 15;5(3):e9693 [Full text]
Poucke SV, Uhlendorff J, Wang Z, et al. Effect of receptor specificity of A/Hong Kong/1/68 (H3N2) influenza virus variants on replication and transmission in pigs. Influenza Other Respi Viruses 2012 (published online May 4) [Abstract]
Pourbohloul B, Ahued A, Davoudi B, et al. Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Resp Viruses 2009 Aug 18;3(5):215-22 [Abstract]
Precioso AR, Miraglia JL, Campos LMA, et al. A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccine with different adjuvant systems. Vaccine 2011 Nov 8;29(48):8974-81 [Abstract]
Presanis AM, De Angelis D, New York City Swine Flu Investigation Team, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009 Dec 8;6(12):e1000207 [Full text]
Presanis AM, Pebody RG, Paterson BJ, et al. Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ 2011 Sep 8;343:d5408 [Full text]
President's Council of Advisors on Science and Technology. Report to the president on reengineering the influenza vaccine production enterprise to meet the challenges of pandemic influenza. Aug 2010 [Full text]
President's Council of Advisors on Science and Technology. Report to the President on U.S. preparations for 2009-H1N1 influenza. Aug 24, 2009 [Full text]
Prosser LA, Lavelle TA, Fiore AE, et al. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS ONE 2011 Jul 29;6(7):e22308 [Full text]
Public Health Agency of Canada. Lessons learned review: Public Health Agency of Canada and Health Canada response to the 2009 H1N1 pandemic. Released Dec 29, 2010 (but dated Nov) [Landing page, with links to full report]
Public Health Agency of Canada. Public health guidance for the prevention and management of influenza-like-illness (ILI), including the pandemic (H1N1) 2009 influenza virus, related to mass gatherings. Sep 9, 2009 [Full text]
Public Health Agency of Canada. Responding to an infectious disease outbreak: progress between SARS and pandemic influenza H1N1. Apr 11, 2012 [Full text]
Public Health Agency of Canada. Your H1N1 preparedness guide. Released Oct 13, 2009 [Web page]
Puig-Barbera J, Arnedo-Pena A, Pardo-Serrano F, et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain: a test-negative, hospital-based, case-control study. Vaccine 2010 Nov 3;28(7):7460-7 [Abstract]
Pushko P, Kort T, Nathan M, et al. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Vaccine 2010 Jul 5;28(30):4771-6 [Full text]
Puzelli S, Buonaguro FM, Facchini M, et al. Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus. J Clin Microbiol 2010 Jun;48(6):2298-300 [Full text]
Puzelli S, Facchini M, De Marco MA, et al. Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. Euro Surveill 2010 Oct 28;15(43):pii=19696 [Full text]
Qian YH, Su J, Shi P, et al. Attempted early detection of influenza A (H1N1) pandemic with surveillance data of influenza-like illness and unexplained pneumonia. Influenza Other Respi Viruses 2011 Nov;5(6):e479-86 [Abstract]
Qiu C, Tian D, Wan Y, et al. Early adaptive humoral immune responses and virus clearance in humans recently infected with pandemic 2009 H1N1 influenza virus. PLoS ONE 2011 Aug 23;6(8):e22603 [Full text]
Qu Y, Zhang R, Cui P, et al. Evolutionary genomics of the pandemic 2009 H1N1 influenza virus (pH1N1v). Virol J 2011 May 21;8:250 [Abstract]
Quach S, Hamid JS, Pereira JA, et al. Time and motion study to compare electronic and hybrid data collection during the pandemic (H1N1) 2009 influenza vaccination campaign. Vaccine 2011 Feb 24;29(10):1997-2003 [Full text]
Quan FS, Vunnava A, Compans RW, et al. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS ONE 2010 Feb 11;5(2):e9161 [Full text]
Quinn SC, Kumar S, Freimuth VS, et al. Public willingness to take a vaccine or drug under emergency use authorization during the 2009 H1N1 pandemic. Biosecur Bioterror 2009 Oct 12;7(3):275-90 [Abstract]
Rahamat-Langendoen JC, Tutuhatunewa ED, Scholvinck EH, et al. Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients. J Clin Virol 2012 Jun;54(2):135-40 [Abstract]
Ramakrishnan MA, Wang P, Abin M, et al. Triple reassortant swine influenza A (H3N2) virus in waterfowl. (Letter) Emerg Infect Dis 2010 Apr;16(4):728-9 [Full text]
Rambhia KJ, Watson M, Sell TK, et al. Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations. Biosecur Bioterror 2010 Dec;8(4):321-30 [Abstract]
Ramirez-Gonzalez JE, Gonzalez-Duran E, Alcantara-Perez P, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico. Emerg Infect Dis 2011 Feb;17(2):283-6 [Full text]
Ramsey MA, Marczinski CA. College students' perceptions of H1N1 flu risk and attitudes toward vaccination. Vaccine 2011 Oct 13;29(44):7599-601 [Abstract]
Randolph AG, Vaughn F, Sullivan R, et al. Critically ill US kids during pH1N1: secondary complications were mortality risk factors. Pediatrics 2011 (published online Nov 7) [Abstract]
Ranjan P, Jayashankar L, Deyde V, et al. 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication. Virol J 2010 May 21;7:102 [Abstract]
Rappuoli R, del Guidice G, Nable GJ, et al. Rethinking influenza. Science 2009 Oct 2;326(5949):50 [Abstract]
Rasmussen SA, Kissin DM, Yeung LF, et al. Preparing for influenza after 2009 H1N1: special consideration for pregnant women and newborns. Am J Obstet Gynecol 2011 Jun;204(6 suppl):S13-20 [Abstract]
Rath B, von Kleist M, Tief F, et al. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with influenza A (H1N1) 2009 and influenza B viruses. Pediatr Infect Dis J 2012 (published online May 10) [Abstract]
Raymond NJ, Berry N, Blackmore TK, et al. Pandemic influenza A(H1N1)2009 in hospital healthcare workers in New Zealand. Infect Control Hosp Epidemiol 2012 Feb;33(2):196-9 [Abstract]
Rebmann T, Citarella B, Subramaniam DS, et al. A home health agency's pandemic preparedness and experience with the 2009 H1N1 pandemic. Am J Infect Control 2011 Nov;39(9):725-31 [Abstract]
Redelings MD, Piron J, Smith LV, et al. Knowledge, attitudes, and beliefs about seasonal influenza and H1N1 vaccinations in a low-income, public health clinic population. Vaccine 2012 Jan 5;30(2):454-8 [Full text]
Redelman-Sidi G, Sepkowitz KA, Huang CK, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010 Apr;60(4):257-63 [Abstract]
Reed C, Angulo FJ, Swerdlow DL, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009 Dec;15(12):2004-7 [Full text]
Reichert T, Chowell G, Nishiura H, et al. Does glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis 2010 Jan 7;10:5 [Abstract]
Reinheimer C, Allwinn R, Doerr HW. Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010. Infection 2011 Apr;39(2):101-4 [Abstract]
Rello J, Rodriguez A, Ibanez P, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009;13(5):R148 (published online Sep 11) [Abstract, with link to full text]
Renaud C, Boudreault AA, Kuypers J, et al. H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients. Emerg Infect Dis 2011 Apr;17(4):653-60 [Full text]
Rhim JW, Lee KY, Youn YS, et al. Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: an observational cohort study. BMC Infect Dis 2011 Aug 24;11:225 [Abstract]
Riley S, Kwok KO, Wu KM, et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 2011 Jun 21;8(6):e1000442 [Full text]
Rinchiuso-Hasselmann A, McKay RL, Williams CA, et al. Protecting the public from H1N1 through points of dispensing (PODs). Biosecur Bioterror 2011 Mar;9(1):13-21 [Abstract]
Riquel R, Torres A, Rioseco ML, et al. Influenza pneumonia: a comparison between seasonal influenza virus and H1N1 pandemic. Eur Respir J 2011 Jul;28(1):106-11 [Abstract]
Riscili BP, Anderson TB, Prescott HC, et al. An assessment of H1N1 influenza-associated acute respiratory distress syndrome severity after adjustment for treatment characteristics. PLoS ONE 2011 Mar 25;6(3):e18166 [Full text]
Rizzo C, Rota MC, Bella A, et al. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 2010 Apr;28(20):3558-62 [Full text]
Rizzo C, Rota MC, Bella A, et al. Response to the 2009 influenza A(H1N1) pandemic in Italy. Euro Surveill 2010 Dec 9;15(49):pii=19744 [Full text]
Roa PL, Catalan P, Giannella M, et al. Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients. Diagn Microbiol Infect Dis 2011 Apr;69(4):428-31 [Abstract]
Robinson S, Averhoff F, Kiel J, et al. Pandemic influenza A in residential summer camps-Maine, 2009. Pediatr Infect Dis J 2012 Jun;31(6):547-50 [Abstract]
Rockman S, Middleton DJ, Pearse MJ, et al. Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines. Vaccine 2012 May 21;30(24):3618-23 [Abstract]
Rodriguez-Noriega E, Gonzalez-Diaz E, Morfin-Otero R, et al. Hospital triage system for adult patients using an influenza-like illness scoring system during the 2009 pandemic -- Mexico. PLoS ONE 2010 May 14;5(5):e10658 [Full text]
Rodriguez-Rieiro C, Esteban-Vasallo MD, Dominguez-Berjon MF, et al. Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain. Vaccine 2011 Feb 1;29(6):1332-8 [Abstract]
Rodwell TC, Robertson AM, Aguirre N, et al. Pandemic (H1N1) 2009 surveillance in marginalized populations, Tijuana, Mexico. Emerg Infect Dis 2010 Aug;16(8):1292-5 [Full text]
Roll U, Yaari R, Katriel G, et al. Onset of a pandemic: characterizing the initial phase of the swine flu (H1N1) epidemic in Israel. BMC Infect Dis 2011 Apr 14;11:92 [Abstract]
Rolland-Harris E, Vachon J, Kropp R, et al. Hospitalization of pregnant women with pandemic A(H1N1) 2009 influenza in Canada. Epidemiol Infect 2011 (published online Sep 16) [Abstract]
Roman F, Vaman T, Kafeja F, et al. AS03A-adjuvanted influenza A (H1N1) 2009 vaccine for adults of up to 85 years of age. Clin Infect Dis 2010 Sep 15;51(6):668-77 [Abstract]
Ropero-Alvarez AM, Whittembury A, Kurtis HJ, et al. Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean. Vaccine 2012 Jan 20;30(5):916-21 [Abstract]
Rosella L, Groenwold RHH, Crowcroft NS, et al. Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine. Vaccine 2011 Nov 15;29(49):9194-200 [Abstract]
Rubin G, Potts H, Michie S. The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK. Health Technol Assess 2010 Jul;14(34):183-266 [Abstract]
Rubin GJ, Amlot R, Carter H, et al. Reassuring and managing patients with concerns about swine flu: qualitative interviews with callers to NHS Direct. BMC Public Health 2010 Aug 2;10:451 [Abstract]
Rubin GJ, Amlot R, Page L, et al. Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak. BMJ 2009 Jul 2;339:b2651 [Abstract]
Rubin GJ, Potts HWW, Michie S. Likely uptake of swine and seasonal flu vaccines among healthcare workers. A cross-sectional analysis of UK telephone survey data. Vaccine 2011 Mar 16;29(13):2421-8 [Abstract]
Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. Lancet 2010 Nov 27;376(9755):1846-52 [Abstract]
Safronetz D, Rockx B, Feldmann F, et al. Pandemic swine-origin H1N1 influenza A isolates show heterogeneous virulence in macaques. J Virol 2011 Feb;85(3):1214-23 [Abstract]
Saidel-Odes L, Borer A, Schlaeffer F, et al. Risk factors for community-acquired pneumonia with influenza A/H1N1 in southern Israel. Int J Infect Dis 2011 Jul;15(7):e470-4 [Abstract]
Sakabe S, Iwastuki-Horimoto K, Horimoto T, et al. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. Antiviral Res 2010 Dec;88(3):249-55 [Abstract]
Salmon DA, Akhtar A, Mergler MJ, et al. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics 2011 May;127(Suppl 1):S78-86 [Abstract]
Sammon CJ, McGrogan A, Snowball J, et al. Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the General Practice Research Database. Vaccine 2012 Mar 23;30(14):2483-9 [Abstract]
Sanchez-Paya J, Hernandez-Garcia I, Garcia-Roman V, et al. Influenza vaccination among healthcare personnel after pandemic influenza H1N1. Vaccine 2012 Jan 20;30(5):911-5 [Abstract]
Sanchez-Torrent L, Trivino-Rodriguez M, Suero-Toledano P, et al. Novel influenza A (H1N1) encephalitis in a 3-month-old infant. Infection 2010 Jun;38(3):227-9 [Abstract]
Sander B, Bauch CT, Fisman D, et al. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian experience. Vaccine 2010 Aug 31;28(38):6210-20 [Abstract]
Sandman P. Pandemics: good hygiene is not enough. (Commentary) Nature 2009 May 21;459(7245):322-3 [Full text]
Santibanez TA, Singleton JA, Santibanez SS, et al. Socio-demographic differences in opinions about 2009 pandemic influenza A (H1N1) and seasonal influenza vaccination and disease among adults during the 2009-2010 influenza season. Influenza Other Respi Viruses 2012 (published online May 8) [Abstract]
Sasaki A, Gatewood A, Ozonoff A, et al. Evidenced-based tool for triggering school closures during influenza outbreaks, Japan. Emerg Infect Dis 2009 Nov;15(11):1841-3 [Full text]
Satterwhite L, Mehta A, Martin GS. Novel findings from the second wave of adult PH1N1 in the United States. Crit Care Med 2010 Oct;38(10):2059-61 [Abstract]
Savage R, Whelan M, Johnson I, et al. Assessing secondary attack rates among household contacts at the beginning of the influenza A (H1N1) pandemic in Ontario, Canada, April-June 2009: a prospective, observational study. BMC Public Health 2011 Apr 14;11:234 [Abstract]
Savas E, Tanriverdi D. Knowledge, attitudes and anxiety towards influenza A/H1N1 vaccination of healthcare workers in Turkey. BMC Infect Dis 2010 Sep 23;10:281 [Full text]
Savoira E, Testa MA, Viswanath K. Predictors of knowledge of H1N1 infection and transmission in the U.S. population. BMC Public Health 2012 May 3;12:328 [Abstract]
Savulescu C, Jimenez-Jorge S, de Mateo S, et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case control studies, Spain, season 2009-2010. BMC Public Health 2011 Nov 30;11:899 [Abstract]
Schanzer DL, Zheng H, Gilmore J. Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian labour force survey. BMC Infect Dis 2011 Apr 12;11:90 [Abstract]
Schatz M, Chambers CD, Jones KL, et al. Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System. Am J Obstet Gynecol 2011 Jun;204(6 suppl):S64-8 [Abstract]
Scheible K, Zhang G, Baer J, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine 2011 Mar 3;29(11):2159-68 [Abstract]
Scheifele DW, Ward BJ, Dionne M, et al. Evaluation of adjuvanted pandemic H1N1 2009 influenza vaccine after one and two doses in young children. Pediatr Infect Dis J 2011 May;30(5):402-7 [Abstract]
Schirmer P, Lucero C, Oda G, et al. Effective detection of the 2009 H1N1 influenza pandemic in U.S. Veterans Affairs medical centers using a national electronic biosurveillance system. PLoS ONE 2010 Mar 4;5(3):e9533 [Full text]
Schoch-Spana M, Bouri N, Rambhia KJ, et al. Stigma, health disparities, and the 2009 H1N1 influenza pandemic: how to protect Latino farmworkers in future health emergencies. Biosecur Bioterror 2010 Sep 8;8(3):243-54 [Abstract]
Schrauwen EJA, Herfst S, Chutinimitkul S, et al. Possible increased pathogenicity of pandemic (H1N1) 2009 influenza virus upon reassortment. Emerg Infect Dis 2011 Feb;17(2):200-8 [Full text]
Schrenzel MD, Tucker TA, Stalis IH, et al. Pandemic (H1N1) 2009 virus in 3 wildlife species, San Diego, California, USA. (Letter) Emerg Infect Dis 2011 Apr;17(4):747-9 [Full text]
Schuchat A, Bell BP, Redd SC. The science behind preparing and responding to pandemic influenza: the lessons and limits of science. Clin Infect Dis 2011 Jan 1;52(suppl 1):S8-12 [Full text]
Schult TM, Awosika ER, Hodgson MJ, et al. 2009 influenza pandemic impact on sick leave use in the Veterans Health Administration: framework for a health care provider-based national syndromic surveillance system. Disaster Med Public Health Prep 2011 Sep;5(suppl 2):S235-41 [Abstract]
Schulze M, Nitsche A, Schweiger B, et al. Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR. PLoS ONE 2010 Apr 1;5(4):e9966 [Full text]
Schuurmans MM, Tini GM, Dalar L, et al. Pandemic 2009 H1N1 influenza virus vaccination in lung tansplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort. J Heart Lung Transplant 2011 Jun;30(6):685-90 [Abstract]
Schwartz RD, Bayles RR. US university response to H1N1: a study of access to online preparedness and response information. Am J Infect Control 2011 (published online Jul 22) [Abstract]
Schwarzinger M, Flicoteaux R, Cortarenoda S, et al. Low acceptability of A/H1N1 pandemic vaccination in French adult population: Did public health policy fuel public dissonance? PLoS ONE 2010 Apr 16;5(4):e10199 [Full text]
Seale H, Heywood AE, McLaws ML, et al. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis 2010 Apr 19;10:99 [Abstract]
Seale H, Kaur R, Wang Q, et al. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China. Vaccine 2011 Feb 11;29(8):1605-10 [Abstract]
Seibert CW, Kaminski M, Philipp J, et al. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol 2010 Nov;84(21):11219-26 [Abstract]
Seibert CW, Rahmat S, Krammer F, et al. Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance. J Virol 2012 May;86(9):5386-9 [Abstract]
Seiter K, Shah D, Sandoval C, et al. Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit. Infect Control Hosp Epidemiol 2011;32(8) (published online Jul 8) [First page]
Sell TK, Nuzzo J, Toner E. Where does H1N1 influenza information come from? an overview of influenza surveillance in the United States. UPMC Center for Biosecurity Issue Brief 2009 Nov 2 [Full text]
Sencer DJ. Swine-origin influenza: 1976 and 2009. (Perspective) Clin Infect Dis 2011 Jan 1;52(suppl 1):S4-7 [Full text]
Setbon M, Raude J. Factors in vaccination intention against the pandemic influenza A/H1N1. Eur J Public Health 2010 Oct;20(5):490-4 [Abstract]
Seto WH, Cowling BJ, Lam HS, et al. Clinical and nonclinical health care workers faced a similar risk of acquiring 2009 pandemic H1N1 infection. Clin Infect Dis 2011 Aug 1;53(3):280-3 [Abstract]
Settembre EC, Dormitzer PR, Rappuoli R. H1N1: can a pandemic cycle be broken? (Perspective) Sci Transl Med 2010 Mar 24;2(24):24 [Abstract]
Seyler T, Bella A, Puzelli S, et al. Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010. Vaccine 2012 Jan 5;30(2):109-11 [Abstract]
Shafir SC, Fuller T, Smith TB, et al. A national study of individuals who handle migratory birds for evidence of avian and swine-origin influenza virus infections. J Clin Virol 2012 (published online May 24) [Abstract]
Shafir SC, O'Keefe KA, Shoaf KI. Evaluation of the seroprevalence of influenza A (H1N1) 2009 on a university campus: a cross-sectional study. BMC Public Health 2011 Dec 13;11:922 [Abstract]
Shah DP, El Taoum KK, Shah JN, et al. Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis 2012 Apr;31(4):373-8 [Abstract]
Shaikh AG, Termsarasab P, Nwankwo C, et al. Atypical forms of Guillain-Barre syndrome and H1N1-influenza vaccination. Vaccine 2012 May 9;30(22):3251-4 [Abstract]
Sharma S, Parida M, Shkla J, et al. Molecular epidemiology of novel swine origin influenza virus (S-OIV) from Gwalior, India, 2009. Virol J 2011 Jun 7;8:280 [Abstract]
Shay DK, Ridenhour BJ. Can we "hedge" against the development of antiviral resistance among pandemic influenza viruses. (Perspective) PLoS Med 2009 Jun 30;6(6):e1000103 [Full text]
Shen HH, Hou J, Chen WW, et al. Immunologic changes during pandemic (H1N1) 2009, China. Emerg Infect Dis 2011 Jun;17(6):1053-5 [Full text]
Shen J, Niu J. Epidemiologic parameters and evaluation of control measure for 2009 novel influenza A (H1N1) in Xiamen, Fujian province, China. Virol J 2012 Jan 17;9:20 [Abstract]
Shen Y, Lu H. Pandemic (H1N1) 2009, Shanghai, China. Emerg Infect Dis 2010 Jun;16(6):1011-3 [Full text]
Sherman SE, Foster J, Vaid S. Emergency use authority and 2009 H1N1 influenza. Biosecur Bioterror 2009 Sep;7(3):245-50 [Abstract]
Shi P, Keskinocak P, Swann JL, et al. The impact of mass gatherings and holiday traveling on the course of an influenza pandemic: a computational model. BMC Public Health 2010 Dec 21;10:778 [Abstract]
Shieh WJ, Blau DM, Denison AM, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 2010 Jul;177(1):166-75 [Abstract]
Shih SI, Ho TS, Chang CM, et al. Impacts of rapid flu clinic services at an emergency department during the pandemic flu season. Am J Infect Control 2011 (published online Jul 21) [Abstract]
Shiino T, Okabe N, Yasui Y, et al. Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS ONE 2010 Jun 10;5(6):e11057 [Full text]
Shiley KT, Nadolski G, Mickus T, et al. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infect Control Hosp Epidemiol 2010 Jul;31(7):676-82 [Abstract]
Shimada T, Gu Y, Kamiya H, et al. Epidemiology of influenza A(H1N1)v virus infection in Japan, May - June 2009. (Rapid communications) Eurosurveill 2009 Jun 18;14(24):pii=19244 [Full text]
Shin DW, Kim Y, Park JH, et al. Practices and predictors of 2009 H1N1 vaccination in cancer patients: a nationwide survey in Korea. Influenza Other Respi Viruses 2012 (published online May 10) [Abstract]
Shin JS, Hwang SD, Kim HS, et al. Protection of ferrets from infection by swine-origin 2009 A (H1N1) influenza virus by the inactivated vaccine. Viral Immunol 2010 Aug 16;23(4):395-402 [Abstract]
Shin JY, Song MS, Lee EH, et al. Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea. J Clin Microbiol 2006 Nov;44(11):3923-7 [Abstract]
Shin SY, Kang C, Gwack J, et al. Drug-resistant pandemic (H1N1) 2009, South Korea. Emerg Infect Dis 2011 Apr;17(4):702-4 [Full text]
Shinde V, Bridges CB, Uyeki TM, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009 Jun 18;360(25):2616-25 [Full text]
Shine KI, Rogers B, Goldfrank LR. Novel H1N1 influenza and respiratory protection for health care workers. (Perspective) N Engl J Med 2009 Nov 5;361(19):1823-5 [Full text]
Short V, Marriott C, Ostroff S, et al. Description and evaluation of the 2009-2010 Pennsylvania influenza sentinel school monitoring system. Am J Public Health 2011 Nov;101(11):2178-83 [Abstract]
Shrestha SS, Swerdlow DL, Borse RH, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 2011 Jan 1;52(suppl 1):S75-82 [Full text]
Shu B, Garten R, Emery S, et al. Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010. Virology 2012 Jan 5;422(1):151-60 [Abstract]
Sigmundsdottir G, Gudnason T, Olafsson O, et al. Surveillance of influenza in Iceland during the 2009 pandemic. Euro Surveill 2010 Dec 9;15(49):pii=19742 [Full text]
Signorini A, Segre AM, Polgreen PM. The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic. PLoS ONE 2011 May 4;6(5):e19467 [Full text]
Sikora C, Fan S, Golonka R, et al. Transmission of pandemic influenza A (H1N1) 2009 within households: Edmonton, Canada. J Clin Virol 2010 Oct;49(2):90-3 [Abstract]
Sills MR, Hall M, Fieldston ES, et al. Inpatient capacity at Children's Hospitals during pandemic. Emerg Infect Dis 2011 Sep;17(9):1685-91 [Full text]
Sills MR, Hall M, Simon HK, et al. Resource burden at children's hospitals experiencing surge volumes during the spring 2009 H1N1 influenza pandemic. Acad Emerg Med 2011 Feb;18(2):158-66 [Abstract]
Sim JA, Ulanika AA, Katikireddi SV, et al. 'Out of two bad choices, I took the slightly better one': vaccination dilemmas for Scottish and polish migrant women during the H1N1 influenza pandemic. Public Health 2011 Aug;125(8):505-11 [Abstract]
Simmerman JM, Suntarattiwong P, Levy J, et al. Influenza virus contamination of common household surfaces during the 2009 influenza A (H1N1) pandemic in Bangkok, Thailand: implications for contact transmission. Clin Infect Dis 2010 Nov 1;51(9):1053-61 [Full text]
Simpson CR, Ritchie LD, Robertson C, et al. Vaccine effectiveness in pandemic influenza -- primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Asses 2010 Jul;14(34):313-46 [Abstract]
Singanayagam A, Singanayagam A, Wood V, et al. Factors associated with severe illness in pandemic 2009 influenza A (H1N1) infection: implications for triage in primary and secondary care. J Infect 2011 Oct;63(4):243-51 [Abstract]
Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010 Apr 21;303(15)1517-25 [Abstract]
Skarbinski J, Jain S, Bramley A, et al. Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States--September-October 2009. Clin Infect Dis 2011 Jan 1;52(suppl 1):S50-9 [Full text]
Skountzou I, Koutsonanos DG, Kim JH, et al. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 2010 Aug 1;185(3):1642-9 [Abstract]
Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010 Apr 6;7(4):e1000258 [Full text]
Skowronski DM, De Serres G, Janjua NZ, et al. Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunization with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010. Euro Surveill 2012 Jan 26;17(4):pii=20066 [Full text]
Skowronski DM, Hottes TS, Janjua NZ, et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 2010 Nov 23;182(17):1851-6 [Abstract]
Skowronski DM, Janjua NZ, Serres GD, et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ 2011 Feb 3;342:c7297 [Abstract]
Smit PM, Bongers KM, Kuiper RJL, et al. Characterization of 2009 H1N1 pandemic influenza in a population of Dutch children with influenza-like signs and symptoms. Acta Paediatr 2011 (published online Jul 18) [Abstract]
Smit PM, Limper M, van Gorp ECM, et al. Adult outpatient experience of the 2009 H1N1 pandemic: clinical course, pathogens, and evaluation of case definitions. J Infect 2011 May;62(5):371-8 [Abstract]
Smith GJ, Vijaykrishna D, Bahl J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. (Letter) Nature 2009 Jun 25;459(7250):1122-5 [Full text]
Smith JH, Nagy T, Driskell E, et al. Comparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts. J Virol 2011 Aug;85(15):7572-81 [Abstract]
Smith S, Smith GE, Olowokure B, et al. Early spread of the 2009 influenza A(H1N1) pandemic in the United Kingdom--use of local syndromic data, May-August 2009. Euro Surveill 2011 Jan 20;16(3):pii=19771 [Full text]
Smud A, Nagel CB, Madsen E, et al. Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 2010 Dec 27;90(12):1458-62 [Abstract]
Solovyov A, Palacios G, Briese T, et al. Cluster analysis of the origins of the new influenza A(H1N1) virus. (Rapid communications) Euro Surveill 2009 May 28;14(21):pii=19224 [Full text]
Song BM, Kang YM, Kim HS, et al. Induction of inflammatory cytokines and toll-like receptors in human normal respiratory epithelial cells infected with seasonal H1N1, 2009 pandemic H1N1, seasonal H3N2, and highly pathogenic H5N1 influenza virus. Viral Immunol 2011 Jun 13;24(3):179-87 [Abstract]
Song D, Moon H, An DJ, et al. A novel reassortant canine H3N1 influenza virus between pandemic H1N1 and canine H3N2 influenza viruses in Korea. J Gen Virol 2011 (published online Nov 30) [Abstract]
Song JY, Cheong HJ, Heo JY, et al. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine 2011 Feb 4;29(7):1395-8 [Abstract]
Song MS, Pascua PNQ, Lee JH, et al. Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 virus and circulating influenza A viruses. J Virol 2011 Jul;85(13):6275-86 [Abstract]
Soonawala D, Rimmelzwaan GF, Gelinck LBS, et al. Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination. PLoS ONE 2011 Jan 31;6(1):e16496 [Full text]
Sorbello A, Jones SC, Carter W, et al. Emergency use authorization for intravelous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus. Clin Infect Dis 2012 (published online Apr 5) [Abstract]
Soto-Abraham MV, Diaz-Quinonez A, Silva-Pereyra J, et al. Pathological changes associated with the 2009 H1N1 virus. (Letter) N Engl J Med 2009 Nov 12;361(20):2001-3 [Full text]
Souza TML, Mesquita M, Resende P, et al. Antiviral resistance surveillance for influenza A virus in Brazil: investigation on 2009 pandemic influenza A (H1N1) resistance to oseltamivir. Diagn Microbiol Infect Dis 2011 Sep;71(1):98-9 [Abstract]
Souza TML, Salluh JIF, Bozza FA, et al. H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis. PLoS ONE 2010 Nov 30;5(11):e14158 [Full text]
Spaeder MC, Stroud JR, Song X. Time-series model to predict impact of H1N1 influenza on children's hospital. Epidemiol Infect 2011 (published online Aug 31) [Abstract]
Sponseller BA, Strait E, Jergens A, et al. Influenza A pandemic (H1N1) 2009 virus infection in domestic cat. Emerg Infect Dis 2010 Mar;16(3):534-7 [Full text]
Sreta D, Kedkovid R, Tuamsang S, et al. Pathogenesis of swine influenza virus (Thai isolates) in weanling pigs: an experimental trial. Virol J 2009 Mar 25;6(1):34 [Abstract]
Sreta D, Tantawet S, Ayudhya SNN, et al. Pandemic (H1N1) 2009 virus on commercial swine farm, Thailand. Emerg Infect Dis 2010 Oct;16(10):1587-90 [Full text]
Steel J, Palese P, Lowen AC. Transmission of a 2009 pandemic influenza virus shows similar sensitivity to temperature and humidity as an H3N2 seasonal strain. J Virol 2011 Feb;85(3):1400-2 [Abstract]
SteelFisher GK, Blendon RJ, Bekheit MM, et al. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol 2011 Jun;204(6):S116-23 [Abstract]
SteelFisher GK, Blendon RJ, Bekheit MM, et al. The public's response to the 2009 H1N1 influenza pandemic. (Perspective) N Engl J Med 2010 Jun 3;362(22):e65 [Full text]
Steens A, Wijnans EG, Dieleman JP, et al. Effectiveness of a MF-59TM-adjuvanted pandemic influenza vaccine to prevent 2009 influenza A/H1N1-related hospitalization: a matched case-control study. BMC Infect Dis 2011 Jul 18;11:196 [Abstract]
Stein M, Tasher D, Glikman D, et al. Hospitalization of children with influenza A(H1N1) virus in Israel during the 2009 outbreak in Israel. Arch Pediatr Adolesc Med 2010 Nov;164(11):1015-22 [Abstract]
Steinhoff MC, Omer SB, Roy E, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012 Apr 3;184(6):645-53 [Abstract]
Stern AM, Cetron MS, Markel H. Closing the schools: lessons from the 1918-19 U.S. influenza pandemic. Health Aff 2009 Nov-Dec;28(6):w1066-78 [Abstract]
Stewart AM. Mandatory vaccination of health care workers. (Perspective) N Engl J Med 2009 Nov 19;361(21):2015-7 [Full text]
Stittelaar KJ, Kroeze EJBV, Rudenko L, et al. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets. Vaccine 2011 Nov 15;29(49):9265-70 [Abstract]
Stockwell MS, Martinez RA, Hofstetter A, et al. Timeliness of 2009 H1N1 vaccine coverage in a low-income pediatric and adolescent population. Vaccine 2011 (published online Mar 31) [Abstract]
Stohr K. Vaccinate before the next pandemic? (Commentary) Nature 2010 May 13;465(7295):161 [Extract]
Stoner TD, Krauss S, DuBois RM, et al. Antiviral susceptibility of avian and swine influenza of the N1 neuraminidase subtype. J Virol 2010 Oct;84(19):9800-9 [Abstract]
Storms AD, Gubareva LV, Su S, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis 2011 (published online Dec 19) [Full text]
Stowe J, Andrews N, Bryan P, et al. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study. Vaccine 2011 Nov 28;29(51):9467-72 [Abstract]
Stramer SL, Collins C, Nugent T, et al. Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors. J Infect Dis 2012 (published online Jan 31) [Abstract]
Strengell M, Ikonen N, Ziegler T, et al. Minor changes in the hemagglutinin of influenza A(H1N1) 2009 virus alter its antigenic properties. PLoS ONE 2011 Oct 11;6(10):e25848 [Full text]
Strong M, Burrows J, Stedman E, et al. Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom. Euro Surveill 2010 May 13;15(19):pii=19565 [Full text]
Subbramanian RA, Basha S, Shata MT, et al. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination. Vaccine 2010 Dec 6;28(52):8258-67 [Abstract]
Subramony H, Lai FYL, Ang LW, et al. An epidemiological study of 1348 cases of pandemic H1N1 influenza admitted to Singapore hospitals from July to September 2009. Ann Acad Med Singapore 2010 Apr;39(4):283-90 [Full text]
Suess T, Bucholz U, Dupke S, et al. Shedding and transmission of novel influenza virus A/H1N1 infection in households--Germany, 2009. Am J Epidemiol 2010 Jun 1;171(11):1157-64 [Abstract]
Suess T, Remschmidt C, Schink S, et al. Facemasks and intensified hand hygiene in a German household trial during the 2009/2010 influenza A(H1N1) pandemic: adherence and tolerability in children and adults. Epidemiol Infect 2011 Dec;139(12):1895-901 [Abstract]
Suess T, Remschmidt C, Schink SB, et al. The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomized trial; Berlin, Germany, 2009-2011. BMC Infect Dis 2012 Jan 26;12:26 [Abstract]
Sugaya N, Shinjoh M, Mitamura K, et al. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children. J Infect 2011 Oct;63(4):288-94 [Abstract]
Suhaila M, Tang JW, Lee HK, et al. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children. Pediatr Infect Dis J 2011 Jul;30(7):625-7 [Abstract]
Sun F, Zhang Y, Tian D, et al. Responses after one dose of a monovalent influenza A (H1N1) 2009 inactivated vaccine in Chinese population--a practical observation. Vaccine 2011 Sep 2;29(38):6527-31 [Abstract]
Sun S, Zhao G, Xiao W, et al. Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J 2011 Feb 8;8:52 [Abstract]
Sun Y, Bi Y, Pu J, et al. Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses. PLoS ONE 2010 Nov 23;5(11):e15537 [Full text]
Sun Y, Bian C, Xu K, et al. Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine. PLoS ONE 2010 Dec 9;5(12):e14270 [Full text]
Sun Y, Qin K, Wang J, et al. High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc Natl Acad Sci 2011 Mar 8;108(10):4164-9 [Abstract]
Suphaphiphat P, Franti M, Hekele A, et al. Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs. Virol J 2010 Jul 14;7:157 [Abstract]
Suresh PS, Thejaswini Y, Rajan T, et al. Factors associated with 2009 pandemic influenza A (H1N1) vaccination acceptance among university students from India during the post-pandemic phase. BMC Infect Dis 2011 Jul 29;11:205 [Abstract]
Surveillance Group for New Influenza A(H1N1) investigation and Control in Spain. New influenza A(H1N1) virus infections in Spain, April-May 2009. Euro Surveill 2009 May 14;14(19):pii=19209 [Full text]
Swaan CM, Appels R, Kretzschmar MEE, et al. Timeliness of contact tracing among flight passengers for influenza A/H1N1 2009. BMC Infect Dis 2011 Dec 28;11:355 [Abstract]
Swayne DE, Pantin-Jackwood M, Kapczynski D, et al. Susceptibility of poultry to pandemic (H1N1) 2009 virus. (Letter) Emerg Infect Dis 2009 Dec;15(12):2061-3 [Full text]
Swendiman KS, Jones NL. The 2009 influenza pandemic: selected legal issues. CRS R40560 2009 Oct 29 [Abstract]
Sypsa V, Bonovas S, Tsiodras S, et al. Estimating the disease burden of 2009 pandemic influenza A(H1N1) from surveillance and household surveys in Greece. PLoS ONE 2011 Jun 9;6(6):e20593 [Full text]
Sypsa V, Hatzakis A. School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study. (Rapid communications) Eurosurveill 2009 Jun 18;14(24):pii=19240 [Full text]
Sypsa V, Livanios T, Psichogiou M, et al. Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Eurosurveill 2009 Dec 10;14(49):1 [Full text]
Tagajdid R, Annaz HE, Doblali T, et al. Healthcare worker acceptance of pandemic (H1N1) 2009 vaccination, Morocco. (Letter) Emerg Infect Dis 2010 Oct;16(10):1638-9 [Full text]
Takahashi N, Kitajima H, Kusuda S, et al. Pandemic (H1N1) 2009 in neonates, Japan. (Letter) Emerg Infect Dis 2011 Sep;17(9):1763-5 [Full text]
Takanashi JI, Takahashi Y, Imamura A, et al. Late delirious behavior with 2009 H1N1 influenza: mild autoimmune-mediated encephalitis? Pediatrics 2012 (published online Mar 12) [Abstract]
Takano T, Tajiri H, Kashiwagi Y, et al. Cytokine and chemokine response in children with 2009 pandemic influenza A (H1N1) virus infection. Eur J Clin Microbiol Infect Dis 2011 Jan;30(1):117-20 [Abstract]
Takao T, Tomimasa S, Yuichiro Y, et al. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among health care workers in two general hospitals after first outbreak in Kobe, Japan. J Infect 2011 Oct;63(4):281-7 [Abstract]
Takemae N, Parchariyanon S, Ruttanapumma R, et al. Swine influenza virus infection in different age groups of pigs in farrow-to-finish farms in Thailand. Virol J 2011 Dec 14;8:537 [Abstract]
Takeuchi M, Yasunaga H, Horiguchi H, et al. Clinical features of infants hospitalized for 2009 pandemic influenza A (H1N1) in Japan: analysis using a national hospital discharge database. Pediatr Infect Dis J 2011 (published online Dec 14) [Abstract]
Talaat KR, Greenberg ME, Lai MH, et al. A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J Infect Dis 2010 Nov 1;202(9):1327-37 [Abstract]
Tan S, Gordon DL, Honda-Okubo Y, et al. Serological responses following influenza A H1N1 2009 infection in adults. J Infect 2011 May;62(5):388-93 [Abstract]
Tanaka T, Nakajima K, Murashima A, et al. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ 2009 Jul 7;181(1-2):55-8 (published early online Jun 15) [Full text]
Tandale BV, Pawar SD, Gurav YK, et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis 2010 Aug 25;10:255 [Abstract]
Tang JW, Shetty N, Lam TY, et al. Emerging, novel, and known influenza virus infections in humans. Infect Dis Clin North Am 2010 Sep;24(3):603-17 [Abstract]
Tang JW, Tambyah PA, Wilder-Smith A, et al. Cross-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore. (Letter) Emerg Infect Dis 2010 May;16(5):874-6 [Full text]
Tang JWT, Lee CK, Lee HK, et al. Tracking the emergence of pandemic influenza A/H1N1/2009 and its interaction with seasonal influenza viruses in Singapore. Ann Acad Med Singapore 2010 Apr;39(4):291-4 [Full text]
Tang JWT, Tambyah PA, Lai FYL, et al. Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med 2010 May 24;170(10):861-7 [Abstract]
Tang S, Xiao Y, Yang Y, et al. Community-based measures for mitigating the 2009 H1N1 pandemic in China. PLoS ONE 2010 Jun 18;5(6):e10911 [Full text]
Tanner HE, Curran MD, Boxall EH, et al. Viral respiratory infections during the 2009 influenza A(H1N1) outbreak in the West Midlands Region, UK. Epidemiol Infect 2011 (published online Nov 11) [Abstract]
Tarabbo M, Lapa D, Castilletti C, et al. Retrospective investigation of an influenza A/H1N1pdm outbreak in an Italian military ship cruising in the Mediterranean sea, May-September 2009. PLoS ONE 2011 Jan 20;6(1):e15933 [Full text]
Tavares F, Delaigle A, Slavin D, et al. Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective. Vaccine 2011 Aug 26;29(37):6402-7 [Abstract]
Tavares F, Nazareth I, Sawchik J, et al. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 2011 Aug 26;29(37):6358-65 [Abstract]
Tay J, Ng YF, Cutter J, et al. Influenza A (H1N1-2009) pandemic in Singapore - public health control measures implemented and lessons learnt. Ann Acad Med Singapore 2010 Apr;39(4):313-24 [Full text]
Thabet AAK, Al-Bahlooli SH, Al-Kohlani A, et al. Oseltamivir-resistant pandemic (H1N1) 2009 in Yemen -- case report. Virol J 2010 May 8;7:88 [Abstract]
The PloS Medicine Editors. Journals, academics and pandemics. (Editorial) PloS Med 2010 May 25;7(5):e1000282 [Full text]
Thompson DL, Jungk J, Hancock E, et al. Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico. Am J Public Health 2011 (published online Jul 21) [Abstract]
Thomson CA, Wang Y, Jackson LM, et al. Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem. Front B Cell Biol 2012 (published online May 8) [Abstract]
Tian LL, Shi WX, Deng Y, et al. Serologic survey of pandemic influenza A (H1N1 2009) in Beijing, China. Prev Med 2011 Jan;52(1):71-4 [Abstract]
Timpka T, Eriksson O, Spreco A, et al. Age as a determinant for dissemination of seasonal and pandemic influenza: an open cohort study of influenza outbreaks in Ostergotland county, Sweden. PLoS ONE 2012 Feb 23;7(2):e31746 [Full text]
To KKW, Hung IFN, Li IWS, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infec Dis 2010 Mar 15;50(6):850-9 [Abstract]
To KW, Lee S, Chan TO, et al. Exploring determinants of acceptance of the pandemic influenza A (H1N1) 2009 vaccination in nurses. Am J Infect Control 2010 Oct;38(8):623-30 [Abstract]
Toh MPHS, Kannan P, Chen Y, et al. Healthcare workers and H1N1 vaccination: does having a chronic disease make a difference? Vaccine 2012 Feb 1;30(6):1064-70 [Abstract]
Tokarz R, Kapoor V, Wu W, et al. Longitudinal molecular microbial analysis of influenza-like illness in New York City, May 2009 through May 2010. Virol J 2011 Jun 9;8:288 [Abstract]
Tom BDM, Van Hoek AJ, Pebody R, et al. Estimating time to onset of swine influenza symptoms after initial novel A(H1N1v) viral infection. Epidemiol Infect 2011 Sep 1;139(9):1418-24 [Abstract]
Tomizuka T, Takayama Y, Shobayashi T, et al. Underlying medical conditions and hospitalization for pandemic (H1N1) 2009, Japan. (Letter) Emerg Infect Dis 2010 Oct;16(10):1646-7 [Full text]
Tong SYC, Dakh F, Hurt AC, et al. Rapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting. PLoS ONE 2011 Jun 24;6(6):e21446 [Full text]
Torii Y, Kimura H, Ochi N, et al. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Vaccine 2011 Jun 6;29(25):4187-9 [Abstract]
Torres JP, O'Ryan M, Herve B, et al. Impact of the novel influenza A (H1N1) during the 2009 autumn-winter season in a large hospital setting in Santiago, Chile. Clin Infec Dis 2010 Mar 15;50(6):860-8 [Abstract]
Torun SD, Torun F, Catak B. Healthcare workers as parents: attitudes toward vaccinating their children against pandemic influenza A/H1N1. BMC Public Health 2010 Oct 10;10(1):596 [Abstract]
Torun SD, Torun F. Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase. Vaccine 2010 Aug 9;28(35):5703-10 [Abstract]
Toyokawa T, Sunagawa T, Yahata Y, et al. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among health care workers in two general hospitals after first outbreak in Kobe, Japan. J Infect 2011 Oct;63(4):281-7 [Abstract]
Tracht SM, Del Valle SY, Hyman JM. Mathematical modeling of the effectiveness of facemasks in reducing the spread of novel influenza A (H1N1). PLoS One 2010 Feb 10;5(2):e9018 [Full text]
Tramontana AR, George B, Hurt AC, et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010 Jul;16(7):1068-75 [Full text]
Tramuto F, Maida CM, Bonura F, et al. Surveillance of hospitalised patients with influenza-like illness during pandemic influenza A(H1N1) season in Sicily, April 2009-December 2010. Euro Surveill 2011 Sep 1;16(35):pii=19957 [Full text]
Tran D, Science M, Dix D, et al. Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients. Influenza Other Respi Viruses 2012 (published online Mar 14) [Abstract]
Trauer JM, Laurie KL, McDonnell J, et al. Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009. Emerg Infect Dis 2011 Sep;17(9):1615-23 [Full text]
Trebbien R, Larsen LE, Viuff BM. Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs. Virol J 2011 Sep 8;8:434 [Abstract]
Tremblay CL, Rouleau D, Fortin C, et al. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients. Vaccine 2011 Feb 4;29(7):1359-63 [Abstract]
Trevennec K, Cowling BJ, Peyre M, et al. Swine influenza surveillance in East and Southeast Asia: a systematic review. Anim Health Res Rev 2011 Dec;12(2):213-23 [Abstract]
Trevennec K, Leger L, Lyazrhi F, et al. Transmission of pandemic influenza H1N1 (2009) in Vietnamese swine in 2009-2010. Influenza Other Respi Viruses 2011 (published online Dec 30) [Abstract]
Trifonov V, Khiabanian H, Greenbaum B, et al. The origin of the recent swine influenza A(H1N1) virus infecting humans. (Rapid communications) Eurosurveill 2009 Apr 30;14(17):pii=19193 [Full text]
Truelove SA, Chitnisa AS, Heffernan RT, et al. Comparison of patients hospitalized with pandemic 2009 influenza A (H1N1) virus infection during the first two pandemic waves in Wisconsin. J Infect Dis 2011 Mar 15;203(6):828-37 [Abstract]
Trust for America's Health. H1N1 challenges ahead. Oct 1, 2009 [Summary, with link to full text]
Trust for America's Health. Pandemic flu: lessons from the frontlines. Jun 4, 2009 [Links to press release and full report]
Tsai TF, Pedotti P, Hilbert A, et al. Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009. Euro Surveill 2010 Jul 29;15(30):pii=19624 [Full text]
Tsatsaris V, Capitant C, Schmitz T, et al. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Ann Intern Med 2011 Dec 6;155(11):733-41 [Abstract]
Tse H, To KKW, Wen X, et al. Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS ONE 2011 Sep 27;6(9):e22534 [Full text]
Tsiodras S, Sypsa V, Hatzakis A. The vaccination campaign against 2009 pandemic influenza A(H1N1) and its continued importance in view of the uncertainty surrounding the risk associated with the pandemic. (Letter) Euro Surveill 2010 Jan 21;15(3):3 [Full text]
Tsubokura M, Nakada H, Matsumura T, et al. The impact of H1N1 influenza A virus pandemic on the blood donations in Hyogo Prefecture, Japan. Transfusion 2010 Aug;50(8):1803-5 [Abstract]
Tsuchihashi Y, Sunagawa T, Yahata Y, et al. Association between seasonal influenza vaccination in 2008-2009 and pandemic influenza A (H1N1) 2009 infection among school students from Kobe, Japan, April-June 2009. Clin Infect Dis 2011 (published online Nov 18) [Abstract]
Tu W, Mao H, Zheng J, et al. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 2010 July;84(13):6527-35 [Abstract]
Tuite AR, Fisman DN, Kwong JC, et al. Optimal pandemic influenza vaccine allocation strategies for the Canadian population. PLoS ONE 2010 May 6;5(5):e10520 [Full text]
Tuite AR, Greer AL, Whelan M, et al. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 2010 Feb 9;182(2):131-6 [Abstract]
Turner P, Turner CL, Watthanaworawit W, et al. Influenza in refugees on the Thailand-Myanmar border, May-October 2009. Emerg Infect Dis 2010 Sep;16(9):1366-72 [Full text]
Turner SJ, Dohert PC, Kelso A. Q&A: H1N1 pandemic influenza -- what's new? BMC Biol 2010 Oct 11;8:130 [Full text]
Uchida M, Tsukahara T, Kanako M, et al. Swine-origin influenza A outbreak 2009 at Shinshu University, Japan. BMC Public Health 2011 Feb 4;11:79 [Abstract]
Uchida M, Tsukahara T, Kaneko M, et al. How the H1N1 influenza epidemic spread among university students in Japan: experience from Shinshu University. Am J Infect Control 2011 (published online Jul 18) [Abstract]
Ujike M, Ejima M, Anraku A, et al. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg Infect Dis 2011 Mar;17(3):470-9 [Full text]
Uphoff H, an der Heiden M, Schweiger B, et al. Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009 -- a comparison of two methods; Germany, 2009/10. PLoS ONE 2011 Jul 18;6(7):e19932 [Full text]
US Chamber of Commerce. It's not flu as usual: an H1N1 business preparedness guide. Sep 18, 2009 [Full text]
Uscher-Pines L, Maurer J, Harris KM. Racial and ethnic disparities in uptake and location of vaccination for 2009-H1N1 and seasonal influenza. Am J Public Health 2011 Jul;101(7):1252-5 [Abstract]
Uyeki T. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med 2009 Dec 3;361(23):e110 [Full text]
Uyeki TM. 2009 H1N1 virus transmission and outbreaks. (Editorial) N Engl J Med 2010 Jun 10;362(23):2221-3 [Full text]
Vaillant L, La Ruche G, Tarantola A, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. (Rapid communications) Eurosurveill 2009 Aug 20;14(33):pii=19309 [Full text]
Vajo Z, Tamas F, Sinka L, et al. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010 Jan 2;375(9708):49-55 [Full text]
Valdivia A, Lopez-Alcalde J, Vicente M, et al. Monitoring influenza activity in Europe with Google flu trends: comparison with the findings of sentinel physician networks -- results for 2009-10. Euro Surveill 2010 Jul 22;15(29):pii=19621 [Full text]
Valenciano M, Kissling E, Cohen JM, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011;Jan 11;8(1):e1000388 [Full text]
Valli MB, Selleri M, Meschi S, et al. Hemagglutinin 222 variants in pandemic (H1N1) 2009 virus. (Letter) Emerg Infect Dis 2011 Apr;17(4):749-51 [Full text]
van 't Klooster TM, Wielders CC, Donker T, et al. Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June - 31 December 2009. Euro Surveill 2010 Jan 14;15(2):4 [Full text]
van Boven M, Donker T, van der Lubben M, et al. Transmission of novel influenza A(H1N1) in households with post-exposure antiviral prophylaxis. PLoS ONE 2010 Jul 7;5(7):e11442 [Full text]
Van D, McLaws ML, Crimmins J, et al. University life and pandemic influenza: attitudes and intended behaviour of staff and students towards pandemic (H1N1) 2009. BMC Public Health 2010 Mar 14;10:130 [Abstract]
van den Brand JMA, Kreijtz JHCM, Bodewes R, et al. Efficacy of vaccination with different combinations of MF59-adjuvanted and non-adjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza in ferrets. J Virol 2011 Mar;85(6):2851-8 [Abstract]
van den Brand JMA, Stittelaar KJ, van Amerongen G, et al. Experimental pandemic (H1N1) 2009 virus infection of cats. Emerg Infect Dis 2010 Nov;16(11):1745-7 [Full text]
van den Brand JMA, Stittelaar KJ, van Amerongen G, et al. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis 2010 Apr 1;201(7):993-9 [Abstract]
van der Vries E, Kroeze EJV, Stittelaar KJ, et al. Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets. PLoS Pathog 2011 Sep 29;7(9):e1002276 [Full text]
van der Vries E, Stelma FF, Boucher CAB. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. (Letter) N Engl J Med 2010 Sep 30;363:1381-2 [Full text]
Van Gemert C, Hellard M, McBryde ES, et al. Intrahousehold transmission of pandemic (H1N1) 2009 virus, Victoria, Australia. Emerg Infect Dis 2011 Sep;17(9):1599-607 [Full text]
van Hoek AJ, Underwood A, Jit M, et al. The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PLoS ONE 2011 Mar 2;6(3):e17030 [Full text]
Van Kerkhove MD, Asikainen T, Becker NG, et al. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. (Commentary) PLoS Med 2010 Jun 1;7(6):e1000275 [Full text]
Van Kerkhove MD, Vandemaele KA, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011 Jul 5:8(7):31001053 [Full text]
van Lier A, Steens A, Ferreira JA, et al. Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands. Vaccine 2012 Apr 16;30(18):2892-9 [Abstract]
Van Poucke SGM, Nicholls JM, Nauwynck HJ, et al. Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution. Virol J 2010 Feb 16;7:38 [Full text]
van Puijenbroek EP, Broos N, van Grootheest K. Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands. Drug Safety 2010 Dec 1;33(12):1097-108 [Abstract]
Van Reeth K, Nicoll A. A human case of swine influenza virus infection in Europe - implications for human health and research. (Editorial) Eurosurveill 2009 Feb 19;14(7):pii=19124 [Full text]
Varella A. Report of the international forum on pandemic influenza 2010: Qingdao, China, 24-25 July 2010. Vaccine 2010 Nov 10;28(48):7579-82 [Full text]
Vasoo S, Singh K, Trenholme GM. Predicting need for hospitalization of patients with pandemic (H1N1) 2009, Chicago, Illinois, USA. Emerg Infect Dis 2010 Oct ;16(10):1594-7 [Full text]
Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1. Clin Infect Dis 2009 Oct 1;49(7):1090-3 [Abstract]
Vaux S, Cauteren DV, Guthmann JP, et al. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health 2011 Jan 12;11:30 [Abstract]
Veen RLV, Loynachan AT, Mogler MA, et al. Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine. Vaccine 2012 Mar 2;30(11):1944-50 [Abstract]
Vellozzi C, Broder KR, Haber P, et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccine adverse events reporting system, United States, October 1, 2009--January 31, 2010. Vaccine 2010 Oct 21;28(45):7248-55 [Full text]
Verity C, Stellitano L, Winstone AM, et al. Guillain-Barre syndrome and H1N1 influenza vaccine in UK children. Lancet 2011 Oct 29;378(9802):1545-6 [Full text]
Verma N, Dimitrova M, Carter DM, et al. H1N1pdm09 infections in young and old: evidence of higher antibody diversity and affinity for HA1 domain in elderly compared with young adults and children. J Virol 2012 May;86(10):5515-22 [Abstract]
Viboud C, Simonsen L. Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus? (Perspective) PLoS Med 2010 Apr 6;7(4):e1000259 [Full text]
Vij NK, Stryker CC, Esper FP, et al. Influenza A/H1N1/09-10 infections in a NICU during the 2009-2010 H1N1 pandemic. Pediatrics 2011 (published online Oct 3) [Abstract]
Vijaykrishna D, Poon LLM, Zhu HC, et al. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 2010 Jun 18;328(5985):1529 [Abstract]
Vijaykrishna D, Smith GJD, Pbus OG, et al. Long-term evolution and transmission dynamics of swine influenza A virus. (Letter) Nature 2011 May 26;473:519-22 [Full text]
Vincent AL, Ciacci-Zanella JR, Lorusso A, et al. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 2010 Mar;28(15):2782-7 [Abstract]
Vincent AL, Lager KM, Harland M, et al. Absence of 2009 pandemic H1N1 influenza A virus in fresh pork. PLoS Med 2009 Dec 18;4(12):e8367 [Full text]
Vinck L, Isken L, Hooiveld M, et al. Impact of the 2009 influenza A(H1N1) pandemic on public health workers in the Netherlands. Euro Surveill 2011 Feb 17;16(7):pii=19793 [Full text]
Virseda S, Restrepo MA, Arranz E, et al. Seasonal and pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish university hospital. Vaccine 2010 Jul 5;28(30):4751-7 [Abstract]
von Kries R, Weiss S, Falkenhorst G, et al. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany. PLoS ONE 2011 Sep 7;6(9):e23955 [Full text]
Vukotich CJ Jr, Coulborn RM, Aragon TJ, et al. Findings, gaps, and future direction for research in nonpharmaceutical interventions for pandemic influenza. (Conference summary) Emerg Infect Dis 2010 Apr;16(4):e2 [Full text]
Waalen K, Kilander A, Dudmand SG, et al. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in Autumn 2009. Euro Surveill 2010 Aug 5;15(31):pii=19633 [Full text]
Waddington CS, Walker WT, Oeser C, et al. Safety and immunogenicity of Aso3B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010 May 27;340:c2649 [Full text]
Wagar LE, Rosella L, Crowcroft N, et al. Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination. PLoS ONE 2011 Nov 23;6(11):e28063 [Full text]
Wagner BG, Coburn BJ, Blower S. Calculating the potential for within-flight transmission of influenza A (H1N1). BMC Med 2009 Dec 24;7:81 [Abstract]
Wailboci LW, Lebo E, Williamson JM, et al. Viral shedding in patients infected with pandemic influenza A (H1N1) virus in Kenya, 2009. PLoS ONE 2011 Jun 10;6(6):e20320 [Full text]
Walker DW, Sloan SS, Kozlica JD. Public health worker attitudes and beliefs concerning 2009 H1N1 and seasonal influenza vaccines. Am J Infect Control 2011 (published online Aug 26) [Abstract]
Walker WT, Whalley PD, Andrews N, et al. H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study. Clin Infect Dis 2012 (published online Jan 19) [Abstract]
Wallinga J, van Bovena M, Lipsitch M. Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci 2010 Jan 12;107(2):923-8 [Abstract]
Walter D, Bohmer MM, Reiter S, et al. Risk perception and information-seeking behavior during the 2009/10 influenza A(H1N1)pdm09 pandemic in Germany. Euro Surveill 2012 Mar 29;17(13):pii=20131 [Full text]
Wang B, Dwyer DE, Blyth CC, et al. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res 2010 Jul;87(1):16-21 [Abstract]
Wang C, Cao B, Liu QQ, et al. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med 2011 Aug 16;155(4):217-25 [Abstract]
Wang M, Yuan J, Li T, et al. Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China. PLoS ONE 2011 Feb 9;6(2):e16809 [Full text]
Wang W, Anderson CM, De Feo CJ, et al. Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2. PLoS Pathog 2011 Jun 9;7(6):e1002081 [Full text]
Wang W, Castelan-Vega JA, Jimenez-Alberto A, et al. A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity. J Virol 2010 Nov 25;407(2):374-80 [Full text]
Wang W, Chen H, Li Q, et al Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia. BMC Infect Dis 2011 Apr 21;11:104 [Abstract]
Wang X, Yang P, Seale H, et al. Estimates of the true number of cases of pandemic (H1N1) 2009, Beijing, China. Emerg Infect Dis 2010 Nov;16(11):1786-8 [Full text]
Wang X, Zoueve O, Zhao J, et al. Stability and infectivity of novel pandemic influenza A (H1N1) virus in blood-derived matrices under different storage conditions. BMC Infect Dis 2011 Dec 22;11:354 [Abstract]
Ward KA, Armstrong P, McAnulty JM, et al. Outbreaks of pandemic (H1N1) 2009 and seasonal influenza A (H3N2) on cruise ship. Emerg Infect Dis 2010 Nov;16(11):1731-7 [Full text]
Ward KA, Spokes PJ, McAnulty JM. Case-control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. Emerg Infect Dis 2011 Aug;17(8):1409-16 [Full text]
Weaver EA, Rubrum AM, Ebby RJ, et al. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. PLoS ONE 2011 Mar 28;6(3):e18314 [Full text]
Weeramanthri TS, Robertson AG, Dowse GK, et al. Response to pandemic (H1N1) 2009 influenza in Australia -- lessons from a state health department perspective. J Aust Healthcare Hosp Assoc 2010 Nov;34(4):477-86 [Abstract]
Weerd WVD, Timmermans DRM, Beaujean DJMA, et al. Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in the Netherlands. BMC Public Health 2011 Jul 19;11:575 [Abstract]
Wei CJ, Boyington JC, Dai K, et al. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med 2010 Mar 24;2(24):24ra21 [Abstract]
Weil-Olivier C, Lina B. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season. Vaccine 2011 Sep 16;29(40):7075-9 [Abstract]
Weinberger DM, Simonsen L, Jordan R, et al. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis 2011 (published online Dec 7) [Abstract]
Weiss TR. Case study: pandemic "dress rehearsal" uncovered glitches for one small firm. Computerworld 2009 (published online Dec 2) [Full text]
Wheln J, Greenland K, Rondy M, et al. Case registry systems for pandemic influenza A(H1N1)pdm09 in Europe: are there lessons for the future? Euro Surveill 2012 May 10;17(19):pii=20167 [Full text]
White DB, Angus DC. Preparing for the sickest patients with 2009 influenza A(H1N1). (Editorial) JAMA 2009 Nov 4;302(17):1905-6 [Full text]
White House Office of the Press Secretary. North American leaders' declaration on H1N1. Aug 10, 2009 [Full text]
White SW, Petersen RW, Quinlivan JA. Pandemic (H1N1) 2009 influenza vaccine uptake in pregnant women entering the 2010 influenza season in Western Australia. Med J Aust 2010 Oct 4;193(7):405-7 [Full text]
WHO Director-General Dr. Margaret Chan. World now at the start of 2009 influenza pandemic. Jun 11, 2009, statement [Full text]
WHO. Antiviral use and the risk of drug resistance: pandemic (H1N1) 2009 briefing note 12. Sep 25, 2009 [Full text]
WHO. Assessing the severity of an influenza pandemic. May 11, 2009 [Full text]
WHO. Characteristics of the emergent influenza A (H1N1) viruses and recommendations for vaccine development. May 26, 2009 [Full text]
WHO. Clinical features of severe cases of pandemic influenza: pandemic (H1N1) 2009 briefing note 13. Oct 16, 2009 [Full text]
WHO. Clinical management of human infection with new influenza A (H1N1) virus: initial guidance. May 21, 2009 [Full text]
WHO. Clinical management of human infection with pandemic influenza (H1N1) 2009: revised guidance. Released Nov 11, 2009 [Full text]
WHO. Comparing deaths from pandemic and seasonal influenza. Pandemic (H1N1) 2009 briefing note 20. Dec 22, 2009 [Full text]
WHO. Director-general statement following the ninth meeting of the emergency committee. Aug 10, 2010 [Full text]
WHO. H1N1 in post-pandemic period. Aug 10, 2010 [Full text]
WHO. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. WHO Wkly Epidemiol Rec 2009 May 22;84(21):185-89 [Full text]
WHO. Interim planning considerations for mass gatherings in the context of pandemic (H1N1) 2009 influenza. Released Nov 13, 2009 [full text]
WHO. Interim WHO guidance for the surveillance of human infection with swine influenza A(H1N1) virus. Apr 27, 2009 [Full text]
WHO. Measures in school settings: pandemic (H1N1) 2009 briefing note 10. Sep 11, 2009 [Full text]
WHO. Pandemic (H1N1) 2009. [Full text]
WHO. Pandemic influenza A (H1N1) 2009 virus vaccine--conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts. Dec 4, 2009 [Full text]
WHO. Pandemic influenza in pregnant women: pandemic (H1N1) 2009 briefing note 5. Jul 31, 2009 [Full text]
WHO. Pandemic influenza vaccine manufacturing process and timeline: pandemic (H1N1) 2009 briefing note 7. Aug 6, 2009 [Full text]
WHO. Patient care checklist: new influenza A (H1N1). May 15, 2009 [Full text]
WHO. Preparing for the second wave: lessons from current outbreaks. WHO Pandemic (H1N1) 2009 briefing note 9. Aug 28, 2009 [Full text]
WHO. Recommendations of the Strategic Advisory Group of Experts (SAGE) on influenza A (H1N1) vaccines. May 19, 2009 [Full text]
WHO. Report of the review committee on the functioning of the International Health Regulations (2005) and on pandemic influenza A (H1N1) 2009. Mar 10, 2011 [Full text]
WHO. Safety of pandemic vaccines. Pandemic (H1N1) 2009 briefing note 16. Nov 19, 2009 [Full text]
WHO. Safety of pandemic vaccines: pandemic (H1N1) 2009 briefing note 6. Aug 6, 2009 [Full text]
WHO. Status of candidate vaccine virus development for the current influenza A(H1N1). May 8, 2009 [Full text]
WHO. Summary report of a high-level consultation: new influenza A (H1N1). May 20, 2009 [Full text]
WHO. Swine flu illness in the United States and Mexico--update 2. Apr 26, 2009 [Full text]
WHO. Swine influenza frequently asked questions. May 2, 2009 [Full text]
WHO. Swine influenza. Apr 29, 2009, statement by Director-General Dr Margaret Chan, explaining move from pandemic alert phase 4 to phase 5 [Full text]
WHO. The international response to the influenza pandemic: WHO responds to the critics: pandemic (H1N1) 2009 briefing note 21. Jun 10, 2010 [Full text]
WHO. Use of antiviral drugs against influenza A(H1N1). May 5, 2009 [Full text]
WHO. Vaccines for the new influenza A(H1N1). May 2, 2009 [Full text]
WHO. What is post-pandemic? (FAQ) Aug 10, 2010 [Full text]
WHO. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Aug 20, 2009 [Full text]
WHO. WHO information on tuberculosis and pandemic influenza A (H1N1). Nov 12, 2009 [Full text]
WHO. WHO recommendations for the post-pandemic period. Pandemic (H1N1) 2009 briefing note 23. Aug 10, 2010 [Full text]
Wichmann O, Stocker P, Poggensee G, et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill 2010 May 6;15(18):1 [Full text]
Widgren K, Nielsen J, Molbak K, et al. Registry-based surveillance of influenza-associated hospitalizations during the 2009 influenza pandemic in Denmark: the hidden burden on the young. PLoS ONE 2010 Nov 11;5(11):e13939 [Full text]
Wielders CCH, van Lier EA, Klooster TMV, et al. The burden of 2009 pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health 2012 Feb 1;22(1):150-7 [Abstract]
Wijnans L, de Bie S, Dieleman J, et al. Safety of pandemic H1N1 vaccines in children and adolescents. Vaccine 2011 Oct 6;29(43):7559-71 [Abstract]
Wijngaard CCVD, Asten LV, Koopmans MPG, et al. Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS ONE 2012 Feb 3;7(2):e31197 [Full text]
Wilking H, Buda S, von der Lippe E, et al. Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill 2010 15(49):pii=19741 [Full text]
Williams SE, Pahud BA, Vellozzi C, et al. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine 2011 Oct 26;29(46):8302-8 [Abstract]
Wilson K. Revisiting influenza deaths estimates--learning from the H1N1 pandemic. (Commentary) Eur J Public Health 2012 Feb 1;22(1):7-8 [Abstract]
Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. (Rapid communications) Eurosurveill 2009 Jul 2;14(26):pii=19255 [Full text]
Wise ME, Perio MD, Halpin J, et al. Transmission of pandemic (H1N1) 2009 influenza to healthcare personnel in the United States. Clin Infect Dis 2011 Jan 1;52(suppl 1):S198-204 [Full text]
Wolfe C, Greenwald I, Chen L. Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients. (Letter) Emerg Infect Dis 2010 Nov;16(11):1809-11 [Full text]
Wong LP, Sam IC. Factors influencing the uptake of 2009 H1N1 influenza vaccine in a multiethnic Asian population. Vaccine 2010 Jun 17;28(28):4499-505 [Full text]
Wong SYS, Wong ELY, Chor J, et al. Willingness to accept H1N1 pandemic influenza vaccine: a cross-sectional study of Hong Kong community nurses. BMC Infect Dis 2010 Oct 29;10(1):316 [Abstract]
Woo PCY, Tung ETK, Chan KH, et al. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis 2009 Feb 1;201(3):346-53 [Abstract]
Wood JM, Major D, Heath A, et al. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 2012 Jan 5;30(2):210-7 [Abstract]
Wrammert J, Koutsonanos D, Li GM, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011 Jan 17;208(1):181-93 [Abstract]
Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010 May 6;362(18):1708-19 [Full text]
Wu J, Li W, Wang HQ, et al. A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trail. J Infect Dis 2010 Sep 1;202(5):675-80 [Abstract]
Wu J, Zhang F, Wang M, et al. Characterization of neuraminidases from the highly pathogenic avian H5N1 and 2009 pandemic H1N1 influenza A viruses. PLoS ONE 2010 Dec 29;5(12):e15825 [Full text]
Wu J, Zhong X, Li CKF, et al. Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine 2011 Jan 29;29(5):1009-16 [Abstract]
Wu JT, Cowling BJ, Lau EHY, et al. School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis 2010 Mar;16(3):538-41 [Full text]
Wu JT, Ma ESK, Lee CK, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010 Nov 15;51(10):1184-91 [Abstract]
Wu UI, Liu mT, Wang JT, et al. Serological response to H1N1 influenza virus infections in adults treated with oseltamivir. Clin Infect Dis 2010 Nov 15;51(10):1223-5 [Abstract]
Wu UI, Wang JT, Chen YC, et al. Severity of pandemic H1N1 2009 influenza virus infection may not be directly correlated with initial viral load in upper respiratory tract. Influenza Other Respi Viruses 2011 (published online Nov 10) [Abstract]
Xi X, Xu Y, Jiang L, et al. Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality. BMC Infect Dis 2010 Aug 27;10:256 [Abstract]
Xie X, Lu SQY, Cheng JQ, et al. Estimate of 2009 H1N1 influenza cases in Shenzhen -- the biggest migratory city in China. Epidemiol Infect 2011 (published online Jul 12) [Abstract]
Xing Z, Cardona CJ. Preexisting immunity to pandemic (H1N1) 2009. (Letter) Emerg Infect Dis 2009 Nov;15(11):1847-9 [Full text]
Xu C, Song X, Fu L, et al. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus. Viral Immunol 2011 Oct 17;24(5):367-74 [Abstract]
Xu J, Huang D, Liu S, et al. Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs. Vaccine 2012 Apr 26;30(20):3119-25 [Abstract]
Xu L, Bao L, Lv Q, et al. A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J 2010 Nov 18;7:325 [Abstract]
Xu L, Bao L, Zhou J, et al. Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo. PLoS ONE 2011 Jun 15;6(6):e20698 [Full text]
Xu R, Ekiert DC, Krause JC, et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 2010 Apr 16;328(5976):357-60 [Abstract]
Xu W, Han L, Lin Z, et al. Screening of random peptide library of hemagglutinin from pandemic 2009 A(H1N1) influenza virus reveals unexpected antigenically important regions. PLoS ONE 2011 Mar 18;6(3):e18016 [Full text]
Yamada S, Hatta M, Staker BL, et al. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog 2010 Aug 5;6(8):e1001034 [Aug PLoS Pathog article]
Yamada T. Poverty, wealth, and access to pandemic influenza vaccines. (Perspective) N Engl J Med 2009 Sep 17;361(12):1129-31 [Full text]
Yan JH, Xiong Y, Yi CH, et al. Pandemic (H1N1) 2009 virus circulating in pigs, Guangxi, China. (Letter) Emerg Infect Dis 2012 Feb;18(2):357-9 [Full text]
Yanagisawa N, Kazuhiro M, Ajisawa A, et al. Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects. Vaccine 2011 Aug 5;29(34):5694-8 [Abstract]
Yang JR, Huang YP, Chang FY, et al. New variants and age shift to high fatality groups contribute to severe successive waves in the 2009 influenza pandemic in Taiwan. PLoS ONE 2011 Nov 30;6(11):e28288 [Full text]
Yang JR, Huang YP, Lin YC, et al. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan. Antiviral Res 2010 Dec;88(3):256-62 [Abstract]
Yang JR, Lin YC, Huang YP, et al. Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009. PLoS ONE 2011 Mar 31;6(3):e18177 [Full text]
Yang L, Chan KP, Cowling BJ, et al. Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong. Epidemiol Infect 2011 (published online Nov 11) [Abstract]
Yang P, Deng Y, Pang X, et al. Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect 2010 Oct;61(4):277-83 [Abstract]
Yang P, Zhang L, Shi W, et al. Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China. Influenza Other Respi Viruses 2011 (published online Dec 30) [Abstract]
Yang PH, Duan YQ, Wang C, et al. Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. Vaccine 2011 Jan 17;29(4):698-705 [Abstract]
Yang Y, Sugimoto JD, Halloran ME, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009 Oct 30;326(5953):729-33 [Abstract]
Yap J, Lee VJ, Yau TY, et al. Knowledge, attitudes and practices towards pandemic influenza among cases, close contacts, and healthcare workers in tropical Singapore: a cross-sectional survey. BMC Public Health 2010 Jul 28;10:442 [Abstract]
Yates L, Pierce M, Stephens S, et al. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess 2010 Jul; 14(34):109-82 [Abstract]
Ye J, Sorrell EM, Cai Y, et al. Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog 2010 Oct 14;6(10):e1001145 [Full text]
Yeh E, Luo RF, Dyner L, et al. Preferential lower respiratory tract infection in swine-origin 2009 A(H1N1) influenza. Clin Infect Dis 2010 Feb 1;50(3):391-4 [Abstract]
Yen CJ, Janice LK, Schechter R, et al. Infants hospitalized in intensive care units with 2009 H1N1 influenza infection, California, 2009-2010. Pediatr Infect Dis J 2012 Mar;31(3):e52-5 [Abstract]
Yen HL, Liang CH, Wu CY, et al. Hemagglutinin--neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci 2011 Aug 23;108(34):14264-9 [Abstract]
Yen TY, Lu CY, Chang LY, et al. Longitudinal seroepidemiologic study of the 2009 pandemic influenza A (H1N1) infection among health care workers in a children's hospital. BMC Infect Dis 2012 Apr 13;12:89 [Abstract]
Yeom JS, Lee JH, Bae IG, et al. 2009 H1N1 influenza infection in Korean healthcare personnel. Eur J Clin Microbiol Infect Dis 2011 Oct;30(10):1201-6 [Abstract]
Yi H, Lee JY, Hong EH, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea. Emerg Infect Dis 2010 Dec;16(12):1938-42 [Full text]
Yi S, Nonaka D, Nomoto M, et al. Predictors of the uptake of A (H1N1) influenza vaccine: findings from a population-based longitudinal study in Tokyo. PloS ONE 2011 Apr 27;6(4):e18893 [Full text]
Yildizdas D, Kendirli T, Ertug A, et al. Neurological complications of pandemic influenza (H1N1) in children. Eur J Pediatr 2011 Jun;170(6):779-88 [Abstract]
Yin JK, Chow MYK, Khandaker G, et al. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. Vaccine 2012 May 2;30(21):3209-22 [Abstract]
Yokota RTC, Skalinski LM, Igansi CN, et al. Risk factors for death from pandemic (H1N1) 2009, southern Brazil. Emerg Infect Dis 2011 Aug;17(8):1467-71 [Full text]
Yu H, Cauchemez S, Donnelly CA, et al. Transmission dynamics, border entry screening, and school holidays during the 2009 influenza A (H1N1) pandemic, China. Emerg Infect Dis 2012 May;18(5):758-66 [Full text]
Yu H, Feng Z, Uyeki TM, et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 2011 Feb 15;52(4):457-65 [Full text]
Yu H, Liao Q, Yuan Y, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010 Sep 28;341:c4779 [Full text]
Yu Y, Garg S, Yu PA, et al. Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009 - June 2010. Clin Infect Dis 2012 (published online Apr 5) [Abstract]
Yu Y, Garg S, Yu PA, et al. Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010. Clin Infect Dis 2012 (published online Apr 5) [Abstract]
Yuan Y, Tao XF, Shi YX, et al. Initial HRCT findings of novel influenza A (H1N1) infection. Influenza Other Respi Viruses 2012 (published online May 2) [Abstract]
Yung M, Slater A, Festa M, et al. Pandemic H1N1 in children requiring intensive care in Australia and New Zealand during winter 2009. Pediatrics 2011 Jan;127(1):e156-63 [Abstract]
Zarogoulidis P, Louliatsis G, Papanas N, et al. Long-term respiratory follow-up of H1N1 infection. Virol J 2011 Jun 25;8:319 [Abstract]
Zarychanski R, Stuart TL, Kumar A, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010 Feb 23;182(3):257-64 [Abstract]
Zeng H, Pappas C, Katz JM, et al. The 2009 pandemic H1N1 and triple reassortant swine H1N1 viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells. J Virol 2011 Jan;85(2):686-96 [Abstract]
Zepeda-Lopez HM, Perea-Araujo L, Miliar-Garcia A, et al. Inside the outbreak of the 2009 influenza A (H1N1)v virus in Mexico. PLoS ONE 2010 Oct 8;5(10):e13256 [Full text]
Zhang J, Zhang Z, Fan X, et al. 2009 pandemic H1N1 influenza virus replicates in human lung tissues. J Infect Dis 2010 May 15;201(10):1522-6 [Abstract]
Zhang PJ, Li XL, Cao B, et al. Clinical features and risk factors for severe and critical pregnant women with 2009 pandemic H1N1 influenza infection in China. BMC Infect Dis 2012 Feb 1;12:29 [Abstract]
Zhang Y, Lin X, Wang G, Zhou J, Lu J, et al. Neuraminidase and hemagglutinin matching patterns of a highly pathogenic avian and two pandemic H1N1 influenza A viruses. PLoS One 2010 Feb 11;5(2):e9167 [Full text]
Zhang Y, May L, Stoto MA. Evaluating syndromic surveillance systems at institutions of higher education (IHEs): a retrospective analysis of the 2009 H1N1 influenza pandemic at two universities. BMC Public Health 2011 Jul 26;11:591 [Abstract]
Zhang Y, Yang P, Liyanage S, et al. The characteristics of imported cases and the effectiveness of outbreak control strategies of pandemic influenza A (H1N1) in China. Asia Pac J Public Health 2011 (published online May 5) [Abstract]
Zhao G, Sun S, Du L, et al. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virol J 2010 Jul 12;7:151 [Abstract]
Zhou B, Li Y, Belser JA, et al. NS-based live attenuated H1N1 pandemic vaccine protect mice and ferrets. Vaccine 2010 Nov 23;28(50):8015-25 [Abstract]
Zhou H, Wang C, Yang Y, et al. Pandemic (H1N1) 2009 virus in swine herds, People's Republic of China. (Letter) Emerg Infect Dis 2011 Sep;17(9):1757-9 [Full text]
Zhou Y, Ng DMW, Seto WH, et al. Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine. PLoS ONE 2011 Nov 10;6(11):e27169 [Full text]
Zhu FC, Wang U, Fang HH, et al. A novel influenza (H1N1) vaccine in various age groups. N Engl J Med 2009 Dec 17;361(25):2414-23 [Full text]
Zhu H, Zhou B, Fan X, et al. Novel reassortment of Eurasian avian-like and pandemic/2009 influenza viruses in swine: infectious potential to humans. J Virol 2011 Oct;85(20):10432-9 [Abstract]
Zimmer SM, Burke DS. Historical perspective--emergence of influenza A (H1N1) viruses. N Engl J Med 2009 Jul 16;361(3):279-85 [Full text]
Zimmer SM, Crevar CJ, Carter DM, et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE 2010 Jul 14;5(7):e11601 [Full text]
Zimmerman O, Rogowski O, Aviram G, et al. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis 2010 Oct 4;10:288 [Abstract]
Ziyaeyan M, Alborzi A, Jamalidoust M, et al. Pandemic 2009 influenza A (H1N1) infection among 2009 Hajj pilgrims from southern Iran: a real-time RT-PCR-based study. Influenza Other Respi Viruses 2012 (published online May 14) [Abstract]
Zonis Z, Englehard D, Hindiyeh M, et al. Community-acquired oseltamivir-resistant pandemic (H1N1) 2009 in child, Israel. (Letter) Emerg Infect Dis 2010 Jun;16(6):1045-6 [Full text]
Zuccotti G, Pogliani L, Pariani E, et al. Transplacental antibody transfer following maternal immunization with pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. (Letter) JAMA 2010 Dec 1;304(21):2360-1 [Extract]
Email Alerts
